# Neurodegeneration

From Wikipedia, the free encyclopedia

Jump to navigation Jump to search

Central nervous system disease

For the medical journal, see [Experimental
Neurology](/wiki/Experimental_Neurology).

Medical condition

Neurodegeneration

![Parasagittal MRI of human head in patient with benign familial macrocephaly
prior to brain injury \(ANIMATED\).gif](//upload.wikimedia.org/wikipedia/commo
ns/5/56/Parasagittal_MRI_of_human_head_in_patient_with_benign_familial_macroce
phaly_prior_to_brain_injury_%28ANIMATED%29.gif)

Para-sagittal MRI of the head in a patient with benign familial
[macrocephaly](/wiki/Macrocephaly)

[Specialty](/wiki/Medical_specialty)

[Neurology](/wiki/Neurology), [Psychiatry](/wiki/Psychiatry)

**Neurodegeneration** is the progressive loss of structure or function of [neurons](/wiki/Neurons), which may ultimately involve [cell death](/wiki/Cell_death). Many **neurodegenerative diseases**—such as [amyotrophic lateral sclerosis](/wiki/Amyotrophic_lateral_sclerosis), [multiple sclerosis](/wiki/Multiple_sclerosis), [Parkinson's disease](/wiki/Parkinson%27s_disease), [Alzheimer's disease](/wiki/Alzheimer%27s_disease), [Huntington's disease](/wiki/Huntington%27s_disease), and [prion diseases](/wiki/Prion_diseases)—occur as a result of neurodegenerative processes. Neurodegeneration can be found in the brain at many different levels of neuronal circuitry, ranging from molecular to systemic. Because there is no known way to reverse the progressive degeneration of neurons, these diseases are considered to be incurable.[1] Biomedical research has revealed many similarities between these diseases at the [sub-cellular](/wiki/Sub-cellular) level, including atypical protein assemblies (like [proteopathy](/wiki/Proteopathy)) and induced cell death.[2][3] These similarities suggest that [therapeutic](/wiki/Therapy) advances against one neurodegenerative disease might ameliorate other diseases as well. 

## Contents

  * 1 Specific disorders
    * 1.1 Alzheimer's disease
    * 1.2 Parkinson's disease
    * 1.3 Huntington's disease
    * 1.4 Multiple sclerosis (MS)
    * 1.5 Amyotrophic lateral sclerosis (ALS)
    * 1.6 Batten disease
  * 2 Risk factor
  * 3 Mechanisms
    * 3.1 Genetics
    * 3.2 Protein misfolding
    * 3.3 Intracellular mechanisms
      * 3.3.1 Protein degradation pathways
      * 3.3.2 Membrane damage
      * 3.3.3 Mitochondrial dysfunction
      * 3.3.4 DNA damage
      * 3.3.5 Axonal transport
    * 3.4 Programmed cell death
      * 3.4.1 Apoptosis (type I)
      * 3.4.2 Autophagic (type II)
      * 3.4.3 Cytoplasmic (type III)
    * 3.5 Transglutaminase
  * 4 Management
    * 4.1 Animal models in research
    * 4.2 Other avenues of investigation
  * 5 See also
  * 6 References

## Specific
disorders[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=1)]

### Alzheimer's
disease[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=2)]

![](//upload.wikimedia.org/wikipedia/commons/thumb/c/cc/Alzheimers_brain.jpg
/220px-Alzheimers_brain.jpg)

Comparison of brain tissue between healthy individual and Alzheimer's disease
patient, demonstrating extent of neuronal death

Main article: [Alzheimer's disease](/wiki/Alzheimer%27s_disease)

Alzheimer's disease (AD) is a chronic neurodegenerative disease that results
in the loss of [neurons](/wiki/Neuron) and [synapses](/wiki/Synapse) in the
[cerebral cortex](/wiki/Cerebral_cortex) and certain subcortical structures,
resulting in gross [atrophy](/wiki/Atrophy) of the [temporal
lobe](/wiki/Temporal_lobe), [parietal lobe](/wiki/Parietal_lobe), and parts of
the [frontal cortex](/wiki/Frontal_cortex) and [cingulate
gyrus](/wiki/Cingulate_gyrus).[4] Even with billions of dollars being used to
find a treatment for Alzheimer's disease, no effective treatments have been
found.[5] However, clinical trials have developed certain compounds that could
potentially change the future of Alzheimer's disease treatments.[6] Currently,
diagnoses of Alzheimer's is subpar, and better methods need to be utilized for
various aspects of clinical diagnoses.[7] Alzheimer's has a 20% misdiagnosis
rate.[7]

AD pathology is primarily characterized by the presence of [senile
plaques](/wiki/Senile_plaques) and [neurofibrillary
tangles](/wiki/Neurofibrillary_tangle). Plaques are made up of small
[peptides](/wiki/Peptide), typically 39–43 amino acids in length, called
[beta-amyloid](/wiki/Beta-amyloid) (also written as A-beta or Aβ). Beta-
amyloid is a fragment from a larger protein called [amyloid precursor
protein](/wiki/Amyloid_precursor_protein) (APP), a [transmembrane
protein](/wiki/Transmembrane_protein) that penetrates through the neuron's
membrane. APP appears to play roles in normal neuron growth, survival and
post-injury repair.[8][9] APP is [cleaved](/wiki/Proteolysis) into smaller
fragments by [enzymes](/wiki/Enzymes) such as [gamma
secretase](/wiki/Gamma_secretase) and [beta
secretase](/wiki/Beta_secretase).[10] One of these fragments gives rise to
fibrils of beta-amyloid which can self-assemble into the dense extracellular
deposits known as senile plaques or amyloid plaques.[11][12]

### Parkinson's
disease[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=3)]

Main article: [Parkinson's disease](/wiki/Parkinson%27s_disease)

Parkinson's disease (PD) is the second most common neurodegenerative
disorder.[13] It typically manifests as [bradykinesia](/wiki/Bradykinesia),
rigidity, resting tremor and posture instability. The crude prevalence rate of
PD has been reported to range from 15 per 100,000 to 12,500 per 100,000, and
the incidence of PD from 15 per 100,000 to 328 per 100,000, with the disease
being less common in Asian countries.

PD is primarily characterized by death of [dopaminergic](/wiki/Dopaminergic)
neurons in the [substantia nigra](/wiki/Substantia_nigra), a region of the
[midbrain](/wiki/Midbrain). The cause of this selective cell death is unknown.
Notably, [alpha-synuclein](/wiki/Alpha-synuclein)-[ubiquitin](/wiki/Ubiquitin)
complexes and aggregates are observed to accumulate in [Lewy
bodies](/wiki/Lewy_bodies) within affected neurons. It is thought that defects
in protein transport machinery and regulation, such as [RAB1](/wiki/RAB1), may
play a role in this disease mechanism.[14] Impaired axonal transport of alpha-
synuclein may also lead to its accumulation in Lewy bodies. Experiments have
revealed reduced transport rates of both wild-type and two familial
Parkinson's disease-associated mutant alpha-synucleins through axons of
cultured neurons.[15] Membrane damage by alpha-synuclein could be another
Parkinson's disease mechanism.[16]

The main known risk factor is age. Mutations in genes such as α-synuclein
(SNCA), [leucine-rich repeat kinase 2](/wiki/LRRK2) (LRRK2),
[glucocerebrosidase](/wiki/Glucocerebrosidase) (GBA), and [tau
protein](/wiki/Tau_protein) (MAPT) can also cause hereditary PD or increase PD
risk.[17] While PD is the second most common neurodegenerative disorder,
problems with diagnoses still persist.[18] Problems with the sense of smell is
a widespread symptom of Parkinson’s disease (PD), however, some neurologists
question its efficacy.[18] This assessment method is a source of controversy
among medical professionals.[18] The [gut microbiome](/wiki/Gut_microbiome)
might play a role in the diagnosis of PD, and research suggests various ways
that could revolutionize the future of PD treatment.[19]

### Huntington's
disease[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=4)]

Main article: [Huntington's disease](/wiki/Huntington%27s_disease)

Huntington's disease (HD) is a rare [autosomal
dominant](/wiki/Autosomal_dominant) neurodegenerative disorder caused by
mutations in the [huntingtin gene](/wiki/Huntingtin_gene) _(HTT)_. HD is
characterized by loss of [medium spiny neurons](/wiki/Medium_spiny_neuron) and
[astrogliosis](/wiki/Astrogliosis).[20][21][22] The first brain region to be
substantially affected is the [striatum](/wiki/Striatum), followed by
degeneration of the [frontal](/wiki/Frontal_lobe) and
[temporal](/wiki/Temporal_lobe) cortices.[23] The striatum's [subthalamic
nuclei](/wiki/Subthalamic_nucleus) send control signals to the [globus
pallidus](/wiki/Globus_pallidus), which initiates and modulates motion. The
weaker signals from subthalamic nuclei thus cause reduced initiation and
modulation of movement, resulting in the characteristic movements of the
disorder, notably [chorea](/wiki/Chorea).[24] Huntington's disease presents
itself later in life even though the proteins that cause the disease works
towards manifestation from their early stages in the humans affected by the
proteins.[25] Along with being a neurodegenerative disorder, HD has links to
problems with neurodevelopment.[25]

HD is caused by [polyglutamine tract](/wiki/Polyglutamine_tract) expansion in
the huntingtin gene, resulting in the mutant huntingtin. Aggregates of mutant
huntingtin form as [inclusion bodies](/wiki/Inclusion_bodies) in neurons, and
may be directly toxic. Additionally, they may damage molecular motors and
microtubules to interfere with normal [axonal
transport](/wiki/Axonal_transport), leading to impaired transport of important
cargoes such as [BDNF](/wiki/BDNF).[15] Huntington's disease currently has no
effective treatments that would modify the disease.[26]

### Multiple sclerosis
(MS)[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=5)]

Main article: [Multiple sclerosis](/wiki/Multiple_sclerosis)

[Multiple sclerosis](/wiki/Multiple_sclerosis) is a chronic debilitating
[demyelinating disease](/wiki/Demyelinating_disease) of the central nervous
system, caused by an autoimmune attack resulting in the progressive loss of
myelin sheath on neuronal axons.[27]    The resultant decrease in the speed of
signal transduction leads to a loss of functionality that includes both
cognitive and motor impairment depending on the location of the lesion.[27]
The progression of MS occurs due to episodes of increasing inflammation, which
is proposed to be due to the release of antigens such as myelin
oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein,
causing an autoimmune response.[28] This sets off a cascade of signaling
molecules that result in T cells, B cells, and Macrophages to cross the blood-
brain barrier and attack myelin on neuronal axons leading to inflammation.[29]
Further release of antigens drives subsequent degeneration causing increased
inflammation.[30] Multiple sclerosis presents itself as a spectrum based on
the degree of inflammation, a majority of patients suffer from early relapsing
and remitting episodes of neuronal deterioration following a period of
recovery. Some of these individuals may transition to a more linear
progression of the disease, while about 15% of others begin with a progressive
course on the onset of Multiple sclerosis. The inflammatory response
contributes to the loss of the grey matter, and as a result current literature
devotes itself to combatting the auto-inflammatory aspect of the disease.[29]
While there are several proposed causal links between EBV and the _HLA-
DRB1*15:01_ allele to the onset of Multiple Sclerosis they may contribute to
the degree of autoimmune attack and the resultant inflammation, they do not
determine the onset of Multiple Sclerosis.[29]

### Amyotrophic lateral sclerosis
(ALS)[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=6)]

Main article: [Amyotrophic lateral
sclerosis](/wiki/Amyotrophic_lateral_sclerosis)

Amyotrophic lateral sclerosis (ALS or [Lou Gehrig](/wiki/Lou_Gehrig)'s
disease) is a disease in which motor neurons are selectively targeted for
degeneration. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative
disorder that negatively impacts the upper motor neurons (UMNs) and lower
motor neurons (LMNs).[31] In 1993, missense mutations in the gene encoding the
antioxidant enzyme Cu/Zn superoxide dismutase 1 ([SOD1](/wiki/SOD1)) were
discovered in a subsets of patients with familial ALS. This discovery led
researchers to focus on unlocking the mechanisms for SOD1-mediated diseases.
However, the pathogenic mechanism underlying SOD1 mutant toxicity has yet to
be resolved. More recently, [TDP-43](/wiki/TDP-43) and
[FUS](/wiki/FUS_\(gene\)) protein aggregates have been implicated in some
cases of the disease, and a mutation in chromosome 9
([C9orf72](/wiki/C9orf72)) is thought to be the most common known cause of
sporadic ALS. It is diagnosed by skeletal muscle weakness that progresses
gradually.[31] Early diagnosis of ALS is harder than with other
neurodegenerative diseases as there are no highly effective means of
determining its early onset.[31] Currently, there is research being done
regarding the diagnosis of ALS through upper motor neuron tests.[32] The Penn
Upper Motor Neuron Score (PUMNS) consists of 28 criteria with a score range of
0-32.[32] A higher score indicates a higher level of burden present on the
upper motor neurons.[32] The PUMNS has proven quite effective in determining
the burden that exists on upper motor neurons in affected patients.[32]

Independent research provided _in vitro_ evidence that the primary cellular
sites where SOD1 mutations act are located on
[astrocytes](/wiki/Astrocyte).[33][34] Astrocytes then cause the toxic effects
on the [motor neurons](/wiki/Motor_neurons). The specific mechanism of
toxicity still needs to be investigated, but the findings are significant
because they implicate cells other than neuron cells in neurodegeneration.[35]

### Batten
disease[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=7)]

Main article: [Batten disease](/wiki/Batten_disease)

Batten disease is a rare and fatal recessive neurodegenerative disorder that
begins in childhood.[36] Batten disease is the common name for a group of
[lysosomal storage disorders](/wiki/Lysosomal_storage_disorder) known as
[neuronal ceroid lipofuscinoses](/wiki/Neuronal_ceroid_lipofuscinosis) (NCLs)
– each caused by a specific gene mutation,[36] of which there are
thirteen.[37] Since Batten disease is quite rare, its worldwide prevalence is
about 1 in every 100,000 live births.[38] In North America, CLN3 disease
(juvenile NCL) typically manifests between the ages of 4 to 7.[39] Batten
disease is characterized by motor impairment, epilepsy, dementia, vision loss,
and shortened lifespan.[40] A loss of vision is common first sign of Batten
disease.[39] Loss of vision is typically preceded by cognitive and behavioral
changes, seizures, and loss of the ability to walk.[39] It is common for
people to establish cardiac arrhythmias and difficulties eating food as the
disease progresses.[39] Batten disease diagnosis depends on a conflation of
many criteria: clinical signs and symptoms, evaluations of the eye,
electroencephalograms (EEG), and brain magnetic resonance imaging (MRI)
results.[38] The diagnosis provided by these results are corroborated by
genetic and biochemical testing.[38] No effective treatments were available to
prevent the disease from being widespread before the past few years.[38] In
recent years, more models have been created to expedite the research process
for methods to treat Batten disease.[38]

## Risk
factor[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=8)]

The greatest risk factor for neurodegenerative diseases is
[aging](/wiki/Ageing). [Mitochondrial DNA mutations](/wiki/Free-
radical_theory_of_aging#Mitochondrial_theory_of_aging) as well as [oxidative
stress](/wiki/Oxidative_stress) both contribute to aging.[41] Many of these
diseases are late-onset, meaning there is some factor that changes as a person
ages for each disease.[2] One constant factor is that in each disease, neurons
gradually lose function as the disease progresses with age. It has been
proposed that [DNA damage](/wiki/DNA_damage_\(naturally_occurring\))
accumulation provides the underlying causative link between
[aging](/wiki/Ageing) and neurodegenerative disease.[42][43] About 20-40% of
healthy people between 60 and 78 years old experience discernable decrements
in cognitive performance in several domains including working, spatial, and
episodic memory, and processing speed.[44]

##
Mechanisms[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=9)]

###
Genetics[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=10)]

See also: [Trinucleotide repeat disorder](/wiki/Trinucleotide_repeat_disorder)
and [Epigenetics of neurodegenerative
diseases](/wiki/Epigenetics_of_neurodegenerative_diseases)

Many neurodegenerative diseases are caused by [genetic
mutations](/wiki/Genetic_mutation), most of which are located in completely
unrelated genes. In many of the different diseases, the mutated gene has a
common feature: a repeat of the CAG nucleotide triplet. CAG codes for the
amino acid [glutamine](/wiki/Glutamine). A repeat of CAG results in a
[polyglutamine (polyQ) tract](/wiki/Polyglutamine_tract). Diseases associated
with such mutations are known as [trinucleotide repeat
disorders](/wiki/Trinucleotide_repeat_disorder).[45][46]

Polyglutamine repeats typically cause dominant pathogenesis. Extra glutamine
residues can acquire toxic properties through a variety of ways, including
irregular protein folding and degradation pathways, altered subcellular
localization, and abnormal interactions with other cellular proteins.[45]
PolyQ studies often use a variety of animal models because there is such a
clearly defined trigger – repeat expansion. Extensive research has been done
using the [models](/wiki/Model_organism) of [nematode](/wiki/Nematode) (_C.
elegans_), and fruit fly (_Drosophila_), mice, and non-human primates.[46][47]

Nine inherited neurodegenerative diseases are caused by the expansion of the
CAG trinucleotide and polyQ tract, including [Huntington's
disease](/wiki/Huntington%27s_disease) and the [spinocerebellar
ataxias](/wiki/Spinocerebellar_ataxia).[48]

### Protein misfolding[[edit](/w/index.php?title=Neurodegeneration&action=edit
&section=11)]

See also: [Stress granule](/wiki/Stress_granule)

Several neurodegenerative diseases are classified as
[proteopathies](/wiki/Proteopathy) as they are associated with the
[aggregation](/wiki/Protein_aggregation) of [misfolded
proteins](/wiki/Protein_folding). Protein toxicity is one of the key
mechanisms of many neurodegenrative diseases.[49]

  * **[alpha-synuclein](/wiki/Alpha-synuclein):** can aggregate to form insoluble fibrils in pathological conditions characterized by [Lewy bodies](/wiki/Lewy_bodies), such as Parkinson's disease, [dementia with Lewy bodies](/wiki/Dementia_with_Lewy_bodies), and multiple system atrophy. Alpha-synuclein is the primary structural component of Lewy body fibrils. In addition, an alpha-synuclein fragment, known as the non-Abeta component (NAC), is found in amyloid plaques in [Alzheimer's disease](/wiki/Alzheimer%27s_disease).
  * **tau:** hyperphosphorylated [tau protein](/wiki/Tau_protein) is the main component of [neurofibrillary tangles](/wiki/Neurofibrillary_tangles) in Alzheimer's disease; tau fibrils are the main component of [Pick bodies](/wiki/Pick_bodies) found in [behavioral variant frontotemporal dementia](/wiki/Behavioral_variant_frontotemporal_dementia).
  * **[beta amyloid](/wiki/Beta_amyloid):** the major component of [senile plaques](/wiki/Senile_plaques) in Alzheimer's disease.
  * **[prion](/wiki/Prion):** main component of [prion diseases](/wiki/Prion_diseases) and [transmissible spongiform encephalopathy](/wiki/Transmissible_spongiform_encephalopathy).

### Intracellular mechanisms[[edit](/w/index.php?title=Neurodegeneration&actio
n=edit&section=12)]

#### Protein degradation
pathways[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=13)]

[Parkinson's](/wiki/Parkinson%27s) disease and
[Huntington's](/wiki/Huntington%27s) disease are both late-onset and
associated with the accumulation of intracellular toxic proteins. Diseases
caused by the aggregation of proteins are known as
[proteinopathies](/wiki/Proteinopathy), and they are primarily caused by
aggregates in the following structures:[2]

  * cytosol, e.g. [Parkinson's](/wiki/Parkinson%27s) & [Huntington's](/wiki/Huntington%27s)
  * nucleus, e.g. [Spinocerebellar ataxia type 1](/wiki/Spinocerebellar_ataxia_type_1) (SCA1)
  * endoplasmic reticulum (ER), (as seen with neuroserpin mutations that cause familial encephalopathy with neuroserpin inclusion bodies)
  * extracellularly excreted proteins, amyloid-β in Alzheimer's disease

There are two main avenues eukaryotic cells use to remove troublesome proteins
or organelles:

  * **ubiquitin–proteasome:** protein [ubiquitin](/wiki/Ubiquitin) along with enzymes is key for the degradation of many proteins that cause proteinopathies including polyQ expansions and alpha-synucleins. Research indicates proteasome enzymes may not be able to correctly cleave these irregular proteins, which could possibly result in a more toxic species. This is the primary route cells use to degrade proteins.[2]
    * Decreased proteasome activity is consistent with models in which intracellular protein aggregates form. It is still unknown whether or not these aggregates are a cause or a result of neurodegeneration.[2]
  * **autophagy–lysosome pathways:** a form of [programmed cell death](/wiki/Programmed_cell_death) (PCD), this becomes the favorable route when a protein is aggregate-prone meaning it is a poor proteasome substrate. This can be split into two forms of autophagy: **[macroautophagy](/wiki/Macroautophagy)** and **chaperone-mediated autophagy (CMA)**.[2]
    * **macroautophagy** is involved with nutrient recycling of macromolecules under conditions of starvation, certain apoptotic pathways, and if absent, leads to the formation of ubiquinated inclusions. Experiments in mice with neuronally confined macroautophagy-gene knockouts develop intraneuronal aggregates leading to neurodegeneration.[2]
    * **chaperone-mediated autophagy** defects may also lead to neurodegeneration. Research has shown that mutant proteins bind to the CMA-pathway receptors on lysosomal membrane and in doing so block their own degradation as well as the degradation of other substrates.[2]

#### Membrane
damage[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=14)]

Damage to the membranes of organelles by monomeric or oligomeric proteins
could also contribute to these diseases. Alpha-synuclein can damage membranes
by inducing membrane curvature,[16] and cause extensive tubulation and
vesiculation when incubated with artificial phospholipid vesicles.[16] [The
tubes formed from these lipid vesicles consist of both micellar as well as
bilayer tubes. Extensive induction of membrane curvature is deleterious to the
cell and would eventually lead to cell
death.](http://www.jbc.org/content/287/35/29301.long)[Apart from tubular
structures, alpha-synuclein can also form lipoprotein nanoparticles similar to
apolipoproteins.](http://www.jbc.org/content/288/24/17620.long)

#### Mitochondrial dysfunction[[edit](/w/index.php?title=Neurodegeneration&act
ion=edit&section=15)]

The most common form of cell death in neurodegeneration is through the
intrinsic mitochondrial apoptotic pathway. This pathway controls the
activation of caspase-9 by regulating the release of [cytochrome
c](/wiki/Cytochrome_c) from the [mitochondrial intermembrane
space](/wiki/Mitochondrion#Intermembrane_space). [Reactive oxygen
species](/wiki/Reactive_oxygen_species) (ROS) are normal byproducts of
mitochondrial respiratory chain activity. ROS concentration is mediated by
mitochondrial antioxidants such as manganese superoxide dismutase (SOD2) and
[glutathione peroxidase](/wiki/Glutathione_peroxidase). Over production of ROS
([oxidative stress](/wiki/Oxidative_stress)) is a central feature of all
neurodegenerative disorders. In addition to the generation of ROS,
mitochondria are also involved with life-sustaining functions including
calcium homeostasis, PCD, [mitochondrial fission](/wiki/Mitochondrial_fission)
and [fusion](/wiki/Mitochondrial_fusion), lipid concentration of the
mitochondrial membranes, and the mitochondrial permeability transition.
[Mitochondrial disease](/wiki/Mitochondrial_disease) leading to
neurodegeneration is likely, at least on some level, to involve all of these
functions.[50]

There is strong evidence that mitochondrial dysfunction and oxidative stress
play a causal role in neurodegenerative disease pathogenesis, including in
four of the more well known diseases [Alzheimer's](/wiki/Alzheimer%27s),
[Parkinson's](/wiki/Parkinson%27s), [Huntington's](/wiki/Huntington%27s), and
[Amyotrophic lateral sclerosis](/wiki/Amyotrophic_lateral_sclerosis).[41]

[Neurons](/wiki/Neuron) are particularly vulnerable to [oxidative
damage](/wiki/Oxidative_stress) due to their strong metabolic activity
associated with high [transcription](/wiki/Transcription_\(biology\)) levels,
high oxygen consumption, and weak [antioxidant](/wiki/Antioxidant)
defense.[51][52]

#### DNA
damage[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=16)]

The brain metabolizes as much as a fifth of consumed oxygen, and [reactive
oxygen species](/wiki/Reactive_oxygen_species) produced by oxidative
metabolism are a major source of [DNA
damage](/wiki/DNA_damage_\(naturally_occurring\)) in the [brain](/wiki/Brain).
Damage to a cell’s [DNA](/wiki/DNA) is particularly harmful because DNA is the
blueprint for protein production and unlike other molecules it cannot simply
be replaced by re-synthesis. The vulnerability of post-mitotic neurons to DNA
damage (such as oxidative lesions or certain types of DNA strand breaks),
coupled with a gradual decline in the activities of [repair
mechanisms](/wiki/DNA_repair), could lead to accumulation of DNA damage with
age and contribute to brain aging and neurodegeneration.[53] DNA single-strand
breaks are common and are associated with the neurodegenerative disease
ataxia-[oculomotor apraxia](/wiki/Oculomotor_apraxia).[54][52] Increased
oxidative DNA damage in the brain is associated with [Alzheimer’s
disease](/wiki/Biochemistry_of_Alzheimer%27s_disease) and [Parkinson’s
disease](/wiki/Pathophysiology_of_Parkinson%27s_disease).[54] Defective DNA
repair has been linked to neurodegenerative disorders such as [Alzheimer’s
disease](/wiki/Biochemistry_of_Alzheimer%27s_disease), [amyotrophic lateral
sclerosis](/wiki/Genetics_of_amyotrophic_lateral_sclerosis), [ataxia
telangiectasia](/wiki/Ataxia_telangiectasia), [Cockayne
syndrome](/wiki/Cockayne_syndrome), [Parkinson’s
disease](/wiki/Pathophysiology_of_Parkinson%27s_disease) and [xeroderma
pigmentosum](/wiki/Xeroderma_pigmentosum).[54][53]

#### Axonal
transport[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=17)]

Main article: [Axonal transport](/wiki/Axonal_transport)

Axonal swelling, and [axonal spheroids](/wiki/Axonal_spheroid) have been
observed in many different neurodegenerative diseases. This suggests that
defective axons are not only present in diseased neurons, but also that they
may cause certain pathological insult due to accumulation of organelles.
[Axonal transport](/wiki/Axonal_transport) can be disrupted by a variety of
mechanisms including damage to: [kinesin](/wiki/Kinesin) and [cytoplasmic
dynein](/wiki/Cytoplasmic_dynein), [microtubules](/wiki/Microtubules),
cargoes, and [mitochondria](/wiki/Mitochondria).[15] When axonal transport is
severely disrupted a degenerative pathway known as [Wallerian-like
degeneration](/wiki/Wallerian_degeneration) is often triggered.[55]

### Programmed cell
death[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=18)]

[Programmed cell death](/wiki/Programmed_cell_death) (**PCD**) is death of a
[cell](/wiki/Cell_\(biology\)) in any form, mediated by an intracellular
program.[56] This process can be activated in neurodegenerative diseases
including Parkinson's disease, amytrophic lateral sclerosis, Alzheimer's
disease and Huntington's disease.[57] PCD observed in neurodegenerative
diseases may be directly pathogenic; alternatively, PCD may occur in response
to other injury or disease processes.[3]

#### Apoptosis (type
I)[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=19)]

[Apoptosis](/wiki/Apoptosis) is a form of programmed cell death in
multicellular organisms. It is one of the main types of [programmed cell
death](/wiki/Programmed_cell_death) (PCD) and involves a series of biochemical
events leading to a characteristic cell morphology and death.

  * **Extrinsic apoptotic pathways:** Occur when factors outside the cell activate cell surface death receptors (e.g., Fas) that result in the activation of [caspases](/wiki/Caspases)-8 or -10.[3]
  * **Intrinsic apoptotic pathways:** Result from mitochondrial release of [cytochrome c](/wiki/Cytochrome_c) or endoplasmic reticulum malfunctions, each leading to the activation of caspase-9. The [nucleus](/wiki/Cell_nucleus) and [Golgi apparatus](/wiki/Golgi_apparatus) are other organelles that have damage sensors, which can lead the cells down apoptotic pathways.[3][58]

[Caspases](/wiki/Caspases) (cysteine-aspartic acid proteases) cleave at very
specific [amino acid](/wiki/Amino_acid) residues. There are two types of
caspases: **initiators** and **effectors**. Initiator caspases cleave inactive
forms of effector caspases. This activates the effectors that in turn cleave
other proteins resulting in apoptotic initiation.[3]

#### Autophagic (type
II)[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=20)]

Autophagy is a form of intracellular [phagocytosis](/wiki/Phagocytosis) in
which a cell actively consumes damaged organelles or misfolded proteins by
encapsulating them into an [autophagosome](/wiki/Autophagosome), which fuses
with a lysosome to destroy the contents of the autophagosome. Because many
neurodegenerative diseases show unusual protein aggregates, it is hypothesized
that defects in autophagy could be a common mechanism of neurodegeneration.[3]

#### Cytoplasmic (type
III)[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=21)]

PCD can also occur via non-apoptotic processes, also known as Type III or
cytoplasmic cell death. For example, type III PCD might be caused by
trophotoxicity, or hyperactivation of trophic factor receptors. Cytotoxins
that induce PCD can cause [necrosis](/wiki/Necrosis) at low concentrations, or
aponecrosis (combination of apoptosis and necrosis) at higher concentrations.
It is still unclear exactly what combination of apoptosis, non-apoptosis, and
necrosis causes different kinds of aponecrosis.[3]

### Transglutaminase[[edit](/w/index.php?title=Neurodegeneration&action=edit&s
ection=22)]

[Transglutaminases](/wiki/Transglutaminase) are human [enzymes](/wiki/Enzymes)
[ubiquitously](/wiki/Ubiquitously) present in the human body and in the brain
in particular.[59]

The main function of [transglutaminases](/wiki/Transglutaminases) is
[bind](/wiki/Molecular_binding) proteins and peptides intra- and
intermolecularly, by a type of [covalent bonds](/wiki/Covalent_bonds) termed
[isopeptide bonds](/wiki/Isopeptide_bond), in a reaction termed
[transamidation](/wiki/Isopeptide_bond) or
[crosslinking](/wiki/Isopeptide_bond).[59]

[Transglutaminase](/wiki/Transglutaminase) [binding](/wiki/Chemical_bond) of
these proteins and peptides make them clump together. The resulting structures
are turned extremely resistant to chemical and mechanical disruption.[59]

Most relevant human neurodegenerative diseases share the property of having
[abnormal structures made up of proteins and
peptides](/wiki/Protein_aggregation).[59]

Each of these neurodegenerative diseases have one (or several) specific main
protein or peptide. In [Alzheimer's disease](/wiki/Alzheimer%27s_disease),
these are [amyloid-beta](/wiki/Amyloid-beta) and [tau](/wiki/Tau). In
[Parkinson’s](/wiki/Parkinson%E2%80%99s) disease, it is [alpha-
synuclein](/wiki/Alpha-synuclein). In
[Huntington’s](/wiki/Huntington%E2%80%99s) disease, it is
[huntingtin](/wiki/Huntingtin).[59]

**[Transglutaminase](/wiki/Transglutaminase) [substrates](/wiki/Substrate_\(chemistry\)):** [Amyloid-beta](/wiki/Amyloid-beta), [tau](/wiki/Tau), [alpha-synuclein](/wiki/Alpha-synuclein) and [huntingtin](/wiki/Huntingtin) have been proved to be [substrates](/wiki/Substrate_\(chemistry\)) of [transglutaminases](/wiki/Transglutaminases) in vitro or in vivo, that is, they can be [bonded](/wiki/Chemical_bond) by trasglutaminases by [covalent bonds](/wiki/Covalent_bonds) to each other and potentially to any other transglutaminase substrate in the brain.[59]

**[Transglutaminase](/wiki/Transglutaminase) augmented expression:** It has been proved that in these neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease) the [expression](/wiki/Gene_expression) of the [transglutaminase](/wiki/Transglutaminase) [enzyme](/wiki/Enzyme) is increased.[59]

**Presence of [isopeptide bonds](/wiki/Isopeptide_bond) in these structures:** The presence of [isopeptide bonds](/wiki/Isopeptide_bond) (the result of the [transglutaminase](/wiki/Transglutaminase) reaction) have been detected in the [abnormal structures that are characteristic of these neurodegenerative diseases](/wiki/Protein_aggregation).[59]

**Co-localization:** Co-localization of transglutaminase mediated [isopeptide bonds](/wiki/Isopeptide_bond) with these [abnormal structures](/wiki/Protein_aggregation) has been detected in the autopsy of brains of patients with these diseases.[59]

## Management[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=
23)]

The process of neurodegeneration is not well understood, so the diseases that
stem from it have, as yet, no cures.

### Animal models in
research[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=24)]

In the search for effective treatments (as opposed to [palliative
care](/wiki/Palliative_care)), investigators employ [animal
models](/wiki/Animal_model) of disease to test potential therapeutic agents.
Model organisms provide an inexpensive and relatively quick means to perform
two main functions: target identification and target validation. Together,
these help show the value of any specific therapeutic strategies and drugs
when attempting to ameliorate disease severity. An example is the drug
[Dimebon](/wiki/Dimebon) by Medivation, Inc. In 2009 this drug was in phase
III clinical trials for use in Alzheimer's disease, and also phase II clinical
trials for use in Huntington's disease.[46] In March 2010, the results of a
clinical trial phase III were released; the investigational Alzheimer's
disease drug Dimebon failed in the pivotal CONNECTION trial of patients with
mild-to-moderate disease.[60] With CONCERT, the remaining Pfizer and
Medivation Phase III trial for Dimebon (latrepirdine) in Alzheimer's disease
failed in 2012, effectively ending the development in this indication.[61]

In another experiment using a rat model of Alzheimer's disease, it was
demonstrated that systemic administration of [hypothalamic proline-rich
peptide (PRP)-1](https://www.ncbi.nlm.nih.gov/pubmed/18790460) offers
neuroprotective effects and can prevent neurodegeneration in hippocampus
[amyloid-beta](/wiki/Amyloid-beta) 25–35. This suggests that there could be
therapeutic value to PRP-1.[62]

### Other avenues of investigation[[edit](/w/index.php?title=Neurodegeneration
&action=edit&section=25)]

Protein degradation offers therapeutic options both in preventing the
synthesis and degradation of irregular proteins. There is also interest in
upregulating autophagy to help clear protein aggregates implicated in
neurodegeneration. Both of these options involve very complex pathways that we
are only beginning to understand.[2]

The goal of [immunotherapy](/wiki/Immunotherapy) is to enhance aspects of the
immune system. Both active and passive vaccinations have been proposed for
Alzheimer's disease and other conditions; however, more research must be done
to prove safety and efficacy in humans.[63]

A current therapeutic target for the treatment of Alzheimer's disease is the
protease β-secretase[64][_[non-primary source needed](/wiki/Wikipedia:No_origi
nal_research#Primary,_secondary_and_tertiary_sources)_], which is involved in
the amyloidogenic processing pathway that leads to the pathological
accumulation of proteins in the brain. When the gene that encodes for amyloid
precursor protein (APP) is spliced by α-secretase[65][_[non-primary source nee
ded](/wiki/Wikipedia:No_original_research#Primary,_secondary_and_tertiary_sour
ces)_] rather than β-secretase, the toxic protein β amyloid is not produced.
Targeted inhibition[66] of β-secretase can potentially prevent the neuronal
death that is responsible for the symptoms of Alzheimer's disease.

## See
also[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=26)]

  * [Amyloids](/wiki/Amyloids)
  * [Dementia](/wiki/Dementia)
  * [JUNQ and IPOD](/wiki/JUNQ_and_IPOD)
  * [Nervous system](/wiki/Nervous_system)
  * [Prevention of dementia](/wiki/Prevention_of_dementia)
  * [Proteopathy](/wiki/Proteopathy)
  * [Trinucleotide repeat disorders](/wiki/Trinucleotide_repeat_disorder)

## References[[edit](/w/index.php?title=Neurodegeneration&action=edit&section=
27)]

  1. **^** ["What is Neurodegenerative Disease?"](http://www.neurodegenerationresearch.eu/about/what/). _JPND Research_. JPND Research. 17 July 2014. Retrieved February 7, 2015.
  2. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ Rubinsztein DC (October 2006). "The roles of intracellular protein-degradation pathways in neurodegeneration". _Nature_. **443** (7113): 780–6. [Bibcode](/wiki/Bibcode_\(identifier\)):[2006Natur.443..780R](https://ui.adsabs.harvard.edu/abs/2006Natur.443..780R). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature05291](https://doi.org/10.1038%2Fnature05291). [PMID](/wiki/PMID_\(identifier\)) [17051204](//pubmed.ncbi.nlm.nih.gov/17051204). [S2CID](/wiki/S2CID_\(identifier\)) [4411895](https://api.semanticscholar.org/CorpusID:4411895).
  3. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ Bredesen DE, Rao RV, Mehlen P (October 2006). ["Cell death in the nervous system"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3970704). _Nature_. **443** (7113): 796–802. [Bibcode](/wiki/Bibcode_\(identifier\)):[2006Natur.443..796B](https://ui.adsabs.harvard.edu/abs/2006Natur.443..796B). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature05293](https://doi.org/10.1038%2Fnature05293). [PMC](/wiki/PMC_\(identifier\)) [3970704](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3970704). [PMID](/wiki/PMID_\(identifier\)) [17051206](//pubmed.ncbi.nlm.nih.gov/17051206).
  4. **^** Wenk GL (2003). "Neuropathologic changes in Alzheimer's disease". _The Journal of Clinical Psychiatry_. 64 Suppl 9: 7–10. [PMID](/wiki/PMID_\(identifier\)) [12934968](//pubmed.ncbi.nlm.nih.gov/12934968).
  5. **^** Lock MM (27 October 2013). _[The Alzheimer conundrum : entanglements of dementia and aging_](https://www.worldcat.org/oclc/859536969). Princeton. [ISBN](/wiki/ISBN_\(identifier\)) [978-1-4008-4846-1](/wiki/Special:BookSources/978-1-4008-4846-1). [OCLC](/wiki/OCLC_\(identifier\)) [859536969](//www.worldcat.org/oclc/859536969).
  6. **^** Delrieu J, Ousset PJ, Caillaud C, Vellas B (January 2012). ["'Clinical trials in Alzheimer's disease': immunotherapy approaches"](https://doi.org/10.1111%2Fj.1471-4159.2011.07458.x). _Journal of Neurochemistry_. 120 Suppl 1: 186–93. [doi](/wiki/Doi_\(identifier\)):[10.1111/j.1471-4159.2011.07458.x](https://doi.org/10.1111%2Fj.1471-4159.2011.07458.x). [PMID](/wiki/PMID_\(identifier\)) [21883222](//pubmed.ncbi.nlm.nih.gov/21883222).
  7. ^ _**a**_ _**b**_ Archer MC, Hall PH, Morgan JC (2017). "[P2–430]: Accuracy of Clinical Diagnosis of Alzheimer's Disease in Alzheimer's Disease Centers (ADCS)". _Alzheimer's & Dementia_. **13** (7S_Part_16): P800–P801. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.jalz.2017.06.1086](https://doi.org/10.1016%2Fj.jalz.2017.06.1086). [S2CID](/wiki/S2CID_\(identifier\)) [54359937](https://api.semanticscholar.org/CorpusID:54359937).
  8. **^** Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (July 2006). ["Synapse formation and function is modulated by the amyloid precursor protein"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6673945). _The Journal of Neuroscience_. **26** (27): 7212–21. [doi](/wiki/Doi_\(identifier\)):[10.1523/JNEUROSCI.1450-06.2006](https://doi.org/10.1523%2FJNEUROSCI.1450-06.2006). [PMC](/wiki/PMC_\(identifier\)) [6673945](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6673945). [PMID](/wiki/PMID_\(identifier\)) [16822978](//pubmed.ncbi.nlm.nih.gov/16822978).
  9. **^** Turner PR, O'Connor K, Tate WP, Abraham WC (May 2003). "Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory". _Progress in Neurobiology_. **70** (1): 1–32. [doi](/wiki/Doi_\(identifier\)):[10.1016/S0301-0082(03)00089-3](https://doi.org/10.1016%2FS0301-0082%2803%2900089-3). [PMID](/wiki/PMID_\(identifier\)) [12927332](//pubmed.ncbi.nlm.nih.gov/12927332). [S2CID](/wiki/S2CID_\(identifier\)) [25376584](https://api.semanticscholar.org/CorpusID:25376584).
  10. **^** Hooper NM (April 2005). "Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein". _Biochemical Society Transactions_. **33** (Pt 2): 335–8. [doi](/wiki/Doi_\(identifier\)):[10.1042/BST0330335](https://doi.org/10.1042%2FBST0330335). [PMID](/wiki/PMID_\(identifier\)) [15787600](//pubmed.ncbi.nlm.nih.gov/15787600).
  11. **^** Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (June 2004). "The importance of neuritic plaques and tangles to the development and evolution of AD". _Neurology_. **62** (11): 1984–9. [doi](/wiki/Doi_\(identifier\)):[10.1212/01.WNL.0000129697.01779.0A](https://doi.org/10.1212%2F01.WNL.0000129697.01779.0A). [PMID](/wiki/PMID_\(identifier\)) [15184601](//pubmed.ncbi.nlm.nih.gov/15184601). [S2CID](/wiki/S2CID_\(identifier\)) [25017332](https://api.semanticscholar.org/CorpusID:25017332).
  12. **^** Ohnishi S, Takano K (March 2004). "Amyloid fibrils from the viewpoint of protein folding". _Cellular and Molecular Life Sciences_. **61** (5): 511–524. [doi](/wiki/Doi_\(identifier\)):[10.1007/s00018-003-3264-8](https://doi.org/10.1007%2Fs00018-003-3264-8). [PMID](/wiki/PMID_\(identifier\)) [15004691](//pubmed.ncbi.nlm.nih.gov/15004691). [S2CID](/wiki/S2CID_\(identifier\)) [25739126](https://api.semanticscholar.org/CorpusID:25739126).
  13. **^** Elbaz A, Carcaillon L, Kab S, Moisan F (January 2016). "Epidemiology of Parkinson's disease". _Revue Neurologique_. **172** (1): 14–26. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.neurol.2015.09.012](https://doi.org/10.1016%2Fj.neurol.2015.09.012). [PMID](/wiki/PMID_\(identifier\)) [26718594](//pubmed.ncbi.nlm.nih.gov/26718594).
  14. **^** "Parkinson's Disease Mechanism Discovered," [HHMI Research News](http://www.hhmi.org/news/lindquist20060622.html) June 22, 2006.
  15. ^ _**a**_ _**b**_ _**c**_ De Vos KJ, Grierson AJ, Ackerley S, Miller CC (2008). "Role of axonal transport in neurodegenerative diseases". _Annual Review of Neuroscience_. **31**: 151–73. [doi](/wiki/Doi_\(identifier\)):[10.1146/annurev.neuro.31.061307.090711](https://doi.org/10.1146%2Fannurev.neuro.31.061307.090711). [PMID](/wiki/PMID_\(identifier\)) [18558852](//pubmed.ncbi.nlm.nih.gov/18558852).
  16. ^ _**a**_ _**b**_ _**c**_ Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, Jao CC, et al. (October 2010). ["Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2952250). _The Journal of Biological Chemistry_. **285** (42): 32486–93. [doi](/wiki/Doi_\(identifier\)):[10.1074/jbc.M110.139576](https://doi.org/10.1074%2Fjbc.M110.139576). [PMC](/wiki/PMC_\(identifier\)) [2952250](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2952250). [PMID](/wiki/PMID_\(identifier\)) [20693280](//pubmed.ncbi.nlm.nih.gov/20693280).
  17. **^** Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C (January 2016). ["Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4688052). _Neurobiology of Aging_. **37**: 209.e1–209.e7. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.neurobiolaging.2015.09.014](https://doi.org/10.1016%2Fj.neurobiolaging.2015.09.014). [PMC](/wiki/PMC_\(identifier\)) [4688052](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4688052). [PMID](/wiki/PMID_\(identifier\)) [26601739](//pubmed.ncbi.nlm.nih.gov/26601739).
  18. ^ _**a**_ _**b**_ _**c**_ Schmidt, Nele; Paschen, Laura; Witt, Karsten (2020-11-16). Mirabella, Giovanni (ed.). ["Invalid Self-Assessment of Olfactory Functioning in Parkinson's Disease Patients May Mislead the Neurologist"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7683170). _Parkinson's Disease_. **2020**: 1–5. [doi](/wiki/Doi_\(identifier\)):[10.1155/2020/7548394](https://doi.org/10.1155%2F2020%2F7548394). [ISSN](/wiki/ISSN_\(identifier\)) [2042-0080](//www.worldcat.org/issn/2042-0080). [PMC](/wiki/PMC_\(identifier\)) [7683170](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7683170). [PMID](/wiki/PMID_\(identifier\)) [33274040](//pubmed.ncbi.nlm.nih.gov/33274040).
  19. **^** Hill-Burns, Erin M.; Debelius, Justine W.; Morton, James T.; Wissemann, William T.; Lewis, Matthew R.; Wallen, Zachary D.; Peddada, Shyamal D.; Factor, Stewart A.; Molho, Eric; Zabetian, Cyrus P.; Knight, Rob (May 2017). ["Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome: PD, Medications, and Gut Microbiome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5469442). _Movement Disorders_. **32** (5): 739–749. [doi](/wiki/Doi_\(identifier\)):[10.1002/mds.26942](https://doi.org/10.1002%2Fmds.26942). [PMC](/wiki/PMC_\(identifier\)) [5469442](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5469442). [PMID](/wiki/PMID_\(identifier\)) [28195358](//pubmed.ncbi.nlm.nih.gov/28195358).
  20. **^** Purves D, Augustine GA, Fitzpatrick D, Hall W, LaMantia AS, McNamara JO, Williams SM (2001). ["Modulation of Movement by the Basal Ganglia - Circuits within the Basal Ganglia System"](https://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=Huntington's%20disease&rid=neurosci.section.1251). In Dale Purves (ed.). _[Neuroscience_](https://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=neurosci.TOC&depth=2) (2nd ed.). Sunderland, MA: Sinauer Associates. [ISBN](/wiki/ISBN_\(identifier\)) [978-0-87893-742-4](/wiki/Special:BookSources/978-0-87893-742-4).
  21. **^** Estrada Sánchez AM, Mejía-Toiber J, Massieu L (April 2008). "Excitotoxic neuronal death and the pathogenesis of Huntington's disease". _Archives of Medical Research_. **39** (3): 265–76. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.arcmed.2007.11.011](https://doi.org/10.1016%2Fj.arcmed.2007.11.011). [PMID](/wiki/PMID_\(identifier\)) [18279698](//pubmed.ncbi.nlm.nih.gov/18279698).
  22. **^** Lobsiger CS, Cleveland DW (November 2007). ["Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3110080). _Nature Neuroscience_. **10** (11): 1355–60. [doi](/wiki/Doi_\(identifier\)):[10.1038/nn1988](https://doi.org/10.1038%2Fnn1988). [PMC](/wiki/PMC_\(identifier\)) [3110080](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3110080). [PMID](/wiki/PMID_\(identifier\)) [17965655](//pubmed.ncbi.nlm.nih.gov/17965655).
  23. **^** Purves D, Augustine GA, Fitzpatrick D, Hall W, LaMantia AS, McNamara JO, Williams SM (2001). ["Modulation of Movement by the Basal Ganglia - Box A. Huntington's Disease"](https://www.ncbi.nlm.nih.gov/books/bv.fcgi?highlight=Huntington's%20disease&rid=neurosci.box.1240). In Dale Purves (ed.). _[Neuroscience_](https://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=neurosci.TOC&depth=2) (2nd ed.). Sunderland, MA: Sinauer Associates. [ISBN](/wiki/ISBN_\(identifier\)) [978-0-87893-742-4](/wiki/Special:BookSources/978-0-87893-742-4).
  24. **^** Crossman AR (May 2000). ["Functional anatomy of movement disorders"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1468094). _Journal of Anatomy_. 196 ( Pt 4) (4): 519–25. [doi](/wiki/Doi_\(identifier\)):[10.1046/j.1469-7580.2000.19640519.x](https://doi.org/10.1046%2Fj.1469-7580.2000.19640519.x). [PMC](/wiki/PMC_\(identifier\)) [1468094](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1468094). [PMID](/wiki/PMID_\(identifier\)) [10923984](//pubmed.ncbi.nlm.nih.gov/10923984).
  25. ^ _**a**_ _**b**_ Barnat, Monia; Capizzi, Mariacristina; Aparicio, Esther; Boluda, Susana; Wennagel, Doris; Kacher, Radhia; Kassem, Rayane; Lenoir, Sophie; Agasse, Fabienne; Braz, Barbara Y.; Liu, Jeh-Ping (2020-08-14). ["Huntington's disease alters human neurodevelopment"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7859879). _Science_. **369** (6505): 787–793. [Bibcode](/wiki/Bibcode_\(identifier\)):[2020Sci...369..787B](https://ui.adsabs.harvard.edu/abs/2020Sci...369..787B). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.aax3338](https://doi.org/10.1126%2Fscience.aax3338). [ISSN](/wiki/ISSN_\(identifier\)) [0036-8075](//www.worldcat.org/issn/0036-8075). [PMC](/wiki/PMC_\(identifier\)) [7859879](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7859879). [PMID](/wiki/PMID_\(identifier\)) [32675289](//pubmed.ncbi.nlm.nih.gov/32675289).
  26. **^** Labbadia J, Morimoto RI (August 2013). ["Huntington's disease: underlying molecular mechanisms and emerging concepts"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3955166). _Trends in Biochemical Sciences_. **38** (8): 378–85. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.tibs.2013.05.003](https://doi.org/10.1016%2Fj.tibs.2013.05.003). [PMC](/wiki/PMC_\(identifier\)) [3955166](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3955166). [PMID](/wiki/PMID_\(identifier\)) [23768628](//pubmed.ncbi.nlm.nih.gov/23768628).
  27. ^ _**a**_ _**b**_ ["Multiple Sclerosis: Hope Through Research | National Institute of Neurological Disorders and Stroke"](https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Multiple-Sclerosis-Hope-Through-Research). _www.ninds.nih.gov_. Retrieved 2020-11-30.
  28. **^** Kaufman, David Myland; Milstein, Mark J. (2013-01-01), Kaufman, David Myland; Milstein, Mark J. (eds.), ["Chapter 15 - Multiple Sclerosis"](http://www.sciencedirect.com/science/article/pii/B9780723437482000153), _Kaufman's Clinical Neurology for Psychiatrists (Seventh Edition)_, Philadelphia: W.B. Saunders, pp. 329–349, [ISBN](/wiki/ISBN_\(identifier\)) [978-0-7234-3748-2](/wiki/Special:BookSources/978-0-7234-3748-2), retrieved 2020-12-07
  29. ^ _**a**_ _**b**_ _**c**_ Stys, Peter K.; Tsutsui, Shigeki (2019-12-13). ["Recent advances in understanding multiple sclerosis"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6915812). _F1000Research_. **8**: 2100. [doi](/wiki/Doi_\(identifier\)):[10.12688/f1000research.20906.1](https://doi.org/10.12688%2Ff1000research.20906.1). [ISSN](/wiki/ISSN_\(identifier\)) [2046-1402](//www.worldcat.org/issn/2046-1402). [PMC](/wiki/PMC_\(identifier\)) [6915812](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6915812). [PMID](/wiki/PMID_\(identifier\)) [31885862](//pubmed.ncbi.nlm.nih.gov/31885862).
  30. **^** Teunissen, Charlotte (2008-07-08). ["Faculty Opinions recommendation of Remyelination protects axons from demyelination-associated axon degeneration"](https://dx.doi.org/10.3410/f.1115522.571562). _Brain: A Journal of Neurology_. **131** (Pt 6). [doi](/wiki/Doi_\(identifier\)):[10.3410/f.1115522.571562](https://doi.org/10.3410%2Ff.1115522.571562). Retrieved 2020-12-07.
  31. ^ _**a**_ _**b**_ _**c**_ Min YG, Choi SJ, Hong YH, Kim SM, Shin JY, Sung JJ (September 2020). ["Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the 'split-leg' sign"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7518279). _Scientific Reports_. **10** (1): 15661. [Bibcode](/wiki/Bibcode_\(identifier\)):[2020NatSR..1015661M](https://ui.adsabs.harvard.edu/abs/2020NatSR..1015661M). [doi](/wiki/Doi_\(identifier\)):[10.1038/s41598-020-72887-7](https://doi.org/10.1038%2Fs41598-020-72887-7). [PMC](/wiki/PMC_\(identifier\)) [7518279](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7518279). [PMID](/wiki/PMID_\(identifier\)) [32973334](//pubmed.ncbi.nlm.nih.gov/32973334).
  32. ^ _**a**_ _**b**_ _**c**_ _**d**_ Quinn C, Edmundson C, Dahodwala N, Elman L (April 2020). "Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis". _Muscle & Nerve_. **61** (4): 508–511. [doi](/wiki/Doi_\(identifier\)):[10.1002/mus.26764](https://doi.org/10.1002%2Fmus.26764). [PMID](/wiki/PMID_\(identifier\)) [31743477](//pubmed.ncbi.nlm.nih.gov/31743477). [S2CID](/wiki/S2CID_\(identifier\)) [208186566](https://api.semanticscholar.org/CorpusID:208186566).
  33. **^** Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S (May 2007). ["Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3799799). _Nature Neuroscience_. **10** (5): 615–22. [doi](/wiki/Doi_\(identifier\)):[10.1038/nn1876](https://doi.org/10.1038%2Fnn1876). [PMC](/wiki/PMC_\(identifier\)) [3799799](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3799799). [PMID](/wiki/PMID_\(identifier\)) [17435755](//pubmed.ncbi.nlm.nih.gov/17435755).
  34. **^** Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K (May 2007). ["Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3139463). _Nature Neuroscience_. **10** (5): 608–14. [doi](/wiki/Doi_\(identifier\)):[10.1038/nn1885](https://doi.org/10.1038%2Fnn1885). [PMC](/wiki/PMC_\(identifier\)) [3139463](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3139463). [PMID](/wiki/PMID_\(identifier\)) [17435754](//pubmed.ncbi.nlm.nih.gov/17435754).
  35. **^** Julien JP (May 2007). ["ALS: astrocytes move in as deadly neighbors"](https://doi.org/10.1038%2Fnn0507-535). _Nature Neuroscience_. **10** (5): 535–7. [doi](/wiki/Doi_\(identifier\)):[10.1038/nn0507-535](https://doi.org/10.1038%2Fnn0507-535). [PMID](/wiki/PMID_\(identifier\)) [17453052](//pubmed.ncbi.nlm.nih.gov/17453052). [S2CID](/wiki/S2CID_\(identifier\)) [2987257](https://api.semanticscholar.org/CorpusID:2987257).
  36. ^ _**a**_ _**b**_ ["Batten Disease Fact Sheet | National Institute of Neurological Disorders and Stroke"](https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Batten-Disease-Fact-Sheet). _www.ninds.nih.gov_. Retrieved 30 November 2020.
  37. **^** Johnson TB, Cain JT, White KA, Ramirez-Montealegre D, Pearce DA, Weimer JM (March 2019). ["Therapeutic landscape for Batten disease: current treatments and future prospects"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6681450). _Nature Reviews. Neurology_. **15** (3): 161–178. [doi](/wiki/Doi_\(identifier\)):[10.1038/s41582-019-0138-8](https://doi.org/10.1038%2Fs41582-019-0138-8). [PMC](/wiki/PMC_\(identifier\)) [6681450](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6681450). [PMID](/wiki/PMID_\(identifier\)) [30783219](//pubmed.ncbi.nlm.nih.gov/30783219).
  38. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Johnson, Tyler B.; Cain, Jacob T.; White, Katherine A.; Ramirez-Montealegre, Denia; Pearce, David A.; Weimer, Jill M. (March 2019). ["Therapeutic landscape for Batten disease: current treatments and future prospects"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6681450). _Nature Reviews Neurology_. **15** (3): 161–178. [doi](/wiki/Doi_\(identifier\)):[10.1038/s41582-019-0138-8](https://doi.org/10.1038%2Fs41582-019-0138-8). [ISSN](/wiki/ISSN_\(identifier\)) [1759-4758](//www.worldcat.org/issn/1759-4758). [PMC](/wiki/PMC_\(identifier\)) [6681450](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6681450). [PMID](/wiki/PMID_\(identifier\)) [30783219](//pubmed.ncbi.nlm.nih.gov/30783219).
  39. ^ _**a**_ _**b**_ _**c**_ _**d**_ Masten MC, Williams JD, Vermilion J, Adams HR, Vierhile A, Collins A, et al. (June 2020). ["The CLN3 Disease Staging System: A new tool for clinical research in Batten disease"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7455368). _Neurology_. **94** (23): e2436–e2440. [doi](/wiki/Doi_\(identifier\)):[10.1212/WNL.0000000000009454](https://doi.org/10.1212%2FWNL.0000000000009454). [PMC](/wiki/PMC_\(identifier\)) [7455368](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7455368). [PMID](/wiki/PMID_\(identifier\)) [32300063](//pubmed.ncbi.nlm.nih.gov/32300063).
  40. **^** Hartnett L (2019-09-30). "Batten disease". _Learning Disability Practice_. **22** (5): 22. [doi](/wiki/Doi_\(identifier\)):[10.7748/ldp.22.5.22.s16](https://doi.org/10.7748%2Fldp.22.5.22.s16).
  41. ^ _**a**_ _**b**_ Lin MT, Beal MF (October 2006). "Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases". _Nature_. **443** (7113): 787–95. [Bibcode](/wiki/Bibcode_\(identifier\)):[2006Natur.443..787L](https://ui.adsabs.harvard.edu/abs/2006Natur.443..787L). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature05292](https://doi.org/10.1038%2Fnature05292). [PMID](/wiki/PMID_\(identifier\)) [17051205](//pubmed.ncbi.nlm.nih.gov/17051205). [S2CID](/wiki/S2CID_\(identifier\)) [4421515](https://api.semanticscholar.org/CorpusID:4421515).
  42. **^** Bernstein C, Bernstein H (1991). _Aging, Sex, and DNA Repair_. San Diego: Academic Press. pp. 121–139. [ISBN](/wiki/ISBN_\(identifier\)) [978-0120928606](/wiki/Special:BookSources/978-0120928606).
  43. **^** Maynard S, Fang EF, Scheibye-Knudsen M, Croteau DL, Bohr VA (September 2015). ["DNA Damage, DNA Repair, Aging, and Neurodegeneration"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4588127). _Cold Spring Harbor Perspectives in Medicine_. **5** (10): a025130. [doi](/wiki/Doi_\(identifier\)):[10.1101/cshperspect.a025130](https://doi.org/10.1101%2Fcshperspect.a025130). [PMC](/wiki/PMC_\(identifier\)) [4588127](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4588127). [PMID](/wiki/PMID_\(identifier\)) [26385091](//pubmed.ncbi.nlm.nih.gov/26385091).
  44. **^** Camandola S, Mattson MP (June 2017). ["Brain metabolism in health, aging, and neurodegeneration"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5452017). _The EMBO Journal_. **36** (11): 1474–1492. [doi](/wiki/Doi_\(identifier\)):[10.15252/embj.201695810](https://doi.org/10.15252%2Fembj.201695810). [PMC](/wiki/PMC_\(identifier\)) [5452017](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5452017). [PMID](/wiki/PMID_\(identifier\)) [28438892](//pubmed.ncbi.nlm.nih.gov/28438892).
  45. ^ _**a**_ _**b**_ Thompson LM (April 2008). ["Neurodegeneration: a question of balance"](https://doi.org/10.1038%2F452707a). _Nature_. **452** (7188): 707–8. [Bibcode](/wiki/Bibcode_\(identifier\)):[2008Natur.452..707T](https://ui.adsabs.harvard.edu/abs/2008Natur.452..707T). [doi](/wiki/Doi_\(identifier\)):[10.1038/452707a](https://doi.org/10.1038%2F452707a). [PMID](/wiki/PMID_\(identifier\)) [18401401](//pubmed.ncbi.nlm.nih.gov/18401401). [S2CID](/wiki/S2CID_\(identifier\)) [205037169](https://api.semanticscholar.org/CorpusID:205037169).
  46. ^ _**a**_ _**b**_ _**c**_ Marsh JL, Lukacsovich T, Thompson LM (March 2009). ["Animal models of polyglutamine diseases and therapeutic approaches"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658038). _The Journal of Biological Chemistry_. **284** (12): 7431–5. [doi](/wiki/Doi_\(identifier\)):[10.1074/jbc.R800065200](https://doi.org/10.1074%2Fjbc.R800065200). [PMC](/wiki/PMC_\(identifier\)) [2658038](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658038). [PMID](/wiki/PMID_\(identifier\)) [18957429](//pubmed.ncbi.nlm.nih.gov/18957429).
  47. **^** Orr HT (March 2009). ["Unstable nucleotide repeat minireview series: a molecular biography of unstable repeat disorders"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658033). _The Journal of Biological Chemistry_. **284** (12): 7405. [doi](/wiki/Doi_\(identifier\)):[10.1074/jbc.R800067200](https://doi.org/10.1074%2Fjbc.R800067200). [PMC](/wiki/PMC_\(identifier\)) [2658033](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658033). [PMID](/wiki/PMID_\(identifier\)) [18957428](//pubmed.ncbi.nlm.nih.gov/18957428).
  48. **^** Zoghbi HY, Orr HT (March 2009). ["Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658037). _The Journal of Biological Chemistry_. **284** (12): 7425–9. [doi](/wiki/Doi_\(identifier\)):[10.1074/jbc.R800041200](https://doi.org/10.1074%2Fjbc.R800041200). [PMC](/wiki/PMC_\(identifier\)) [2658037](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2658037). [PMID](/wiki/PMID_\(identifier\)) [18957430](//pubmed.ncbi.nlm.nih.gov/18957430).
  49. **^** Chung, CG; Lee, H; Lee, SB (September 2018). ["Mechanisms of protein toxicity in neurodegenerative diseases"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6063327). _Cellular and Molecular Life Sciences_. **75** (17): 3159–3180. [doi](/wiki/Doi_\(identifier\)):[10.1007/s00018-018-2854-4](https://doi.org/10.1007%2Fs00018-018-2854-4). [PMC](/wiki/PMC_\(identifier\)) [6063327](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6063327). [PMID](/wiki/PMID_\(identifier\)) [29947927](//pubmed.ncbi.nlm.nih.gov/29947927).
  50. **^** DiMauro S, Schon EA (2008). "Mitochondrial disorders in the nervous system". _Annual Review of Neuroscience_. **31**: 91–123. [doi](/wiki/Doi_\(identifier\)):[10.1146/annurev.neuro.30.051606.094302](https://doi.org/10.1146%2Fannurev.neuro.30.051606.094302). [PMID](/wiki/PMID_\(identifier\)) [18333761](//pubmed.ncbi.nlm.nih.gov/18333761).
  51. **^** Liu Z, Zhou T, Ziegler AC, Dimitrion P, Zuo L (2017). ["Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5529664). _Oxidative Medicine and Cellular Longevity_. **2017**: 2525967. [doi](/wiki/Doi_\(identifier\)):[10.1155/2017/2525967](https://doi.org/10.1155%2F2017%2F2525967). [PMC](/wiki/PMC_\(identifier\)) [5529664](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5529664). [PMID](/wiki/PMID_\(identifier\)) [28785371](//pubmed.ncbi.nlm.nih.gov/28785371).
  52. ^ _**a**_ _**b**_ Wang H, Dharmalingam P, Vasquez V, Mitra J, Boldogh I, Rao KS, et al. (January 2017). ["Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5316312). _Mechanisms of Ageing and Development_. **161** (Pt A): 163–176. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.mad.2016.09.005](https://doi.org/10.1016%2Fj.mad.2016.09.005). [PMC](/wiki/PMC_\(identifier\)) [5316312](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5316312). [PMID](/wiki/PMID_\(identifier\)) [27663141](//pubmed.ncbi.nlm.nih.gov/27663141).
  53. ^ _**a**_ _**b**_ Madabhushi R, Pan L, Tsai LH (July 2014). ["DNA damage and its links to neurodegeneration"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5564444). _Neuron_. **83** (2): 266–282. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.neuron.2014.06.034](https://doi.org/10.1016%2Fj.neuron.2014.06.034). [PMC](/wiki/PMC_\(identifier\)) [5564444](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5564444). [PMID](/wiki/PMID_\(identifier\)) [25033177](//pubmed.ncbi.nlm.nih.gov/25033177).
  54. ^ _**a**_ _**b**_ _**c**_ Jeppesen DK, Bohr VA, Stevnsner T (July 2011). ["DNA repair deficiency in neurodegeneration"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3123739). _Progress in Neurobiology_. **94** (2): 166–200. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.pneurobio.2011.04.013](https://doi.org/10.1016%2Fj.pneurobio.2011.04.013). [PMC](/wiki/PMC_\(identifier\)) [3123739](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3123739). [PMID](/wiki/PMID_\(identifier\)) [21550379](//pubmed.ncbi.nlm.nih.gov/21550379).
  55. **^** Coleman MP & Freeman MF 'Wallerian degeneration, WldS and Nmnat' Annual Review of Neuroscience 2010, 33: 245-67
  56. **^** Engelberg-Kulka H, Amitai S, Kolodkin-Gal I, Hazan R (October 2006). ["Bacterial programmed cell death and multicellular behavior in bacteria"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1626106). _PLOS Genetics_. **2** (10): e135. [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pgen.0020135](https://doi.org/10.1371%2Fjournal.pgen.0020135). [PMC](/wiki/PMC_\(identifier\)) [1626106](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1626106). [PMID](/wiki/PMID_\(identifier\)) [17069462](//pubmed.ncbi.nlm.nih.gov/17069462).
  57. **^** Vila M, Przedborski S (May 2003). "Targeting programmed cell death in neurodegenerative diseases". _Nature Reviews. Neuroscience_. **4** (5): 365–75. [doi](/wiki/Doi_\(identifier\)):[10.1038/nrn1100](https://doi.org/10.1038%2Fnrn1100). [PMID](/wiki/PMID_\(identifier\)) [12728264](//pubmed.ncbi.nlm.nih.gov/12728264). [S2CID](/wiki/S2CID_\(identifier\)) [33018251](https://api.semanticscholar.org/CorpusID:33018251).
  58. **^** Green DR, Kroemer G (October 2005). ["Pharmacological manipulation of cell death: clinical applications in sight?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1236695). _The Journal of Clinical Investigation_. **115** (10): 2610–7. [doi](/wiki/Doi_\(identifier\)):[10.1172/JCI26321](https://doi.org/10.1172%2FJCI26321). [PMC](/wiki/PMC_\(identifier\)) [1236695](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1236695). [PMID](/wiki/PMID_\(identifier\)) [16200193](//pubmed.ncbi.nlm.nih.gov/16200193).
  59. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ Caccamo D, Currò M, Condello S, Ferlazzo N, Ientile R (February 2010). "Critical role of transglutaminase and other stress proteins during neurodegenerative processes". _Amino Acids_. **38** (2): 653–8. [doi](/wiki/Doi_\(identifier\)):[10.1007/s00726-009-0428-3](https://doi.org/10.1007%2Fs00726-009-0428-3). [PMID](/wiki/PMID_\(identifier\)) [19960212](//pubmed.ncbi.nlm.nih.gov/19960212). [S2CID](/wiki/S2CID_\(identifier\)) [19739739](https://api.semanticscholar.org/CorpusID:19739739).
  60. **^** [Dimebon Disappoints in Phase 3 Trial](http://www.alzforum.org/new/detail.asp?id=2387)
  61. **^** Sweetlove M: Phase III CONCERT Trial of Latrepirdine. Negative results. Pharm Med 2012;26(2):113-115
  62. **^** Galoyan AA, Sarkissian JS, Chavushyan VA, Meliksetyan IB, Avagyan ZE, Poghosyan MV, et al. (September 2008). "Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Abeta25-35 model of Alzheimer's disease". _Alzheimer's & Dementia_. **4** (5): 332–44. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.jalz.2007.10.019](https://doi.org/10.1016%2Fj.jalz.2007.10.019). [PMID](/wiki/PMID_\(identifier\)) [18790460](//pubmed.ncbi.nlm.nih.gov/18790460). [S2CID](/wiki/S2CID_\(identifier\)) [39817779](https://api.semanticscholar.org/CorpusID:39817779).
  63. **^** Brody DL, Holtzman DM (2008). ["Active and passive immunotherapy for neurodegenerative disorders"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2561172). _Annual Review of Neuroscience_. **31**: 175–93. [doi](/wiki/Doi_\(identifier\)):[10.1146/annurev.neuro.31.060407.125529](https://doi.org/10.1146%2Fannurev.neuro.31.060407.125529). [PMC](/wiki/PMC_\(identifier\)) [2561172](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2561172). [PMID](/wiki/PMID_\(identifier\)) [18352830](//pubmed.ncbi.nlm.nih.gov/18352830).
  64. **^** Pastorino L, Ikin AF, Lamprianou S, Vacaresse N, Revelli JP, Platt K, et al. (April 2004). "BACE (beta-secretase) modulates the processing of APLP2 in vivo". _Molecular and Cellular Neurosciences_. **25** (4): 642–9. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.mcn.2003.12.013](https://doi.org/10.1016%2Fj.mcn.2003.12.013). [PMID](/wiki/PMID_\(identifier\)) [15080893](//pubmed.ncbi.nlm.nih.gov/15080893). [S2CID](/wiki/S2CID_\(identifier\)) [54334969](https://api.semanticscholar.org/CorpusID:54334969).
  65. **^** Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, et al. (June 1990). "Cleavage of amyloid beta peptide during constitutive processing of its precursor". _Science_. **248** (4959): 1122–4. [Bibcode](/wiki/Bibcode_\(identifier\)):[1990Sci...248.1122E](https://ui.adsabs.harvard.edu/abs/1990Sci...248.1122E). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.2111583](https://doi.org/10.1126%2Fscience.2111583). [PMID](/wiki/PMID_\(identifier\)) [2111583](//pubmed.ncbi.nlm.nih.gov/2111583).
  66. **^** Schenk D, Basi GS, Pangalos MN (September 2012). ["Treatment strategies targeting amyloid β-protein"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3426815). _Cold Spring Harbor Perspectives in Medicine_. **2** (9): a006387. [doi](/wiki/Doi_\(identifier\)):[10.1101/cshperspect.a006387](https://doi.org/10.1101%2Fcshperspect.a006387). [PMC](/wiki/PMC_\(identifier\)) [3426815](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3426815). [PMID](/wiki/PMID_\(identifier\)) [22951439](//pubmed.ncbi.nlm.nih.gov/22951439).

Classification

[D](https://www.wikidata.org/wiki/Q1755122)

  * **[ICD](/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems)-[10](/wiki/ICD-10)**: [G30](https://icd.who.int/browse10/2019/en#/G30)-[G32](https://icd.who.int/browse10/2019/en#/G32)
  * **[MeSH](/wiki/Medical_Subject_Headings)**: [D019636](https://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&term=D019636)

  * [v](/wiki/Template:Central_nervous_system_disease)
  * [t](/wiki/Template_talk:Central_nervous_system_disease)
  * [e](https://en.wikipedia.org/w/index.php?title=Template:Central_nervous_system_disease&action=edit)

Diseases of the [nervous system](/wiki/Nervous_system), primarily
[CNS](/wiki/Central_nervous_system_disease)

[Inflammation](/wiki/Inflammation)

[Brain](/wiki/Human_brain)

  * [Encephalitis](/wiki/Encephalitis)
    * [Viral encephalitis](/wiki/Viral_encephalitis)
    * [Herpesviral encephalitis](/wiki/Herpesviral_encephalitis)
    * [Limbic encephalitis](/wiki/Limbic_encephalitis)
    * [Encephalitis lethargica](/wiki/Encephalitis_lethargica)
  * [Cavernous sinus thrombosis](/wiki/Cavernous_sinus_thrombosis)
  * [Brain abscess](/wiki/Brain_abscess)
    * [Amoebic](/wiki/Amoebic_brain_abscess)

Brain and [spinal cord](/wiki/Spinal_cord)

  * [Encephalomyelitis](/wiki/Encephalomyelitis)
    * [Acute disseminated](/wiki/Acute_disseminated_encephalomyelitis)
  * [Meningitis](/wiki/Meningitis)
  * [Meningoencephalitis](/wiki/Meningoencephalitis)

[Brain](/wiki/Human_brain)/  
[encephalopathy](/wiki/Encephalopathy)

Degenerative

[Extrapyramidal](/wiki/Extrapyramidal_system) and  
[movement disorders](/wiki/Movement_disorders)

  * [Basal ganglia disease](/wiki/Basal_ganglia_disease)
    * [Parkinsonism](/wiki/Parkinsonism)
      * [PD](/wiki/Parkinson%27s_disease)
      * [Postencephalitic](/wiki/Postencephalitic_parkinsonism)
      * [NMS](/wiki/Neuroleptic_malignant_syndrome)
    * [PKAN](/wiki/Pantothenate_kinase-associated_neurodegeneration)
    * [Tauopathy](/wiki/Tauopathy)
      * [PSP](/wiki/Progressive_supranuclear_palsy)
    * [Striatonigral degeneration](/wiki/Multiple_system_atrophy)
    * [Hemiballismus](/wiki/Hemiballismus)
    * [HD](/wiki/Huntington%27s_disease)
    * [OA](/wiki/Olivopontocerebellar_atrophy)
  * [Dyskinesia](/wiki/Dyskinesia)
    * [Dystonia](/wiki/Dystonia)
      * [Status dystonicus](/wiki/Status_dystonicus)
      * [Spasmodic torticollis](/wiki/Spasmodic_torticollis)
      * [Meige's](/wiki/Meige%27s_syndrome)
      * [Blepharospasm](/wiki/Blepharospasm)
    * [Athetosis](/wiki/Athetosis)
    * [Chorea](/wiki/Chorea)
      * [Choreoathetosis](/wiki/Choreoathetosis)
    * [Myoclonus](/wiki/Myoclonus)
      * [Myoclonic epilepsy](/wiki/Myoclonic_epilepsy)
    * [Akathisia](/wiki/Akathisia)
  * [Tremor](/wiki/Tremor)
    * [Essential tremor](/wiki/Essential_tremor)
    * [Intention tremor](/wiki/Intention_tremor)
  * [Restless legs](/wiki/Restless_legs_syndrome)
  * [Stiff-person](/wiki/Stiff-person_syndrome)

[Dementia](/wiki/Dementia)

  * [Tauopathy](/wiki/Tauopathy)
    * [Alzheimer's](/wiki/Alzheimer%27s_disease)
      * [Early-onset](/wiki/Early-onset_Alzheimer%27s_disease)
    * [Primary progressive aphasia](/wiki/Primary_progressive_aphasia)
  * [Frontotemporal dementia](/wiki/Frontotemporal_dementia)/[Frontotemporal lobar degeneration](/wiki/Frontotemporal_lobar_degeneration)
    * [Pick's](/wiki/Pick%27s_disease)
    * [Dementia with Lewy bodies](/wiki/Dementia_with_Lewy_bodies)
  * [Posterior cortical atrophy](/wiki/Posterior_cortical_atrophy)
  * [Vascular dementia](/wiki/Vascular_dementia)

[Mitochondrial disease](/wiki/Mitochondrial_disease)

  * [Leigh syndrome](/wiki/Leigh_syndrome)

[Demyelinating](/wiki/Demyelinating_disease)

  * [Autoimmune](/wiki/CNS_demyelinating_autoimmune_diseases)
  * [Inflammatory](/wiki/Inflammatory_demyelinating_diseases_of_the_central_nervous_system)
  * [Multiple sclerosis](/wiki/Multiple_sclerosis)
  * For more detailed coverage, see [Template:Demyelinating diseases of CNS](/wiki/Template:Demyelinating_diseases_of_CNS)

Episodic/  
[paroxysmal](/wiki/Paroxysmal_attack)

[Seizures](/wiki/Epileptic_seizure) and [epilepsy](/wiki/Epilepsy)

  * [Focal](/wiki/Focal_seizure)
  * [Generalised](/wiki/Generalized_epilepsy)
  * [Status epilepticus](/wiki/Status_epilepticus)
  * For more detailed coverage, see [Template:Epilepsy](/wiki/Template:Epilepsy)

[Headache](/wiki/Headache)

  * [Migraine](/wiki/Migraine)
  * [Cluster](/wiki/Cluster_headache)
  * [Tension](/wiki/Tension_headache)
  * For more detailed coverage, see [Template:Headache](/wiki/Template:Headache)

[Cerebrovascular](/wiki/Cerebrovascular_disease)

  * [TIA](/wiki/Transient_ischemic_attack)
  * [Stroke](/wiki/Stroke)
  * For more detailed coverage, see [Template:Cerebrovascular diseases](/wiki/Template:Cerebrovascular_diseases)

Other

  * [Sleep disorders](/wiki/Sleep_disorders)
    * For more detailed coverage, see [Template:Sleep](/wiki/Template:Sleep)

[CSF](/wiki/Cerebrospinal_fluid)

  * [Intracranial hypertension](/wiki/Intracranial_pressure)
    * [Hydrocephalus](/wiki/Hydrocephalus)
    * [Normal pressure hydrocephalus](/wiki/Normal_pressure_hydrocephalus)
    * [Choroid plexus papilloma](/wiki/Choroid_plexus_papilloma)
    * [Idiopathic intracranial hypertension](/wiki/Idiopathic_intracranial_hypertension)
  * [Cerebral edema](/wiki/Cerebral_edema)
  * [Intracranial hypotension](/wiki/Spontaneous_cerebrospinal_fluid_leak)

Other

  * [Brain herniation](/wiki/Brain_herniation)
  * [Reye syndrome](/wiki/Reye_syndrome)
  * [Hepatic encephalopathy](/wiki/Hepatic_encephalopathy)
  * [Toxic encephalopathy](/wiki/Toxic_encephalopathy)
  * [Hashimoto's encephalopathy](/wiki/Hashimoto%27s_encephalopathy)

Both/either

Degenerative

[SA](/wiki/Spinocerebellar_ataxia)

  * [Friedreich's ataxia](/wiki/Friedreich%27s_ataxia)
  * [Ataxia–telangiectasia](/wiki/Ataxia%E2%80%93telangiectasia)

[MND](/wiki/Motor_neuron_disease)

  * _[UMN](/wiki/Upper_motor_neuron) only:_
    * [Primary lateral sclerosis](/wiki/Primary_lateral_sclerosis)
    * [Pseudobulbar palsy](/wiki/Pseudobulbar_palsy)
    * [Hereditary spastic paraplegia](/wiki/Hereditary_spastic_paraplegia)
  * _[LMN](/wiki/Lower_motor_neuron) only:_
    * [Distal hereditary motor neuronopathies](/wiki/Distal_hereditary_motor_neuronopathies)
    * [Spinal muscular atrophies](/wiki/Spinal_muscular_atrophies)
      * [SMA](/wiki/Spinal_muscular_atrophy)
      * [SMAX1](/wiki/Spinal_and_bulbar_muscular_atrophy)
      * [SMAX2](/wiki/X-linked_spinal_muscular_atrophy_type_2)
      * [DSMA1](/wiki/Distal_spinal_muscular_atrophy_type_1)
      * [Congenital DSMA](/wiki/Congenital_distal_spinal_muscular_atrophy)
      * Spinal muscular atrophy with lower extremity predominance (SMALED) 
        * [SMALED1](/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_1)
        * [SMALED2A](/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2A)
        * [SMALED2B](/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2B)
      * [SMA-PCH](/wiki/Pontocerebellar_hypoplasia)
      * [SMA-PME](/wiki/Spinal_muscular_atrophy_with_progressive_myoclonic_epilepsy)
    * [Progressive muscular atrophy](/wiki/Progressive_muscular_atrophy)
    * [Progressive bulbar palsy](/wiki/Progressive_bulbar_palsy)
      * [Fazio–Londe](/wiki/Fazio%E2%80%93Londe_disease)
      * [Infantile progressive bulbar palsy](/wiki/Infantile_progressive_bulbar_palsy)
  * _both:_
    * [Amyotrophic lateral sclerosis](/wiki/Amyotrophic_lateral_sclerosis)

  * [v](/wiki/Template:Neuroscience)
  * [t](/wiki/Template_talk:Neuroscience)
  * [e](https://en.wikipedia.org/w/index.php?title=Template:Neuroscience&action=edit)

[Neuroscience](/wiki/Neuroscience)

  * [Outline of neuroscience](/wiki/Outline_of_neuroscience)
  * [History of neuroscience](/wiki/History_of_neuroscience)

[Basic  
science](/wiki/Basic_research)

  * [Behavioral epigenetics](/wiki/Behavioral_epigenetics)
  * [Behavioral genetics](/wiki/Behavioural_genetics)
  * [Brain mapping](/wiki/Brain_mapping)
  * [Brain-reading](/wiki/Brain-reading)
  * [Cellular neuroscience](/wiki/Cellular_neuroscience)
  * [Computational neuroscience](/wiki/Computational_neuroscience)
  * [Connectomics](/wiki/Connectomics)
  * [Imaging genetics](/wiki/Imaging_genetics)
  * [Integrative neuroscience](/wiki/Integrative_neuroscience)
  * [Molecular neuroscience](/wiki/Molecular_neuroscience)
  * [Neural decoding](/wiki/Neural_decoding)
  * [Neural engineering](/wiki/Neural_engineering)
  * [Neuroanatomy](/wiki/Neuroanatomy)
  * [Neurochemistry](/wiki/Neurochemistry)
  * [Neuroendocrinology](/wiki/Neuroendocrinology)
  * [Neurogenetics](/wiki/Neurogenetics)
  * [Neuroinformatics](/wiki/Neuroinformatics)
  * [Neurometrics](/wiki/Neurometrics)
  * [Neuromorphology](/wiki/Neuromorphology)
  * [Neurophysics](/wiki/Neurophysics)
  * [Neurophysiology](/wiki/Neurophysiology)
  * [Systems neuroscience](/wiki/Systems_neuroscience)

![Gray739.png](//upload.wikimedia.org/wikipedia/commons/thumb/9/96/Gray739.png
/130px-Gray739.png)

[Clinical  
neuroscience](/wiki/Clinical_neuroscience)

  * [Behavioral neurology](/wiki/Behavioral_neurology)
  * [Clinical neurophysiology](/wiki/Clinical_neurophysiology)
  * [Neurocardiology](/wiki/Neurocardiology)
  * [Neuroepidemiology](/wiki/Neuroepidemiology)
  * [Neurogastroenterology](/wiki/Neurogastroenterology)
  * [Neuroimmunology](/wiki/Neuroimmunology)
  * [Neurointensive care](/wiki/Neurointensive_care)
  * [Neurology](/wiki/Neurology)
  * [Neurooncology](/wiki/Neurooncology)
  * [Neuro-ophthalmology](/wiki/Neuro-ophthalmology)
  * [Neuropathology](/wiki/Neuropathology)
  * [Neuropharmacology](/wiki/Neuropharmacology)
  * [Neuroprosthetics](/wiki/Neuroprosthetics)
  * [Neuropsychiatry](/wiki/Neuropsychiatry)
  * [Neuroradiology](/wiki/Neuroradiology)
  * [Neurorehabilitation](/wiki/Neurorehabilitation)
  * [Neurosurgery](/wiki/Neurosurgery)
  * [Neurotology](/wiki/Neurotology)
  * [Neurovirology](/wiki/Neurovirology)
  * [Nutritional neuroscience](/wiki/Nutritional_neuroscience)
  * [Psychiatry](/wiki/Psychiatry)

[Cognitive  
neuroscience](/wiki/Cognitive_neuroscience)

  * [Affective neuroscience](/wiki/Affective_neuroscience)
  * [Behavioral neuroscience](/wiki/Behavioral_neuroscience)
  * [Chronobiology](/wiki/Chronobiology)
  * [Molecular cellular cognition](/wiki/Molecular_cellular_cognition)
  * [Motor control](/wiki/Motor_control)
  * [Neurolinguistics](/wiki/Neurolinguistics)
  * [Neuropsychology](/wiki/Neuropsychology)
  * [Sensory neuroscience](/wiki/Sensory_neuroscience)
  * [Social cognitive neuroscience](/wiki/Social_cognitive_neuroscience)

Interdisciplinary  
fields

  * [Consumer neuroscience](/wiki/Consumer_neuroscience)
  * [Cultural neuroscience](/wiki/Cultural_neuroscience)
  * [Educational neuroscience](/wiki/Educational_neuroscience)
  * [Evolutionary neuroscience](/wiki/Evolutionary_neuroscience)
  * [Neuroanthropology](/wiki/Neuroanthropology)
  * [Neurobioengineering](/wiki/Neurobioengineering)
  * [Neurobiotics](/wiki/Neurobiotics)
  * [Neurocriminology](/wiki/Neurocriminology)
  * [Neuroeconomics](/wiki/Neuroeconomics)
  * [Neuroepistemology](/wiki/Neuroepistemology)
  * [Neuroesthetics](/wiki/Neuroesthetics)
  * [Neuroethics](/wiki/Neuroethics)
  * [Neuroethology](/wiki/Neuroethology)
  * [Neurohistory](/wiki/Neurohistory)
  * [Neurolaw](/wiki/Neurolaw)
  * [Neuromarketing](/wiki/Neuromarketing)
  * [Neuromorphics](/wiki/Neuromorphics)
  * [Neurophenomenology](/wiki/Neurophenomenology)
  * [Neurophilosophy](/wiki/Neurophilosophy)
  * [Neuropolitics](/wiki/Neuropolitics)
  * [Neurorobotics](/wiki/Neurorobotics)
  * [Neurotheology](/wiki/Neurotheology)
  * [Paleoneurobiology](/wiki/Paleoneurobiology)
  * [Social neuroscience](/wiki/Social_neuroscience)

Concepts

  * [Brain–computer interface](/wiki/Brain%E2%80%93computer_interface)
  * [Neural development](/wiki/Neural_development)
  * [Neural network (artificial)](/wiki/Artificial_neural_network)
  * [Neural network (biological)](/wiki/Biological_neural_network)
  * [Detection theory](/wiki/Detection_theory)
  * [Intraoperative neurophysiological monitoring](/wiki/Intraoperative_neurophysiological_monitoring)
  * [Neurochip](/wiki/Neurochip)
  * Neurodegeneration
  * [Neurodevelopmental disorder](/wiki/Neurodevelopmental_disorder)
  * [Neurodiversity](/wiki/Neurodiversity)
  * [Neurogenesis](/wiki/Neurogenesis)
  * [Neuroimaging](/wiki/Neuroimaging)
  * [Neuroimmune system](/wiki/Neuroimmune_system)
  * [Neuromanagement](/wiki/Neuromanagement)
  * [Neuromodulation](/wiki/Neuromodulation)
  * [Neuroplasticity](/wiki/Neuroplasticity)
  * [Neurotechnology](/wiki/Neurotechnology)
  * [Neurotoxin](/wiki/Neurotoxin)

  * ![Category](//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/16px-Symbol_category_class.svg.png) **[Category](/wiki/Category:Neuroscience)**

[Authority control](/wiki/Help:Authority_control) ![Edit this at
Wikidata](//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-
ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)

General

  * [Integrated Authority File (Germany)](https://d-nb.info/gnd/4300182-8)

National libraries

  * [Spain](http://catalogo.bne.es/uhtbin/authoritybrowse.cgi?action=display&authority_id=XX548538)
  * [France](https://catalogue.bnf.fr/ark:/12148/cb11965374p) [(data)](https://data.bnf.fr/ark:/12148/cb11965374p)
  * [United States](https://id.loc.gov/authorities/subjects/sh85090923)

Other

  * [Microsoft Academic](https://academic.microsoft.com/v2/detail/2776925932)

![](//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1)

Retrieved from "[https://en.wikipedia.org/w/index.php?title=Neurodegeneration&
oldid=1043688812](https://en.wikipedia.org/w/index.php?title=Neurodegeneration
&oldid=1043688812)"

[Categories](/wiki/Help:Category):

  * [Neurological disorders](/wiki/Category:Neurological_disorders)
  * [Neuroscience](/wiki/Category:Neuroscience)
  * [Senescence](/wiki/Category:Senescence)

Hidden categories:

  * [CS1: long volume value](/wiki/Category:CS1:_long_volume_value)
  * [Articles with short description](/wiki/Category:Articles_with_short_description)
  * [Short description matches Wikidata](/wiki/Category:Short_description_matches_Wikidata)
  * [Short description is different from Wikidata](/wiki/Category:Short_description_is_different_from_Wikidata)
  * [Articles with GND identifiers](/wiki/Category:Articles_with_GND_identifiers)
  * [Articles with BNE identifiers](/wiki/Category:Articles_with_BNE_identifiers)
  * [Articles with BNF identifiers](/wiki/Category:Articles_with_BNF_identifiers)
  * [Articles with LCCN identifiers](/wiki/Category:Articles_with_LCCN_identifiers)
  * [Articles with MA identifiers](/wiki/Category:Articles_with_MA_identifiers)

## Navigation menu

### Personal tools

  * Not logged in
  * [Talk](/wiki/Special:MyTalk)
  * [Contributions](/wiki/Special:MyContributions)
  * [Create account](/w/index.php?title=Special:CreateAccount&returnto=Neurodegeneration)
  * [Log in](/w/index.php?title=Special:UserLogin&returnto=Neurodegeneration)

### Namespaces

  * [Article](/wiki/Neurodegeneration)
  * [Talk](/wiki/Talk:Neurodegeneration)

### Variants

### Views

  * [Read](/wiki/Neurodegeneration)
  * [Edit](/w/index.php?title=Neurodegeneration&action=edit)
  * [View history](/w/index.php?title=Neurodegeneration&action=history)

### More

###  Search

### Navigation

  * [Main page](/wiki/Main_Page)
  * [Contents](/wiki/Wikipedia:Contents)
  * [Current events](/wiki/Portal:Current_events)
  * [Random article](/wiki/Special:Random)
  * [About Wikipedia](/wiki/Wikipedia:About)
  * [Contact us](//en.wikipedia.org/wiki/Wikipedia:Contact_us)
  * [Donate](https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en)

### Contribute

  * [Help](/wiki/Help:Contents)
  * [Learn to edit](/wiki/Help:Introduction)
  * [Community portal](/wiki/Wikipedia:Community_portal)
  * [Recent changes](/wiki/Special:RecentChanges)
  * [Upload file](/wiki/Wikipedia:File_Upload_Wizard)

### Tools

  * [What links here](/wiki/Special:WhatLinksHere/Neurodegeneration)
  * [Related changes](/wiki/Special:RecentChangesLinked/Neurodegeneration)
  * [Upload file](/wiki/Wikipedia:File_Upload_Wizard)
  * [Special pages](/wiki/Special:SpecialPages)
  * [Permanent link](/w/index.php?title=Neurodegeneration&oldid=1043688812)
  * [Page information](/w/index.php?title=Neurodegeneration&action=info)
  * [Cite this page](/w/index.php?title=Special:CiteThisPage&page=Neurodegeneration&id=1043688812&wpFormIdentifier=titleform)
  * [Wikidata item](https://www.wikidata.org/wiki/Special:EntityPage/Q1755122)

### Print/export

  * [Download as PDF](/w/index.php?title=Special:DownloadAsPdf&page=Neurodegeneration&action=show-download-screen)
  * [Printable version](/w/index.php?title=Neurodegeneration&printable=yes)

### In other projects

  * [Wikimedia Commons](https://commons.wikimedia.org/wiki/Category:Neurodegenerative_diseases_and_disorders)

### Languages

  * [العربية](https://ar.wikipedia.org/wiki/%D8%AA%D8%AD%D9%84%D9%84_%D8%B9%D8%B5%D8%A8%D9%8A)
  * [Беларуская](https://be.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B9%D1%80%D0%B0%D0%B4%D1%8D%D0%B3%D0%B5%D0%BD%D0%B5%D1%80%D0%B0%D1%82%D1%8B%D1%9E%D0%BD%D1%8B%D1%8F_%D0%B7%D0%B0%D1%85%D0%B2%D0%BE%D1%80%D0%B2%D0%B0%D0%BD%D0%BD%D1%96)
  * [Català](https://ca.wikipedia.org/wiki/Neurodegeneraci%C3%B3)
  * [Deutsch](https://de.wikipedia.org/wiki/Neurodegenerative_Erkrankung)
  * [Español](https://es.wikipedia.org/wiki/Enfermedad_neurodegenerativa)
  * [فارسی](https://fa.wikipedia.org/wiki/%D8%B2%D9%88%D8%A7%D9%84_%D8%B9%D8%B5%D8%A8%DB%8C)
  * [Français](https://fr.wikipedia.org/wiki/Maladie_neurod%C3%A9g%C3%A9n%C3%A9rative)
  * [हिन्दी](https://hi.wikipedia.org/wiki/%E0%A4%A4%E0%A4%82%E0%A4%A4%E0%A5%8D%E0%A4%B0%E0%A4%BF%E0%A4%95%E0%A4%BE_%E0%A4%85%E0%A4%AA%E0%A4%B5%E0%A4%BF%E0%A4%95%E0%A4%BE%E0%A4%B8)
  * [Italiano](https://it.wikipedia.org/wiki/Malattie_neurodegenerative)
  * [Latina](https://la.wikipedia.org/wiki/Neurodegeneratio)
  * [Македонски](https://mk.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B2%D1%80%D0%BE%D0%B4%D0%B5%D0%B3%D0%B5%D0%BD%D0%B5%D1%80%D0%B0%D1%86%D0%B8%D1%98%D0%B0)
  * [മലയാളം](https://ml.wikipedia.org/wiki/%E0%B4%A8%E0%B5%8D%E0%B4%AF%E0%B5%81%E0%B4%B1%E0%B5%8B_%E0%B4%A1%E0%B4%BF%E0%B4%9C%E0%B5%86%E0%B4%A8%E0%B5%86%E0%B4%B0%E0%B5%86%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B5%80%E0%B4%B5%E0%B5%8D_%E0%B4%B0%E0%B5%8B%E0%B4%97%E0%B4%99%E0%B5%8D%E0%B4%99%E0%B5%BE)
  * [Bahasa Melayu](https://ms.wikipedia.org/wiki/Neurodegenerasi)
  * [Nederlands](https://nl.wikipedia.org/wiki/Neurodegeneratie)
  * [日本語](https://ja.wikipedia.org/wiki/%E7%A5%9E%E7%B5%8C%E5%A4%89%E6%80%A7%E7%96%BE%E6%82%A3)
  * [Polski](https://pl.wikipedia.org/wiki/Choroby_neurodegeneracyjne)
  * [Português](https://pt.wikipedia.org/wiki/Neurodegenera%C3%A7%C3%A3o)
  * [Русский](https://ru.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B9%D1%80%D0%BE%D0%B4%D0%B5%D0%B3%D0%B5%D0%BD%D0%B5%D1%80%D0%B0%D1%82%D0%B8%D0%B2%D0%BD%D0%BE%D0%B5_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D0%B5)
  * [Simple English](https://simple.wikipedia.org/wiki/Neurodegeneration)
  * [Српски / srpski](https://sr.wikipedia.org/wiki/%D0%9D%D0%B5%D1%83%D1%80%D0%BE%D0%B4%D0%B5%D0%B3%D0%B5%D0%BD%D0%B5%D1%80%D0%B0%D1%86%D0%B8%D1%98%D0%B0)
  * [Svenska](https://sv.wikipedia.org/wiki/Neurodegenerativa_sjukdomar)
  * [ไทย](https://th.wikipedia.org/wiki/%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%80%E0%B8%AA%E0%B8%B7%E0%B9%88%E0%B8%AD%E0%B8%A1%E0%B8%82%E0%B8%AD%E0%B8%87%E0%B8%A3%E0%B8%B0%E0%B8%9A%E0%B8%9A%E0%B8%9B%E0%B8%A3%E0%B8%B0%E0%B8%AA%E0%B8%B2%E0%B8%97)
  * [Türkçe](https://tr.wikipedia.org/wiki/N%C3%B6rodejenerasyon)
  * [Tiếng Việt](https://vi.wikipedia.org/wiki/Tho%C3%A1i_h%C3%B3a_th%E1%BA%A7n_kinh)
  * [粵語](https://zh-yue.wikipedia.org/wiki/%E7%A5%9E%E7%B6%93%E9%80%80%E5%8C%96%E7%97%85)
  * [中文](https://zh.wikipedia.org/wiki/%E7%A5%9E%E7%B6%93%E9%80%80%E5%8C%96%E9%9A%9C%E7%A4%99)

[Edit links](https://www.wikidata.org/wiki/Special:EntityPage/Q1755122
#sitelinks-wikipedia)

  * This page was last edited on 11 September 2021, at 12:25 (UTC).
  * Text is available under the [Creative Commons Attribution-ShareAlike License](//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License); additional terms may apply. By using this site, you agree to the [Terms of Use](//foundation.wikimedia.org/wiki/Terms_of_Use) and [Privacy Policy](//foundation.wikimedia.org/wiki/Privacy_policy). Wikipedia® is a registered trademark of the [Wikimedia Foundation, Inc.](//www.wikimediafoundation.org/), a non-profit organization.
  * [Privacy policy](https://foundation.wikimedia.org/wiki/Privacy_policy)
  * [About Wikipedia](/wiki/Wikipedia:About)
  * [Disclaimers](/wiki/Wikipedia:General_disclaimer)
  * [Contact Wikipedia](//en.wikipedia.org/wiki/Wikipedia:Contact_us)
  * [Mobile view](//en.m.wikipedia.org/w/index.php?title=Neurodegeneration&mobileaction=toggle_view_mobile)
  * [Developers](https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute)
  * [Statistics](https://stats.wikimedia.org/#/en.wikipedia.org)
  * [Cookie statement](https://foundation.wikimedia.org/wiki/Cookie_statement)
  * ![Wikimedia Foundation](/static/images/footer/wikimedia-button.png)
  * ![Powered by MediaWiki](/static/images/footer/poweredby_mediawiki_88x31.png)
  *[[v]: View this template
  *[[e]: Edit this template
  *[[t]: Discuss this template

# Human genome

From Wikipedia, the free encyclopedia

Jump to navigation Jump to search

For a non-technical introduction to the topic, see [Introduction to
genetics](/wiki/Introduction_to_genetics).

Complete set of nucleic acid sequences for humans

Genomic information

![Karyotype.png](//upload.wikimedia.org/wikipedia/commons/thumb/b/b2/Karyotype
.png/260px-Karyotype.png)

Graphical representation of the idealized human diploid
[karyotype](/wiki/Karyotype), showing the organization of the genome into
chromosomes. This drawing shows both the female (XX) and male (XY) versions of
the 23rd chromosome pair. Chromosomes are shown aligned at their
[centromeres](/wiki/Centromeres). The mitochondrial DNA is not shown.

[NCBI](/wiki/National_Center_for_Biotechnology_Information) genome ID

[51](https://www.ncbi.nlm.nih.gov/genome/?term=51)

[Ploidy](/wiki/Ploidy)

diploid

[Genome size](/wiki/Genome_size)

3,100 Mbp[1] (mega-basepairs) per haploid genome  
6,200 Mbp total (diploid).

Number of [chromosomes](/wiki/Chromosome)

23 pairs

The **human genome** is a complete set of [nucleic acid
sequences](/wiki/Nucleic_acid_sequence) for [humans](/wiki/Humans), encoded as
[DNA](/wiki/DNA) within the 23 [chromosome](/wiki/Chromosome) pairs in [cell
nuclei](/wiki/Cell_nuclei) and in a small DNA molecule found within individual
[mitochondria](/wiki/Mitochondrial_DNA). These are usually treated separately
as the nuclear genome and the [mitochondrial
genome](/wiki/Human_mitochondrial_genetics).[2] Human [genomes](/wiki/Genome)
include both protein-coding DNA genes and [noncoding
DNA](/wiki/Noncoding_DNA). [Haploid](/wiki/Haploid) human genomes, which are
contained in [germ cells](/wiki/Germ_cells) (the [egg](/wiki/Egg) and
[sperm](/wiki/Sperm) [gamete](/wiki/Gamete) cells created in the
[meiosis](/wiki/Meiosis) phase of [sexual
reproduction](/wiki/Sexual_reproduction) before
[fertilization](/wiki/Fertilization) creates a [zygote](/wiki/Zygote)) consist
of three billion [DNA](/wiki/DNA) [base pairs](/wiki/Base_pair), while
[diploid](/wiki/Diploid) genomes (found in [somatic
cells](/wiki/Somatic_cells)) have twice the DNA content. While there are
significant differences among the genomes of human individuals (on the order
of 0.1% due to [single-nucleotide variants](/wiki/Single-
nucleotide_variant)[3] and 0.6% when considering [indels](/wiki/Indel)),[4]
these are considerably smaller than the differences between humans and their
closest living relatives, the [bonobos](/wiki/Bonobo) and
[chimpanzees](/wiki/Common_chimpanzee) (~1.1%
[fixed](/wiki/Fixation_\(population_genetics\)) single-nucleotide variants [5]
and 4% when including indels).[6]

Although the sequence of the human genome has been (almost) completely
determined by DNA sequencing, it is not yet fully understood. Most (though
probably not all) [genes](/wiki/Gene) have been identified by a combination of
high throughput experimental and [bioinformatics](/wiki/Bioinformatics)
approaches, yet much work still needs to be done to further elucidate the
biological functions of their protein and [RNA](/wiki/RNA) products. Recent
results suggest that most of the vast quantities of noncoding DNA within the
genome have associated biochemical activities, including [regulation of gene
expression](/wiki/Regulation_of_gene_expression), organization of [chromosome
architecture](/wiki/Chromatin), and signals controlling [epigenetic
inheritance](/wiki/Epigenetic_inheritance).

Prior to the acquisition of the full genome sequence, estimates of the number
of human genes ranged from 50,000 to 140,000 (with occasional vagueness about
whether these estimates included non-protein coding genes).[7] As genome
sequence quality and the methods for identifying protein-coding genes
improved,[8] the count of recognized protein-coding genes dropped to
19,000-20,000.[9] However, a fuller understanding of the role played by
sequences that do not encode proteins, but instead express regulatory RNA, has
raised the total number of genes to at least 46,831,[10] plus another 2300
[micro-RNA](/wiki/Micro-RNA) genes.[11] By 2012, functional DNA elements that
encode neither RNA nor proteins have been noted.[12] A 2018 population survey
found another 300 million bases of human genome that was not in the reference
sequence.[13]

[Protein](/wiki/Protein)-coding sequences account for only a very small
fraction of the genome (approximately 1.5%), and the rest is associated with
[non-coding RNA](/wiki/Non-coding_RNA) genes, [regulatory DNA
sequences](/wiki/Regulatory_sequences), [LINEs](/wiki/LINEs),
[SINEs](/wiki/Short_interspersed_nuclear_element), [introns](/wiki/Intron),
and sequences for which as yet [no function](/wiki/Noncoding_DNA) has been
determined.[14]

## Contents

  * 1 Sequencing
  * 2 Completeness
  * 3 Molecular organization and gene content
    * 3.1 Information content
  * 4 Coding vs. noncoding DNA
  * 5 Coding sequences (protein-coding genes)
  * 6 Noncoding DNA (ncDNA)
    * 6.1 Pseudogenes
    * 6.2 Genes for noncoding RNA (ncRNA)
    * 6.3 Introns and untranslated regions of mRNA
    * 6.4 Regulatory DNA sequences
    * 6.5 Repetitive DNA sequences
    * 6.6 Mobile genetic elements (transposons) and their relics
  * 7 Genomic variation in humans
    * 7.1 Human reference genome
    * 7.2 Measuring human genetic variation
      * 7.2.1 Mapping human genomic variation
    * 7.3 Structural variation
    * 7.4 SNP frequency across the human genome
    * 7.5 Personal genomes
    * 7.6 Human knockouts
  * 8 Human genetic disorders
  * 9 Evolution
  * 10 Mitochondrial DNA
  * 11 Epigenome
  * 12 See also
  * 13 References
  * 14 External links

## Sequencing[[edit](/w/index.php?title=Human_genome&action=edit&section=1)]

The first human genome sequences were published in nearly complete draft form
in February 2001 by the [Human Genome Project](/wiki/Human_Genome_Project)[15]
and [Celera Corporation](/wiki/Celera_Corporation).[16] Completion of the
Human Genome Project's sequencing effort was announced in 2004 with the
publication of a draft genome sequence, leaving just 341 gaps in the sequence,
representing highly-repetitive and other DNA that could not be sequenced with
the technology available at the time.[8] The human genome was the first of all
vertebrates to be sequenced to such near-completion, and as of 2018, the
diploid genomes of over a million individual humans had been determined using
[next-generation sequencing](/wiki/Next-generation_sequencing).[17] In 2021 it
was reported that the T2T consortium had filled in all of the gaps. Thus there
came into existence a complete human genome with no gaps.[18]

These data are used worldwide in [biomedical
science](/wiki/Biomedical_science),
[anthropology](/wiki/Biological_anthropology), [forensics](/wiki/Forensic_DNA)
and other branches of science. Such genomic studies have led to advances in
the diagnosis and treatment of diseases, and to new insights in many fields of
biology, including [human evolution](/wiki/Human_evolution).

In June 2016, scientists formally announced [HGP-Write](/wiki
/Human_Genome_Project_-_Write), a plan to synthesize the human genome.[19][20]

## Completeness[[edit](/w/index.php?title=Human_genome&action=edit&section=2)]

Main article: [Human Genome Project § State of
completion](/wiki/Human_Genome_Project#State_of_completion)

Although the 'completion' of the human genome project was announced in
2001,[14] there remained hundreds of gaps, with about 5–10% of the total
sequence remaining undetermined. The missing genetic information was mostly in
repetitive [heterochromatic](/wiki/Heterochromatin) regions and near the
[centromeres](/wiki/Centromere) and [telomeres](/wiki/Telomere), but also some
gene-encoding [euchromatic](/wiki/Euchromatin) regions.[21] There remained 160
euchromatic gaps in 2015 when the sequences spanning another 50 formerly-
unsequenced regions were determined.[22] Only in 2020 was the first truly
complete telomere-to-telomere sequence of a human chromosome determined,
namely of the [X chromosome](/wiki/X_chromosome).[23] Level "complete genome"
(without Y chromosome) was achieved in May 2021.[24][25]

## Molecular organization and gene
content[[edit](/w/index.php?title=Human_genome&action=edit&section=3)]

See also: [Lists of human genes](/wiki/Lists_of_human_genes)

The total length of the human [reference genome](/wiki/Reference_genome), that
does not represent the sequence of any specific individual, is over 3 billion
base pairs. The genome is organized into 22 paired chromosomes, termed
[autosomes](/wiki/Autosome), plus the 23rd pair of [sex
chromosomes](/wiki/Sex_chromosome) (XX) in the female, and (XY) in the male.
These are all large linear DNA molecules contained within the cell nucleus.
The genome also includes the [mitochondrial DNA](/wiki/Mitochondrial_DNA), a
comparatively small circular molecule present in multiple copies in each the
[mitochondrion](/wiki/Mitochondrion).

Human reference genome data, by chromosome[26]

Chromosome Length  
([mm](/wiki/Millimetre)) Base  
pairs Variations Protein-  
coding  
genes Pseudo-  
genes Total  
long  
ncRNA Total  
small  
ncRNA miRNA rRNA snRNA snoRNA Misc  
ncRNA Links Centromere  
position  
([Mbp](/wiki/Mega_base_pairs)) Cumulative  
(%)

[1](/wiki/Chromosome_1_\(human\))

85

248,956,422

12,151,146

2058

1220

1200

496

134

66

221

145

192

[EBI](https://archive.today/20130414235101/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=1)

125

7.9

[2](/wiki/Chromosome_2_\(human\))

83

242,193,529

12,945,965

1309

1023

1037

375

115

40

161

117

176

[EBI](https://archive.today/20130414170207/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=2)

93.3

16.2

[3](/wiki/Chromosome_3_\(human\))

67

198,295,559

10,638,715

1078

763

711

298

99

29

138

87

134

[EBI](https://archive.today/20130414155057/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=3)

91

23

[4](/wiki/Chromosome_4_\(human\))

65

190,214,555

10,165,685

752

727

657

228

92

24

120

56

104

[EBI](https://archive.today/20130414184734/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=4)

50.4

29.6

[5](/wiki/Chromosome_5_\(human\))

62

181,538,259

9,519,995

876

721

844

235

83

25

106

61

119

[EBI](https://archive.today/20130414165438/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=5)

48.4

35.8

[6](/wiki/Chromosome_6_\(human\))

58

170,805,979

9,130,476

1048

801

639

234

81

26

111

73

105

[EBI](https://archive.today/20130414210620/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=6)

61

41.6

[7](/wiki/Chromosome_7_\(human\))

54

159,345,973

8,613,298

989

885

605

208

90

24

90

76

143

[EBI](https://archive.today/20130414191348/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=7)

59.9

47.1

[8](/wiki/Chromosome_8_\(human\))

50

145,138,636

8,221,520

677

613

735

214

80

28

86

52

82

[EBI](https://archive.today/20130414151536/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=8)

45.6

52

[9](/wiki/Chromosome_9_\(human\))

48

138,394,717

6,590,811

786

661

491

190

69

19

66

51

96

[EBI](https://archive.today/20130414154313/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=9)

49

56.3

[10](/wiki/Chromosome_10_\(human\))

46

133,797,422

7,223,944

733

568

579

204

64

32

87

56

89

[EBI](https://archive.today/20130414155104/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=10)

40.2

60.9

[11](/wiki/Chromosome_11_\(human\))

46

135,086,622

7,535,370

1298

821

710

233

63

24

74

76

97

[EBI](https://archive.today/20130414155450/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=11)

53.7

65.4

[12](/wiki/Chromosome_12_\(human\))

45

133,275,309

7,228,129

1034

617

848

227

72

27

106

62

115

[EBI](https://archive.today/20130414163842/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=12)

35.8

70

[13](/wiki/Chromosome_13_\(human\))

39

114,364,328

5,082,574

327

372

397

104

42

16

45

34

75

[EBI](https://archive.today/20130414153908/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=13)

17.9

73.4

[14](/wiki/Chromosome_14_\(human\))

36

107,043,718

4,865,950

830

523

533

239

92

10

65

97

79

[EBI](https://archive.today/20130414221716/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=14)

17.6

76.4

[15](/wiki/Chromosome_15_\(human\))

35

101,991,189

4,515,076

613

510

639

250

78

13

63

136

93

[EBI](https://archive.today/20130414185000/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=15)

19

79.3

[16](/wiki/Chromosome_16_\(human\))

31

90,338,345

5,101,702

873

465

799

187

52

32

53

58

51

[EBI](https://archive.today/20130414182905/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=16)

36.6

82

[17](/wiki/Chromosome_17_\(human\))

28

83,257,441

4,614,972

1197

531

834

235

61

15

80

71

99

[EBI](https://archive.today/20130414171249/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=17)

24

84.8

[18](/wiki/Chromosome_18_\(human\))

27

80,373,285

4,035,966

270

247

453

109

32

13

51

36

41

[EBI](https://archive.today/20130414160719/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=18)

17.2

87.4

[19](/wiki/Chromosome_19_\(human\))

20

58,617,616

3,858,269

1472

512

628

179

110

13

29

31

61

[EBI](https://archive.today/20130414165626/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=19)

26.5

89.3

[20](/wiki/Chromosome_20_\(human\))

21

64,444,167

3,439,621

544

249

384

131

57

15

46

37

68

[EBI](https://archive.today/20130414185621/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=20)

27.5

91.4

[21](/wiki/Chromosome_21_\(human\))

16

46,709,983

2,049,697

234

185

305

71

16

5

21

19

24

[EBI](https://archive.today/20130414191700/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=21)

13.2

92.6

[22](/wiki/Chromosome_22_\(human\))

17

50,818,468

2,135,311

488

324

357

78

31

5

23

23

62

[EBI](https://archive.today/20130414213655/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=22)

14.7

93.8

[X](/wiki/X_chromosome)

53

156,040,895

5,753,881

842

874

271

258

128

22

85

64

100

[EBI](https://archive.today/20130414192751/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=X)

60.6

99.1

[Y](/wiki/Y_chromosome)

20

57,227,415

211,643

71

388

71

30

15

7

17

3

8

[EBI](https://archive.today/20130414161928/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=Y)

10.4

100

[mtDNA](/wiki/Mitochondrial_DNA)

0.0054

16,569

929

13

0

0

24

0

2

0

0

0

[EBI](https://archive.today/20130414220526/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=MT)

N/A

100

total

3,088,286,401

155,630,645

20412

14600

14727

5037

1756

532

1944

1521

2213

_Original analysis published in the [Ensembl](/wiki/Ensembl) database at the
[European Bioinformatics Institute](/wiki/European_Bioinformatics_Institute)
(EBI) and [Wellcome Trust Sanger
Institute](/wiki/Wellcome_Trust_Sanger_Institute). Chromosome lengths
estimated by multiplying the number of base pairs by 0.34 nanometers (distance
between base pairs in the most common structure of the [DNA double
helix](/wiki/DNA#Properties); a recent estimate of human chromosome lengths
based on updated data reports 205.00 cm for the diploid male genome and 208.23
cm for female, corresponding to weights of 6.41 and 6.51 picograms (pg),
respectively[27]). Number of proteins is based on the number of initial
[precursor mRNA](/wiki/Precursor_mRNA) transcripts, and does not include
products of [alternative pre-mRNA splicing](/wiki/Alternative_splicing), or
modifications to protein structure that occur after
[translation](/wiki/Translation_\(biology\))._

_[Variations](/wiki/Human_genetic_variation) are unique DNA sequence
differences that have been identified in the individual human genome sequences
analyzed by Ensembl as of December 2016. The number of identified variations
is expected to increase as further [personal genomes](/wiki/Personal_genomics)
are sequenced and analyzed. In addition to the gene content shown in this
table, a large number of non-expressed functional sequences have been
identified throughout the human genome (see below). Links open windows to the
reference chromosome sequences in the EBI genome browser._

_Small [non-coding RNAs](/wiki/Non-coding_RNA) are RNAs of as many as 200
bases that do not have protein-coding potential. These include:
[microRNAs](/wiki/MicroRNA), or miRNAs (post-transcriptional regulators of
gene expression), [small nuclear RNAs](/wiki/Small_nuclear_RNA), or snRNAs
(the RNA components of [spliceosomes](/wiki/Spliceosome)), and [small
nucleolar RNAs](/wiki/Small_nucleolar_RNA), or snoRNA (involved in guiding
chemical modifications to other RNA molecules). [Long non-coding RNAs](/wiki
/Long_non-coding_RNA) are RNA molecules longer than 200 bases that do not have
protein-coding potential. These include: [ribosomal
RNAs](/wiki/Ribosomal_RNA), or rRNAs (the RNA components of
[ribosomes](/wiki/Ribosome)), and a variety of other long RNAs that are
involved in [regulation of gene
expression](/wiki/Regulation_of_gene_expression),
[epigenetic](/wiki/Epigenetic) modifications of DNA nucleotides and
[histone](/wiki/Histone) proteins, and regulation of the activity of protein-
coding genes. Small discrepancies between total-small-ncRNA numbers and the
numbers of specific types of small ncNRAs result from the former values being
sourced from Ensembl release 87 and the latter from Ensembl release 68._

_The number of genes in the human genome is not entirely clear because the
function of numerous [transcripts](/wiki/Transcription_\(biology\)) remains
unclear. This is especially true for [non-coding RNA](/wiki/Non-coding_RNA).
The number of protein-coding genes is better known but there are still on the
order of 1,400 questionable genes which may or may not encode functional
proteins, usually encoded by short [open reading
frames](/wiki/Open_reading_frame)._

Discrepancies in human gene number estimates among different databases, as of
July 2018[28]

Gencode[29] Ensembl[30] Refseq[31] CHESS[32]

protein-coding genes

19,901

20,376

20,345

21,306

lncRNA genes

15,779

14,720

17,712

18,484

antisense RNA

5501

28

2694

miscellaneous RNA

2213

2222

13,899

4347

Pseudogenes

14,723

1740

15,952

total transcripts

203,835

203,903

154,484

328,827

![](//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Genes_and_base_pairs_o
n_chromosomes.svg/400px-Genes_and_base_pairs_on_chromosomes.svg.png)

Number of genes (orange) and base pairs (green, in millions) on each
chromosome.

### Information
content[[edit](/w/index.php?title=Human_genome&action=edit&section=4)]

The [haploid](/wiki/Haploid) human genome (23
[chromosomes](/wiki/Chromosomes)) is about 3 billion base pairs long and
contains around 30,000 genes.[33] Since every base pair can be coded by 2
bits, this is about 750 [megabytes](/wiki/Megabyte) of data. An individual
somatic ([diploid](/wiki/Diploid)) cell contains twice this amount, that is,
about 6 billion base pairs. Men have fewer than women because the Y chromosome
is about 57 million base pairs whereas the X is about 156 million. Since
individual genomes vary in sequence by less than 1% from each other, the
variations of a given human's genome from a common reference can be
[losslessly compressed](/wiki/Lossless_data_compression) to roughly 4
megabytes.[34]

The [entropy rate](/wiki/Entropy_rate) of the genome differs significantly
between coding and non-coding sequences. It is close to the maximum of 2 bits
per base pair for the coding sequences (about 45 million base pairs), but less
for the non-coding parts. It ranges between 1.5 and 1.9 bits per base pair for
the individual chromosome, except for the Y-chromosome, which has an entropy
rate below 0.9 bits per base pair.[35]

## Coding vs. noncoding
DNA[[edit](/w/index.php?title=Human_genome&action=edit&section=5)]

The content of the human genome is commonly divided into coding and noncoding
DNA sequences. [Coding DNA](/wiki/Coding_region) is defined as those sequences
that can be transcribed into [mRNA](/wiki/MRNA) and
[translated](/wiki/Translation_\(biology\)) into proteins during the human
life cycle; these sequences occupy only a small fraction of the genome (<2%).
[Noncoding DNA](/wiki/Noncoding_DNA) is made up of all of those sequences (ca.
98% of the genome) that are not used to encode proteins.

Some noncoding DNA contains genes for RNA molecules with important biological
functions ([noncoding RNA](/wiki/Noncoding_RNA), for example [ribosomal
RNA](/wiki/Ribosomal_RNA) and [transfer RNA](/wiki/Transfer_RNA)). The
exploration of the function and evolutionary origin of noncoding DNA is an
important goal of contemporary genome research, including the
[ENCODE](/wiki/ENCODE) (Encyclopedia of DNA Elements) project, which aims to
survey the entire human genome, using a variety of experimental tools whose
results are indicative of molecular activity.

Because non-coding DNA greatly outnumbers coding DNA, the concept of the
sequenced genome has become a more focused analytical concept than the
classical concept of the DNA-coding gene.[36][37]

## Coding sequences (protein-coding genes)
[[edit](/w/index.php?title=Human_genome&action=edit&section=6)]

For a comprehensive list, see [List of human protein-coding genes 1](/wiki
/List_of_human_protein-coding_genes_1), [List of human protein-coding genes
2](/wiki/List_of_human_protein-coding_genes_2), [List of human protein-coding
genes 3](/wiki/List_of_human_protein-coding_genes_3), and [List of human
protein-coding genes 4](/wiki/List_of_human_protein-coding_genes_4).

![](//upload.wikimedia.org/wikipedia/commons/thumb/6/6b/Human_genome_by_functi
ons.svg/480px-Human_genome_by_functions.svg.png)

Human genes categorized by function of the transcribed proteins, given both as
number of encoding genes and percentage of all genes.[38]

Protein-coding sequences represent the most widely studied and best understood
component of the human genome. These sequences ultimately lead to the
production of all human [proteins](/wiki/Protein), although several biological
processes (e.g. [DNA rearrangements](/wiki/V\(D\)J_recombination) and
[alternative pre-mRNA splicing](/wiki/Alternative_splicing)) can lead to the
production of many more unique proteins than the number of protein-coding
genes. The complete modular protein-coding capacity of the genome is contained
within the [exome](/wiki/Exome), and consists of DNA sequences encoded by
[exons](/wiki/Exon) that can be translated into proteins. Because of its
biological importance, and the fact that it constitutes less than 2% of the
genome, sequencing of the exome was the first major milepost of the Human
Genome Project.

**Number of protein-coding genes**. About 20,000 human proteins have been annotated in databases such as [Uniprot](/wiki/Uniprot).[39] Historically, estimates for the number of protein genes have varied widely, ranging up to 2,000,000 in the late 1960s,[40] but several researchers pointed out in the early 1970s that the estimated [mutational load](/wiki/Genetic_load) from deleterious mutations placed an upper limit of approximately 40,000 for the total number of functional loci (this includes protein-coding and functional non-coding genes).[41] The number of human protein-coding genes is not significantly larger than that of many less complex organisms, such as the [roundworm](/wiki/Caenorhabditis_elegans) and the [fruit fly](/wiki/Drosophila_melanogaster). This difference may result from the extensive use of [alternative pre-mRNA splicing](/wiki/Alternative_splicing) in humans, which provides the ability to build a very large number of modular proteins through the selective incorporation of exons. 

**Protein-coding capacity per chromosome**. Protein-coding genes are distributed unevenly across the chromosomes, ranging from a few dozen to more than 2000, with an especially high [gene density](/wiki/Gene_density) within chromosomes 1, 11, and 19. Each chromosome contains various gene-rich and gene-poor regions, which may be correlated with [chromosome bands](/wiki/Cytogenetics) and [GC-content](/wiki/GC-content).[42] The significance of these nonrandom patterns of gene density is not well understood.[43]

**Size of protein-coding genes**. The size of protein-coding genes within the human genome shows enormous variability. For example, the gene for [histone H1a](/wiki/Histone_H1) (HIST1HIA) is relatively small and simple, lacking introns and encoding an 781 nucleotide-long mRNA that produces a 215 amino acid protein from its 648 nucleotide [open reading frame](/wiki/Open_reading_frame). [Dystrophin](/wiki/Dystrophin) (DMD) was the largest protein-coding gene in the 2001 human reference genome, spanning a total of 2.2 million nucleotides,[44] while more recent systematic meta-analysis of updated human genome data identified an even larger protein-coding gene, _RBFOX1_ (RNA binding protein, fox-1 homolog 1), spanning a total of 2.47 million nucleotides.[45] [Titin](/wiki/Titin) (TTN) has the longest coding sequence (114,414 nucleotides), the largest number of [exons](/wiki/Exons) (363),[44] and the longest single exon (17,106 nucleotides). As estimated based on a curated set of protein-coding genes over the whole genome, the median size is 26,288 nucleotides (mean = 66,577), the median exon size, 133 nucleotides (mean = 309), the median number of exons, 8 (mean = 11), and the median encoded protein is 425 amino acids (mean = 553) in length.[45]

Examples of human protein-coding genes[46]__

Protein Chrom Gene Length Exons Exon length Intron length Alt splicing

[Breast cancer type 2 susceptibility protein](/wiki/BRCA2)

13

[BRCA2](http://omim.org/entry/600185)

83,736

27

11,386

72,350

yes

[Cystic fibrosis transmembrane conductance
regulator](/wiki/Cystic_fibrosis_transmembrane_conductance_regulator)

7

[CFTR](http://omim.org/entry/602421)

202,881

27

4,440

198,441

yes

[Cytochrome b](/wiki/Cytochrome_b)

MT

[MTCYB](http://omim.org/entry/516020)

1,140

1

1,140

0

no

[Dystrophin](/wiki/Dystrophin)

X

[DMD](http://omim.org/entry/300377)

2,220,381

79

10,500

2,209,881

yes

[Glyceraldehyde-3-phosphate
dehydrogenase](/wiki/Glyceraldehyde-3-phosphate_dehydrogenase)

12

[GAPDH](http://omim.org/entry/138400)

4,444

9

1,425

3,019

yes

[Hemoglobin beta subunit](/wiki/Hemoglobin)

11

[HBB](http://omim.org/entry/141900?search=hbb%20gene&highlight=gene%20hbb)

1,605

3

626

979

no

[Histone H1A](/wiki/Histone_H1)

6

[HIST1H1A](http://omim.org/entry/142709?search=histone%20h1&highlight=h1%20his
tone)

781

1

781

0

no

[Titin](/wiki/Titin)

2

[TTN](http://omim.org/entry/188840?search=ttn&highlight=ttn)

281,434

364

104,301

177,133

yes

## Noncoding DNA
(ncDNA)[[edit](/w/index.php?title=Human_genome&action=edit&section=7)]

Main article: [Noncoding DNA](/wiki/Noncoding_DNA)

Noncoding DNA is defined as all of the DNA sequences within a genome that are
not found within protein-coding exons, and so are never represented within the
amino acid sequence of expressed proteins. By this definition, more than 98%
of the human genomes is composed of ncDNA.

Numerous classes of noncoding DNA have been identified, including genes for
noncoding RNA (e.g. tRNA and rRNA), pseudogenes, introns, untranslated regions
of mRNA, regulatory DNA sequences, repetitive DNA sequences, and sequences
related to mobile genetic elements.

Numerous sequences that are included within genes are also defined as
noncoding DNA. These include genes for noncoding RNA (e.g. tRNA, rRNA), and
untranslated components of protein-coding genes (e.g. introns, and 5' and 3'
untranslated regions of mRNA).

Protein-coding sequences (specifically, coding [exons](/wiki/Exon)) constitute
less than 1.5% of the human genome.[14] In addition, about 26% of the human
genome is [introns](/wiki/Introns).[47] Aside from genes (exons and introns)
and known regulatory sequences (8–20%), the human genome contains regions of
noncoding DNA. The exact amount of noncoding DNA that plays a role in cell
physiology has been hotly debated. Recent analysis by the
[ENCODE](/wiki/ENCODE) project indicates that 80% of the entire human genome
is either transcribed, binds to regulatory proteins, or is associated with
some other biochemical activity.[12]

It however remains controversial whether all of this biochemical activity
contributes to cell physiology, or whether a substantial portion of this is
the result transcriptional and biochemical noise, which must be actively
filtered out by the organism.[48] Excluding protein-coding sequences, introns,
and regulatory regions, much of the non-coding DNA is composed of: Many DNA
sequences that do not play a role in [gene expression](/wiki/Gene_expression)
have important biological functions. [Comparative
genomics](/wiki/Comparative_genomics) studies indicate that about 5% of the
genome contains sequences of noncoding DNA that are highly
[conserved](/wiki/Conserved_sequence), sometimes on time-scales representing
hundreds of millions of years, implying that these noncoding regions are under
strong [evolutionary](/wiki/Evolution) pressure and [positive
selection](/wiki/Natural_selection).[49]

Many of these sequences regulate the structure of chromosomes by limiting the
regions of [heterochromatin](/wiki/Heterochromatin) formation and regulating
structural features of the chromosomes, such as the
[telomeres](/wiki/Telomeres) and [centromeres](/wiki/Centromeres). Other
noncoding regions serve as [origins of DNA
replication](/wiki/DNA_replication#Origins). Finally several regions are
transcribed into functional noncoding RNA that regulate the expression of
protein-coding genes (for example[50] ), mRNA translation and stability (see
[miRNA](/wiki/MiRNA)), chromatin structure (including [histone](/wiki/Histone)
modifications, for example[51] ), DNA methylation (for example[52] ), DNA
recombination (for example[53] ), and cross-regulate other noncoding RNAs (for
example[54] ). It is also likely that many transcribed noncoding regions do
not serve any role and that this transcription is the product of non-specific
[RNA Polymerase](/wiki/RNA_Polymerase) activity.[48]

### Pseudogenes[[edit](/w/index.php?title=Human_genome&action=edit&section=8)]

Main article: [Pseudogene](/wiki/Pseudogene)

Pseudogenes are inactive copies of protein-coding genes, often generated by
[gene duplication](/wiki/Gene_duplication), that have become nonfunctional
through the accumulation of inactivating mutations. The number of pseudogenes
in the human genome is on the order of 13,000,[55] and in some chromosomes is
nearly the same as the number of functional protein-coding genes. Gene
duplication is a major mechanism through which new genetic material is
generated during [molecular evolution](/wiki/Molecular_evolution).

For example, the [olfactory receptor](/wiki/Olfactory_receptor) gene family is
one of the best-documented examples of pseudogenes in the human genome. More
than 60 percent of the genes in this family are non-functional pseudogenes in
humans. By comparison, only 20 percent of genes in the mouse olfactory
receptor gene family are pseudogenes. Research suggests that this is a
species-specific characteristic, as the most closely related primates all have
proportionally fewer pseudogenes. This genetic discovery helps to explain the
less acute sense of smell in humans relative to other mammals.[56]

### Genes for noncoding RNA
(ncRNA)[[edit](/w/index.php?title=Human_genome&action=edit&section=9)]

Main article: [Noncoding RNA](/wiki/Noncoding_RNA)

Noncoding RNA molecules play many essential roles in cells, especially in the
many reactions of [protein synthesis](/wiki/Translation_\(biology\)) and [RNA
processing](/wiki/Post-transcriptional_modification). Noncoding RNA include
[tRNA](/wiki/TRNA), [ribosomal](/wiki/Ribosome) RNA,
[microRNA](/wiki/MicroRNA), [snRNA](/wiki/SnRNA) and other non-coding RNA
genes including about 60,000 [long non-coding RNAs](/wiki/LncRNA)
(lncRNAs).[12][57][58][59] Although the number of reported lncRNA genes
continues to rise and the exact number in the human genome is yet to be
defined, many of them are argued to be non-functional.[60]

Many ncRNAs are critical elements in gene regulation and expression. Noncoding
RNA also contributes to epigenetics, transcription, RNA splicing, and the
translational machinery. The role of RNA in genetic regulation and disease
offers a new potential level of unexplored genomic complexity.[61]

### Introns and untranslated regions of
mRNA[[edit](/w/index.php?title=Human_genome&action=edit&section=10)]

In addition to the ncRNA molecules that are encoded by discrete genes, the
initial transcripts of protein coding genes usually contain extensive
noncoding sequences, in the form of [introns](/wiki/Introns), [5'-untranslated
regions](/wiki/Five_prime_untranslated_region) (5'-UTR), and [3'-untranslated
regions](/wiki/Three_prime_untranslated_region) (3'-UTR). Within most protein-
coding genes of the human genome, the length of intron sequences is 10- to
100-times the length of exon sequences.

### Regulatory DNA
sequences[[edit](/w/index.php?title=Human_genome&action=edit&section=11)]

The human genome has many different [regulatory
sequences](/wiki/Regulatory_regions) which are crucial to controlling [gene
expression](/wiki/Gene_expression). Conservative estimates indicate that these
sequences make up 8% of the genome,[62] however extrapolations from the
[ENCODE](/wiki/ENCODE) project give that 20[63]-40%[64] of the genome is gene
regulatory sequence. Some types of non-coding DNA are genetic "switches" that
do not encode proteins, but do regulate when and where genes are expressed
(called [enhancers](/wiki/Enhancer_\(genetics\))).[65]

Regulatory sequences have been known since the late 1960s.[66] The first
identification of regulatory sequences in the human genome relied on
recombinant DNA technology.[67] Later with the advent of genomic sequencing,
the identification of these sequences could be inferred by evolutionary
conservation. The evolutionary branch between the [primates](/wiki/Primates)
and [mouse](/wiki/Mouse), for example, occurred 70–90 million years ago.[68]
So computer comparisons of gene sequences that identify [conserved non-coding
sequences](/wiki/Conserved_non-coding_sequence) will be an indication of their
importance in duties such as gene regulation.[69]

Other genomes have been sequenced with the same intention of aiding
conservation-guided methods, for exampled the [pufferfish](/wiki/Pufferfish)
genome.[70] However, regulatory sequences disappear and re-evolve during
evolution at a high rate.[71][72][73]

As of 2012, the efforts have shifted toward finding interactions between DNA
and regulatory proteins by the technique [ChIP-Seq](/wiki/ChIP-Seq), or gaps
where the DNA is not packaged by [histones](/wiki/Histone) ([DNase
hypersensitive sites](/wiki/Hypersensitive_site)), both of which tell where
there are active regulatory sequences in the investigated cell type.[62]

### Repetitive DNA
sequences[[edit](/w/index.php?title=Human_genome&action=edit&section=12)]

[Repetitive DNA sequences](/wiki/Repetitive_DNA) comprise approximately 50% of
the human genome.[74]

About 8% of the human genome consists of tandem DNA arrays or tandem repeats,
low complexity repeat sequences that have multiple adjacent copies (e.g.
"CAGCAGCAG...").[75] The tandem sequences may be of variable lengths, from two
nucleotides to tens of nucleotides. These sequences are highly variable, even
among closely related individuals, and so are used for [genealogical DNA
testing](/wiki/Genealogical_DNA_testing) and [forensic DNA
analysis](/wiki/Forensic_DNA).[76]

Repeated sequences of fewer than ten nucleotides (e.g. the dinucleotide repeat
(AC)n) are termed microsatellite sequences. Among the microsatellite
sequences, trinucleotide repeats are of particular importance, as sometimes
occur within [coding regions](/wiki/Coding_region) of genes for proteins and
may lead to genetic disorders. For example, Huntington's disease results from
an expansion of the trinucleotide repeat (CAG)n within the
_[Huntingtin](/wiki/Huntingtin)_ gene on human chromosome 4.
[Telomeres](/wiki/Telomeres) (the ends of linear chromosomes) end with a
microsatellite hexanucleotide repeat of the sequence (TTAGGG)n.

Tandem repeats of longer sequences (arrays of repeated sequences 10–60
nucleotides long) are termed [minisatellites](/wiki/Minisatellite).

### Mobile genetic elements (transposons) and their
relics[[edit](/w/index.php?title=Human_genome&action=edit&section=13)]

[Transposable genetic elements](/wiki/Transposable_element), DNA sequences
that can replicate and insert copies of themselves at other locations within a
host genome, are an abundant component in the human genome. The most abundant
transposon lineage, _Alu_, has about 50,000 active copies,[77] and can be
inserted into intragenic and intergenic regions.[78] One other lineage,
LINE-1, has about 100 active copies per genome (the number varies between
people).[79] Together with non-functional relics of old transposons, they
account for over half of total human DNA.[80] Sometimes called "jumping
genes", transposons have played a major role in sculpting the human genome.
Some of these sequences represent [endogenous
retroviruses](/wiki/Endogenous_retroviruses), DNA copies of viral sequences
that have become permanently integrated into the genome and are now passed on
to succeeding generations.

Mobile elements within the human genome can be classified into [LTR
retrotransposons](/wiki/Retrotransposon#LTR_retrotransposons) (8.3% of total
genome), [SINEs](/wiki/Short_interspersed_nuclear_element) (13.1% of total
genome) including [Alu elements](/wiki/Alu_elements),
[LINEs](/wiki/Long_interspersed_nuclear_element) (20.4% of total genome), SVAs
and [Class II DNA transposons](/wiki/Transposable_element#Classification)
(2.9% of total genome).

## Genomic variation in
humans[[edit](/w/index.php?title=Human_genome&action=edit&section=14)]

Main article: [Human genetic variation](/wiki/Human_genetic_variation)

### Human reference
genome[[edit](/w/index.php?title=Human_genome&action=edit&section=15)]

With the exception of identical twins, all humans show significant variation
in genomic DNA sequences. The human [reference genome](/wiki/Reference_genome)
(HRG) is used as a standard sequence reference.

There are several important points concerning the human reference genome:

  * The HRG is a haploid sequence. Each chromosome is represented once.
  * The HRG is a composite sequence, and does not correspond to any actual human individual.
  * The HRG is periodically updated to correct errors, ambiguities, and unknown "gaps".
  * The HRG in no way represents an "ideal" or "perfect" human individual. It is simply a standardized representation or model that is used for comparative purposes.

The [Genome Reference Consortium](/wiki/Genome_Reference_Consortium) is
responsible for updating the HRG. Version 38 was released in December
2013.[81]

### Measuring human genetic
variation[[edit](/w/index.php?title=Human_genome&action=edit&section=16)]

Most studies of human genetic variation have focused on [single-nucleotide
polymorphisms](/wiki/Single-nucleotide_polymorphism) (SNPs), which are
substitutions in individual bases along a chromosome. Most analyses estimate
that SNPs occur 1 in 1000 base pairs, on average, in the
[euchromatic](/wiki/Euchromatin) human genome, although they do not occur at a
uniform density. Thus follows the popular statement that "we are all,
regardless of [race](/wiki/Race_\(classification_of_human_beings\)),
genetically 99.9% the same",[82] although this would be somewhat qualified by
most geneticists. For example, a much larger fraction of the genome is now
thought to be involved in [copy number
variation](/wiki/Copy_number_variation).[83] A large-scale collaborative
effort to catalog SNP variations in the human genome is being undertaken by
the [International HapMap Project](/wiki/International_HapMap_Project).

The genomic loci and length of certain types of small [repetitive
sequences](/wiki/Repeated_sequence_\(DNA\)) are highly variable from person to
person, which is the basis of [DNA fingerprinting](/wiki/DNA_fingerprinting)
and [DNA paternity testing](/wiki/DNA_paternity_testing) technologies. The
[heterochromatic](/wiki/Heterochromatin) portions of the human genome, which
total several hundred million base pairs, are also thought to be quite
variable within the human population (they are so repetitive and so long that
they cannot be accurately sequenced with current technology). These regions
contain few genes, and it is unclear whether any significant
[phenotypic](/wiki/Phenotype) effect results from typical variation in repeats
or heterochromatin.

Most gross genomic mutations in [gamete](/wiki/Gamete) germ cells probably
result in inviable embryos; however, a number of human diseases are related to
large-scale genomic abnormalities. [Down syndrome](/wiki/Down_syndrome),
[Turner Syndrome](/wiki/Turner_Syndrome), and a number of other diseases
result from [nondisjunction](/wiki/Nondisjunction) of entire chromosomes.
[Cancer](/wiki/Cancer) cells frequently have [aneuploidy](/wiki/Aneuploidy) of
chromosomes and chromosome arms, although a [cause and
effect](/wiki/Causality) relationship between aneuploidy and cancer has not
been established.

#### Mapping human genomic
variation[[edit](/w/index.php?title=Human_genome&action=edit&section=17)]

Whereas a genome sequence lists the order of every DNA base in a genome, a
genome map identifies the landmarks. A genome map is less detailed than a
genome sequence and aids in navigating around the genome.[84][85]

An example of a variation map is the HapMap being developed by the
[International HapMap Project](/wiki/International_HapMap_Project). The HapMap
is a [haplotype](/wiki/Haplotype) map of the human genome, "which will
describe the common patterns of human DNA sequence variation."[86] It catalogs
the patterns of small-scale variations in the genome that involve single DNA
letters, or bases.

Researchers published the first sequence-based map of large-scale structural
variation across the human genome in the journal
_[Nature](/wiki/Nature_\(journal\))_ in May 2008.[87][88] Large-scale
structural variations are differences in the genome among people that range
from a few thousand to a few million DNA bases; some are gains or losses of
stretches of genome sequence and others appear as re-arrangements of stretches
of sequence. These variations include [differences in the number of
copies](/wiki/Copy_number_variation) individuals have of a particular gene,
deletions, translocations and inversions.

### Structural
variation[[edit](/w/index.php?title=Human_genome&action=edit&section=18)]

Structural variation refers to genetic variants that affect larger segments of
the human genome, as opposed to point mutations. Often, structural variants
(SVs) are defined as variants of 50 base pairs (bp) or greater, such as
deletions, duplications, insertions, inversions and other rearrangements.
About 90% of structural variants are noncoding deletions but most individuals
have more than a thousand such deletions; the size of deletions ranges from
dozens of base pairs to tens of thousands of bp.[89] On average, individuals
carry ~3 rare structural variants that alter coding regions, e.g. delete
[exons](/wiki/Exon). About 2% of individuals carry ultra-rare megabase-scale
structural variants, especially rearrangements. That is, millions of base
pairs may be inverted within a chromosome; ultra-rare means that they are only
found in individuals or their family members and thus have arisen very
recently.[89]

### SNP frequency across the human
genome[[edit](/w/index.php?title=Human_genome&action=edit&section=19)]

Single-nucleotide polymorphisms (SNPs) do not occur homogeneously across the
human genome. In fact, there is enormous diversity in [SNP](/wiki/Single-
nucleotide_polymorphism) frequency between genes, reflecting different
selective pressures on each gene as well as different mutation and
recombination rates across the genome. However, studies on SNPs are biased
towards coding regions, the data generated from them are unlikely to reflect
the overall distribution of SNPs throughout the genome. Therefore, the [SNP
Consortium](/wiki/SNP_Consortium) protocol was designed to identify SNPs with
no bias towards coding regions and the Consortium's 100,000 SNPs generally
reflect sequence diversity across the human chromosomes. The [SNP
Consortium](/wiki/SNP_Consortium) aims to expand the number of SNPs identified
across the genome to 300 000 by the end of the first quarter of 2001.[90]

![](//upload.wikimedia.org/wikipedia/commons/thumb/5/55/TSC_SNP_Distribution.j
pg/220px-TSC_SNP_Distribution.jpg)

TSC SNP distribution along the long arm of chromosome 22 (from
<https://web.archive.org/web/20130903043223/http://snp.cshl.org/> ). Each
column represents a 1 Mb interval; the approximate cytogenetic position is
given on the x-axis. Clear peaks and troughs of SNP density can be seen,
possibly reflecting different rates of mutation, recombination and selection.

Changes in **non-coding sequence** and synonymous changes in **coding
sequence** are generally more common than non-synonymous changes, reflecting
greater selective pressure reducing diversity at positions dictating amino
acid identity. Transitional changes are more common than transversions, with
CpG dinucleotides showing the highest mutation rate, presumably due to
deamination.

### Personal
genomes[[edit](/w/index.php?title=Human_genome&action=edit&section=20)]

See also: [Personal genomics](/wiki/Personal_genomics)

A personal genome sequence is a (nearly) complete
[sequence](/wiki/DNA_sequencing) of the chemical base pairs that make up the
[DNA](/wiki/DNA) of a single person. Because medical treatments have different
effects on different people due to genetic variations such as [single-
nucleotide polymorphisms](/wiki/Single-nucleotide_polymorphisms) (SNPs), the
analysis of personal genomes may lead to personalized medical treatment based
on individual genotypes.[91]

The first personal genome sequence to be determined was that of [Craig
Venter](/wiki/Craig_Venter) in 2007. Personal genomes had not been sequenced
in the public Human Genome Project to protect the identity of volunteers who
provided DNA samples. That sequence was derived from the DNA of several
volunteers from a diverse population.[92] However, early in the Venter-led
[Celera Genomics](/wiki/Celera_Genomics) genome sequencing effort the decision
was made to switch from sequencing a composite sample to using DNA from a
single individual, later revealed to have been Venter himself. Thus the Celera
human genome sequence released in 2000 was largely that of one man. Subsequent
replacement of the early composite-derived data and determination of the
diploid sequence, representing both sets of [chromosomes](/wiki/Chromosomes),
rather than a haploid sequence originally reported, allowed the release of the
first personal genome.[93] In April 2008, that of [James
Watson](/wiki/James_Watson) was also completed. In 2009, Stephen Quake
published his own genome sequence derived from a sequencer of his own design,
the Heliscope.[94] A Stanford team led by [Euan Ashley](/wiki/Euan_Ashley)
published a framework for the medical interpretation of human genomes
implemented on Quake’s genome and made whole genome-informed medical decisions
for the first time.[95] That team further extended the approach to the West
family, the first family sequenced as part of Illumina’s Personal Genome
Sequencing program.[96] Since then hundreds of personal genome sequences have
been released,[97] including those of [Desmond
Tutu](/wiki/Desmond_Tutu),[98][99] and of a [Paleo-Eskimo](/wiki/Paleo-
Eskimo).[100] In 2012, the whole genome sequences of two family trios among
1092 genomes was made public.[3] In November 2013, a Spanish family made four
personal exome datasets (about 1% of the genome) publicly available under a
[Creative Commons public domain
license](/wiki/CC0#Zero_.2F_Public_domain).[101][102] The [Personal Genome
Project](/wiki/Personal_Genome_Project) (started in 2005) is among the few to
make both genome sequences and corresponding medical phenotypes publicly
available.[103][104]

The sequencing of individual genomes further unveiled levels of genetic
complexity that had not been appreciated before. Personal genomics helped
reveal the significant level of diversity in the human genome attributed not
only to SNPs but structural variations as well. However, the application of
such knowledge to the treatment of disease and in the medical field is only in
its very beginnings.[105] [Exome sequencing](/wiki/Exome_sequencing) has
become increasingly popular as a tool to aid in diagnosis of genetic disease
because the exome contributes only 1% of the genomic sequence but accounts for
roughly 85% of mutations that contribute significantly to disease.[106]

### Human
knockouts[[edit](/w/index.php?title=Human_genome&action=edit&section=21)]

In humans, [gene knockouts](/wiki/Gene_knockouts) naturally occur as
[heterozygous](/wiki/Heterozygous) or [homozygous](/wiki/Homozygous) [loss-of-
function](/wiki/Loss-of-function) gene knockouts. These knockouts are often
difficult to distinguish, especially within
[heterogeneous](/wiki/Heterogeneous) genetic backgrounds. They are also
difficult to find as they occur in low frequencies.

![](//upload.wikimedia.org/wikipedia/commons/thumb/9/96/Gene_Knockouts_in_Outb
red_vs._Parentally-related_populations.jpg/220px-Gene_Knockouts_in_Outbred_vs
._Parentally-related_populations.jpg)

Populations with a high level of parental-relatedness result in a larger
number of homozygous gene knockouts as compared to outbred populations.[107]

Populations with high rates of [consanguinity](/wiki/Consanguinity), such as
countries with high rates of first-cousin marriages, display the highest
frequencies of homozygous gene knockouts. Such populations include Pakistan,
Iceland, and Amish populations. These populations with a high level of
parental-relatedness have been subjects of human knock out research which has
helped to determine the function of specific genes in humans. By
distinguishing specific knockouts, researchers are able to use phenotypic
analyses of these individuals to help characterize the gene that has been
knocked out.

![](//upload.wikimedia.org/wikipedia/commons/thumb/d/d4/Consanguineous_Mating_
resulting_in_Knockout.jpg/220px-
Consanguineous_Mating_resulting_in_Knockout.jpg)

A pedigree displaying a first-cousin mating (carriers both carrying
heterozygous knockouts mating as marked by double line) leading to offspring
possessing a homozygous gene knockout.

Knockouts in specific genes can cause genetic diseases, potentially have
beneficial effects, or even result in no phenotypic effect at all. However,
determining a knockout's phenotypic effect and in humans can be challenging.
Challenges to characterizing and clinically interpreting knockouts include
difficulty calling of DNA variants, determining disruption of protein function
(annotation), and considering the amount of influence
[mosaicism](/wiki/Mosaicism) has on the phenotype.[107]

One major study that investigated human knockouts is the Pakistan Risk of
Myocardial Infarction study. It was found that individuals possessing a
heterozygous loss-of-function gene knockout for the [APOC3](/wiki/APOC3) gene
had lower triglycerides in the blood after consuming a high fat meal as
compared to individuals without the mutation. However, individuals possessing
homozygous loss-of-function gene knockouts of the APOC3 gene displayed the
lowest level of triglycerides in the blood after the fat load test, as they
produce no functional APOC3 protein.[108]

## Human genetic
disorders[[edit](/w/index.php?title=Human_genome&action=edit&section=22)]

Further information: [Genetic disorder](/wiki/Genetic_disorder)

Most aspects of human biology involve both genetic (inherited) and non-genetic
(environmental) factors. Some inherited variation influences aspects of our
biology that are not medical in nature (height, eye color, ability to taste or
smell certain compounds, etc.). Moreover, some genetic disorders only cause
disease in combination with the appropriate environmental factors (such as
diet). With these caveats, genetic disorders may be described as clinically
defined diseases caused by genomic DNA sequence variation. In the most
straightforward cases, the disorder can be associated with variation in a
single gene. For example, [cystic fibrosis](/wiki/Cystic_fibrosis) is caused
by mutations in the CFTR gene and is the most common recessive disorder in
caucasian populations with over 1,300 different mutations known.[109]

Disease-causing mutations in specific genes are usually severe in terms of
gene function and are fortunately rare, thus genetic disorders are similarly
individually rare. However, since there are many genes that can vary to cause
genetic disorders, in aggregate they constitute a significant component of
known medical conditions, especially in pediatric medicine. Molecularly
characterized genetic disorders are those for which the underlying causal gene
has been identified. Currently there are approximately 2,200 such disorders
annotated in the [OMIM](/wiki/Online_Mendelian_Inheritance_in_Man)
database.[109]

Studies of genetic disorders are often performed by means of family-based
studies. In some instances, population based approaches are employed,
particularly in the case of so-called founder populations such as those in
Finland, French-Canada, Utah, Sardinia, etc. Diagnosis and treatment of
genetic disorders are usually performed by a
[geneticist](/wiki/Geneticist)-physician trained in clinical/medical genetics.
The results of the [Human Genome Project](/wiki/Human_Genome_Project) are
likely to provide increased availability of [genetic
testing](/wiki/Genetic_testing) for gene-related disorders, and eventually
improved treatment. Parents can be screened for hereditary conditions and
[counselled](/wiki/Genetic_counseling) on the consequences, the probability of
inheritance, and how to avoid or ameliorate it in their offspring.

There are many different kinds of DNA sequence variation, ranging from
complete extra or missing chromosomes down to single nucleotide changes. It is
generally presumed that much naturally occurring genetic variation in human
populations is phenotypically neutral, i.e., has little or no detectable
effect on the physiology of the individual (although there may be fractional
differences in fitness defined over evolutionary time frames). Genetic
disorders can be caused by any or all known types of sequence variation. To
molecularly characterize a new genetic disorder, it is necessary to establish
a causal link between a particular genomic sequence variant and the clinical
disease under investigation. Such studies constitute the realm of human
molecular genetics.

With the advent of the Human Genome and [International HapMap
Project](/wiki/International_HapMap_Project), it has become feasible to
explore subtle genetic influences on many common disease conditions such as
diabetes, asthma, migraine, schizophrenia, etc. Although some causal links
have been made between genomic sequence variants in particular genes and some
of these diseases, often with much publicity in the general media, these are
usually not considered to be genetic disorders _per se_ as their causes are
complex, involving many different genetic and environmental factors. Thus
there may be disagreement in particular cases whether a specific medical
condition should be termed a genetic disorder.

Additional genetic disorders of mention are [Kallman
syndrome](/wiki/Kallmann_syndrome) and [Pfeiffer
syndrome](/wiki/Pfeiffer_syndrome) (gene FGFR1), [Fuchs corneal
dystrophy](/wiki/Fuchs%27_dystrophy) (gene TCF4), [Hirschsprung's
disease](/wiki/Hirschsprung%27s_disease) (genes RET and FECH), Bardet-Biedl
syndrome 1 (genes CCDC28B and BBS1), Bardet-Biedl syndrome 10 (gene BBS10),
and facioscapulohumeral muscular dystrophy type 2 (genes D4Z4 and
SMCHD1).[110]

Genome sequencing is now able to narrow the genome down to specific locations
to more accurately find mutations that will result in a genetic disorder.
[Copy number variants](/wiki/Copy-number_variation) (CNVs) and [single
nucleotide variants](/wiki/Single-nucleotide_polymorphism) (SNVs) are also
able to be detected at the same time as genome sequencing with newer
sequencing procedures available, called [Next Generation
Sequencing](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944141/) (NGS). This
only analyzes a small portion of the genome, around 1-2%. The results of this
sequencing can be used for clinical diagnosis of a genetic condition,
including [Usher syndrome](/wiki/Usher_syndrome), retinal disease, hearing
impairments, diabetes, epilepsy, [Leigh disease](/wiki/Leigh_syndrome),
hereditary cancers, neuromuscular diseases, primary immunodeficiencies,
[severe combined immunodeficiency](/wiki/Severe_combined_immunodeficiency)
(SCID), and diseases of the mitochondria.[111] NGS can also be used to
identify carriers of diseases before conception. The diseases that can be
detected in this sequencing include [Tay-Sachs
disease](/wiki/Tay%E2%80%93Sachs_disease), [Bloom
syndrome](/wiki/Bloom_syndrome), [Gaucher disease](/wiki/Gaucher%27s_disease),
[Canavan disease](/wiki/Canavan_disease), [familial
dysautonomia](/wiki/Familial_dysautonomia), cystic fibrosis, [spinal muscular
atrophy](/wiki/Spinal_muscular_atrophy), and [fragile-X
syndrome](/wiki/Fragile_X_syndrome). The Next Genome Sequencing can be
narrowed down to specifically look for diseases more prevalent in certain
ethnic populations.[112]

Prevalence and associated gene/chromosome for some human genetic disorders

Disorder  Prevalence  Chromosome or gene involved

Chromosomal conditions

[Down syndrome](/wiki/Down_syndrome)

1:600

Chromosome 21

[Klinefelter syndrome](/wiki/Klinefelter_syndrome)

1:500–1000 males

Additional X chromosome

[Turner syndrome](/wiki/Turner_syndrome)

1:2000 females

Loss of X chromosome

[Sickle cell anemia](/wiki/Sickle_cell_anemia)

1 in 50 births in parts of Africa; rarer elsewhere

[β-globin (on chromosome 11)](/wiki/HBB)

[Bloom syndrome](/wiki/Bloom_syndrome)

1:48000 Ashkenazi Jews

BLM

Cancers

[Breast](/wiki/Breast_cancer)/[Ovarian cancer](/wiki/Ovarian_cancer)
(susceptibility)

~5% of cases of these cancer types

BRCA1, BRCA2

[FAP](/wiki/Familial_adenomatous_polyposis) (hereditary nonpolyposis coli)

1:3500

[APC](/wiki/Adenomatous_polyposis_coli)

[Lynch syndrome](/wiki/Lynch_syndrome)

5–10% of all cases of bowel cancer

MLH1, MSH2, MSH6, PMS2

[Fanconi anemia](/wiki/Fanconi_anemia)

1:130000 births

FANCC

Neurological conditions

[Huntington disease](/wiki/Huntington_disease)

1:20000

Huntingtin

[Alzheimer disease](/wiki/Alzheimer_disease) ‐ early onset

1:2500

PS1, PS2, APP

[Tay-Sachs](/wiki/Tay%E2%80%93Sachs_disease)

1:3600 births in Ashkenazi Jews

[HEXA gene (on chromosome 15)](/wiki/HEXA)

[Canavan disease](/wiki/Canavan_disease)

2.5% Eastern European Jewish ancestry

[ASPA](/wiki/Aspartoacylase) gene (on chromosome 17)

[Familial dysautonomia](/wiki/Familial_dysautonomia)

600 known cases worldwide since discovery

IKBKAP gene (on chromosome 9)

[Fragile X syndrome](/wiki/Fragile_X_syndrome)

1.4:10000 in males, 0.9:10000 in females

FMR1 gene (on X chromosome)

[Mucolipidosis type IV](/wiki/Mucolipidosis_type_IV)

1:90 to 1:100 in Ashkenazi Jews

MCOLN1

Other conditions

[Cystic fibrosis](/wiki/Cystic_fibrosis)

1:2500

CFTR

[Duchenne muscular dystrophy](/wiki/Duchenne_muscular_dystrophy)

1:3500 boys

Dystrophin

[Becker muscular dystrophy](/wiki/Becker_muscular_dystrophy)

1.5-6:100000 males

DMD

[Beta thalassemia](/wiki/Beta_thalassemia)

1:100000

HBB

[Congenital adrenal hyperplasia](/wiki/Congenital_adrenal_hyperplasia)

1:280 in Native Americans and Yupik Eskimos

1:15000 in American Caucasians

CYP21A2

[Glycogen storage disease type I](/wiki/Glycogen_storage_disease_type_I)

1:100000 births in America

G6PC

[Maple syrup urine disease](/wiki/Maple_syrup_urine_disease)

1:180000 in the U.S.

1:176 in Mennonite/Amish communities

1:250000 in Austria

BCKDHA, BCKDHB, DBT, DLD

[Niemann–Pick disease,
SMPD1-associated](/wiki/Niemann%E2%80%93Pick_disease,_SMPD1-associated)

1,200 cases worldwide

SMPD1

[Usher syndrome](/wiki/Usher_syndrome)

1:23000 in the U.S.

1:28000 in Norway

1:12500 in Germany

CDH23, CLRN1, DFNB31, GPR98, MYO7A, PCDH15, USH1C, USH1G, USH2A

## Evolution[[edit](/w/index.php?title=Human_genome&action=edit&section=23)]

[Hominin timeline](/wiki/Timeline_of_human_evolution)

This box:

  * [view](/wiki/Template:Human_timeline)
  * [talk](/wiki/Template_talk:Human_timeline)
  * [edit](https://en.wikipedia.org/w/index.php?title=Template:Human_timeline&action=edit)

−10 --

-

−9.5 --

-

−9 --

-

−8.5 --

-

−8 --

-

−7.5 --

-

−7 --

-

−6.5 --

-

−6 --

-

−5.5 --

-

−5 --

-

−4.5 --

-

−4 --

-

−3.5 --

-

−3 --

-

−2.5 --

-

−2 --

-

−1.5 --

-

−1 --

-

−0.5 --

-

0 --

**

[Miocene

](/wiki/Miocene)**

**

[Pliocene

](/wiki/Pliocene)**

**

[Pleistocene

](/wiki/Pleistocene)**

**[Hominini](/wiki/Hominini)**

_[Nakalipithecus](/wiki/Nakalipithecus)_

_[Ouranopithecus](/wiki/Ouranopithecus)_

_[Oreopithecus](/wiki/Oreopithecus)_

_[Sahelanthropus](/wiki/Sahelanthropus)_

_[Orrorin](/wiki/Orrorin)_

_[Ardipithecus](/wiki/Ardipithecus)_

_[Australopithecus](/wiki/Australopithecus)_

_[Homo habilis](/wiki/Homo_habilis)_

_[Homo erectus](/wiki/Homo_erectus)_

_[Homo heidelbergensis](/wiki/Homo_heidelbergensis)_

_[Homo sapiens](/wiki/Anatomically_modern_human)_

[Neanderthals](/wiki/Neanderthal),[Denisovans](/wiki/Denisovan)

<-

[Earlier apes](/wiki/Timeline_of_human_evolution#Hominidae)

<-

[Gorilla split](/wiki/Gorilla%E2%80%93human_last_common_ancestor)

<-

[Chimpanzee split](/wiki/Chimpanzee%E2%80%93human_last_common_ancestor)

<-

[Earliest bipedal](/wiki/Human_skeletal_changes_due_to_bipedalism)

<-

[Stone tools](/wiki/Stone_Age#Beginning_of_the_Stone_Age)

<-

[Dispersal beyond Africa](/wiki/Early_expansions_of_hominins_out_of_Africa)

<-

[Earliest fire](/wiki/Control_of_fire_by_early_humans) /
[cooking](/wiki/Cooking#History)

<-

[Earliest clothes](/wiki/Clothing#Early_use)

<-

[Modern humans](/wiki/Behavioral_modernity)

**  
[H  
  
o  
  
m  
  
i  
  
n  
  
i  
  
d  
  
s](/wiki/Hominidae)**

([million years ago](/wiki/Myr))

See also: [Human evolution](/wiki/Human_evolution) and [Chimpanzee Genome
Project](/wiki/Chimpanzee_Genome_Project)

[Comparative genomics](/wiki/Comparative_genomics) studies of mammalian
genomes suggest that approximately 5% of the human genome has been conserved
by evolution since the divergence of extant lineages approximately 200 million
years ago, containing the vast majority of genes.[113][114] The published
[chimpanzee](/wiki/Common_chimpanzee) genome differs from that of the human
genome by 1.23% in direct sequence comparisons.[115] Around 20% of this figure
is accounted for by variation within each species, leaving only ~1.06%
consistent sequence divergence between humans and chimps at shared genes.[116]
This nucleotide by nucleotide difference is dwarfed, however, by the portion
of each genome that is not shared, including around 6% of functional genes
that are unique to either humans or chimps.[117]

In other words, the considerable observable differences between humans and
chimps may be due as much or more to genome level variation in the number,
function and expression of genes rather than DNA sequence changes in shared
genes. Indeed, even within humans, there has been found to be a previously
unappreciated amount of copy number variation (CNV) which can make up as much
as 5 – 15% of the human genome. In other words, between humans, there could be
+/- 500,000,000 base pairs of DNA, some being active genes, others
inactivated, or active at different levels. The full significance of this
finding remains to be seen. On average, a typical human protein-coding gene
differs from its chimpanzee [ortholog](/wiki/Ortholog) by only two [amino
acid](/wiki/Amino_acid) substitutions; nearly one third of human genes have
exactly the same protein translation as their chimpanzee orthologs. A major
difference between the two genomes is human [chromosome
2](/wiki/Chromosome_2_\(human\)), which is equivalent to a fusion product of
chimpanzee chromosomes 12 and 13.[118] (later renamed to chromosomes 2A and
2B, respectively).

Humans have undergone an extraordinary loss of [olfactory
receptor](/wiki/Olfactory_receptor) genes during our recent evolution, which
explains our relatively crude sense of [smell](/wiki/Olfaction) compared to
most other mammals. Evolutionary evidence suggests that the emergence of
[color vision](/wiki/Color_vision) in humans and several other
[primate](/wiki/Primate) species has diminished the need for the sense of
smell.[119]

In September 2016, scientists reported that, based on human DNA genetic
studies, all [non-Africans in the world today](/wiki/Behavioral_modernity) can
be traced to a [single population](/wiki/Anatomically_modern_human) that
[exited Africa](/wiki/Recent_African_origin_of_modern_humans) between 50,000
and 80,000 years ago.[120]

## Mitochondrial
DNA[[edit](/w/index.php?title=Human_genome&action=edit&section=24)]

The human [mitochondrial DNA](/wiki/Mitochondrial_DNA) is of tremendous
interest to geneticists, since it undoubtedly plays a role in [mitochondrial
disease](/wiki/Mitochondrial_disease). It also sheds light on human evolution;
for example, analysis of variation in the human mitochondrial genome has led
to the postulation of a recent common ancestor for all humans on the maternal
line of descent (see [Mitochondrial Eve](/wiki/Mitochondrial_Eve)).

Due to the lack of a system for checking for copying errors,[121]
mitochondrial DNA (mtDNA) has a more rapid rate of variation than nuclear DNA.
This 20-fold higher mutation rate allows mtDNA to be used for more accurate
tracing of maternal ancestry.[_[citation
needed](/wiki/Wikipedia:Citation_needed)_] Studies of mtDNA in populations
have allowed ancient migration paths to be traced, such as the migration of
[Native Americans](/wiki/Indigenous_peoples_of_the_Americas) from
[Siberia](/wiki/Siberia)[122] or [Polynesians](/wiki/Polynesia) from
southeastern [Asia](/wiki/Asia).[_[citation
needed](/wiki/Wikipedia:Citation_needed)_] It has also been used to show that
there is no trace of [Neanderthal](/wiki/Neanderthal) DNA in the European gene
mixture inherited through purely maternal lineage.[123] Due to the restrictive
all or none manner of mtDNA inheritance, this result (no trace of Neanderthal
mtDNA) would be likely unless there were a large percentage of Neanderthal
ancestry, or there was strong positive selection for that mtDNA. For example,
going back 5 generations, only 1 of a person's 32 ancestors contributed to
that person's mtDNA, so if one of these 32 was pure Neanderthal an expected
~3% of that person's autosomal DNA would be of Neanderthal origin, yet they
would have a ~97% chance of having no trace of Neanderthal mtDNA.[_[citation
needed](/wiki/Wikipedia:Citation_needed)_]

## Epigenome[[edit](/w/index.php?title=Human_genome&action=edit&section=25)]

See also: [Epigenetics](/wiki/Epigenetics)

Epigenetics describes a variety of features of the human genome that transcend
its primary DNA sequence, such as [chromatin](/wiki/Chromatin) packaging,
[histone](/wiki/Histone) modifications and [DNA
methylation](/wiki/DNA_methylation), and which are important in regulating
gene expression, genome replication and other cellular processes. Epigenetic
markers strengthen and weaken transcription of certain genes but do not affect
the actual sequence of DNA nucleotides. DNA methylation is a major form of
epigenetic control over gene expression and one of the most highly studied
topics in epigenetics. During development, the human DNA methylation profile
experiences dramatic changes. In early germ line cells, the genome has very
low methylation levels. These low levels generally describe active genes. As
development progresses, parental imprinting tags lead to increased methylation
activity.[124][125]

Epigenetic patterns can be identified between tissues within an individual as
well as between individuals themselves. Identical genes that have differences
only in their epigenetic state are called **epialleles**. Epialleles can be
placed into three categories: those directly determined by an individual's
genotype, those influenced by genotype, and those entirely independent of
genotype. The epigenome is also influenced significantly by environmental
factors. Diet, toxins, and hormones impact the epigenetic state. Studies in
dietary manipulation have demonstrated that methyl-deficient diets are
associated with hypomethylation of the epigenome. Such studies establish
epigenetics as an important interface between the environment and the
genome.[126]

## See also[[edit](/w/index.php?title=Human_genome&action=edit&section=26)]

  * [Human Genome Organisation](/wiki/Human_Genome_Organisation)
  * [Genome Reference Consortium](/wiki/Genome_Reference_Consortium)
  * [Human Genome Project](/wiki/Human_Genome_Project)
  * [Genetics](/wiki/Genetics)
  * [Genomics](/wiki/Genomics)
  * [Genographic Project](/wiki/Genographic_Project)
  * [Genomic organization](/wiki/Genomic_organization)
  * [Low copy repeats](/wiki/Low_copy_repeats)
  * [Non-coding DNA](/wiki/Non-coding_DNA)
  * [Whole genome sequencing](/wiki/Whole_genome_sequencing)
  * [Universal Declaration on the Human Genome and Human Rights](/wiki/Universal_Declaration_on_the_Human_Genome_and_Human_Rights)

## References[[edit](/w/index.php?title=Human_genome&action=edit&section=27)]

  1. **^** ["GRCh38.p13"](https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.39). _ncbi_. Genome Reference Consortium. Retrieved 8 June 2020.
  2. **^** Brown TA (2002). _[The Human Genome_](https://www.ncbi.nlm.nih.gov/books/NBK21134/) (2nd ed.). Oxford: Wiley-Liss.
  3. ^ _**a**_ _**b**_ Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA (November 2012). ["An integrated map of genetic variation from 1,092 human genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3498066). _Nature_. **491** (7422): 56–65. [Bibcode](/wiki/Bibcode_\(identifier\)):[2012Natur.491...56T](https://ui.adsabs.harvard.edu/abs/2012Natur.491...56T). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature11632](https://doi.org/10.1038%2Fnature11632). [PMC](/wiki/PMC_\(identifier\)) [3498066](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3498066). [PMID](/wiki/PMID_\(identifier\)) [23128226](//pubmed.ncbi.nlm.nih.gov/23128226).
  4. **^** Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. (October 2015). ["A global reference for human genetic variation"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4750478). _Nature_. **526** (7571): 68–74. [Bibcode](/wiki/Bibcode_\(identifier\)):[2015Natur.526...68T](https://ui.adsabs.harvard.edu/abs/2015Natur.526...68T). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature15393](https://doi.org/10.1038%2Fnature15393). [PMC](/wiki/PMC_\(identifier\)) [4750478](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4750478). [PMID](/wiki/PMID_\(identifier\)) [26432245](//pubmed.ncbi.nlm.nih.gov/26432245).
  5. **^** Chimpanzee Sequencing Analysis Consortium (2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](http://www.genome.gov/Pages/Research/DIR/Chimp_Analysis.pdf) (PDF). _[Nature](/wiki/Nature_\(journal\))_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). [S2CID](/wiki/S2CID_\(identifier\)) [2638825](https://api.semanticscholar.org/CorpusID:2638825).
  6. **^** Varki A, Altheide TK (December 2005). ["Comparing the human and chimpanzee genomes: searching for needles in a haystack"](https://doi.org/10.1101%2Fgr.3737405). _Genome Research_. **15** (12): 1746–58. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.3737405](https://doi.org/10.1101%2Fgr.3737405). [PMID](/wiki/PMID_\(identifier\)) [16339373](//pubmed.ncbi.nlm.nih.gov/16339373).
  7. **^** Wade N (23 September 1999). ["Number of Human Genes Is Put at 140,000, a Significant Gain"](https://archive.nytimes.com/www.nytimes.com/library/national/science/092399sci-human-genome.html). _The New York Times_.
  8. ^ _**a**_ _**b**_ International Human Genome Sequencing Consortium (October 2004). ["Finishing the euchromatic sequence of the human genome"](https://doi.org/10.1038%2Fnature03001). _Nature_. **431** (7011): 931–45. [Bibcode](/wiki/Bibcode_\(identifier\)):[2004Natur.431..931H](https://ui.adsabs.harvard.edu/abs/2004Natur.431..931H). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature03001](https://doi.org/10.1038%2Fnature03001). [PMID](/wiki/PMID_\(identifier\)) [15496913](//pubmed.ncbi.nlm.nih.gov/15496913).
  9. **^** Ezkurdia I, Juan D, Rodriguez JM, Frankish A, Diekhans M, Harrow J, Vazquez J, Valencia A, Tress ML (November 2014). ["Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4204768). _Human Molecular Genetics_. **23** (22): 5866–78. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/ddu309](https://doi.org/10.1093%2Fhmg%2Fddu309). [PMC](/wiki/PMC_\(identifier\)) [4204768](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4204768). [PMID](/wiki/PMID_\(identifier\)) [24939910](//pubmed.ncbi.nlm.nih.gov/24939910).
  10. **^** Saey TH (17 September 2018). ["A recount of human genes ups the number to at least 46,831"](https://www.sciencenews.org/article/recount-human-genes-ups-number-least-46831). _Science News_.
  11. **^** Alles J, Fehlmann T, Fischer U, Backes C, Galata V, Minet M, et al. (April 2019). ["An estimate of the total number of true human miRNAs"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6468295). _Nucleic Acids Research_. **47** (7): 3353–3364. [doi](/wiki/Doi_\(identifier\)):[10.1093/nar/gkz097](https://doi.org/10.1093%2Fnar%2Fgkz097). [PMC](/wiki/PMC_\(identifier\)) [6468295](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6468295). [PMID](/wiki/PMID_\(identifier\)) [30820533](//pubmed.ncbi.nlm.nih.gov/30820533).
  12. ^ _**a**_ _**b**_ _**c**_ Pennisi E (September 2012). "Genomics. ENCODE project writes eulogy for junk DNA". _Science_. **337** (6099): 1159–1161. [doi](/wiki/Doi_\(identifier\)):[10.1126/science.337.6099.1159](https://doi.org/10.1126%2Fscience.337.6099.1159). [PMID](/wiki/PMID_\(identifier\)) [22955811](//pubmed.ncbi.nlm.nih.gov/22955811).
  13. **^** Zhang S (28 November 2018). "300 Million Letters of DNA Are Missing From the Human Genome". _The Atlantic_.
  14. ^ _**a**_ _**b**_ _**c**_ International Human Genome Sequencing Consortium (February 2001). ["Initial sequencing and analysis of the human genome"](https://doi.org/10.1038%2F35057062). _Nature_. **409** (6822): 860–921. [Bibcode](/wiki/Bibcode_\(identifier\)):[2001Natur.409..860L](https://ui.adsabs.harvard.edu/abs/2001Natur.409..860L). [doi](/wiki/Doi_\(identifier\)):[10.1038/35057062](https://doi.org/10.1038%2F35057062). [PMID](/wiki/PMID_\(identifier\)) [11237011](//pubmed.ncbi.nlm.nih.gov/11237011).
  15. **^** [International Human Genome Sequencing Consortium Publishes Sequence and Analysis of the Human Genome](https://www.genome.gov/10002192)
  16. **^** Pennisi E (February 2001). "The human genome". _Science_. **291** (5507): 1177–80. [doi](/wiki/Doi_\(identifier\)):[10.1126/science.291.5507.1177](https://doi.org/10.1126%2Fscience.291.5507.1177). [PMID](/wiki/PMID_\(identifier\)) [11233420](//pubmed.ncbi.nlm.nih.gov/11233420). [S2CID](/wiki/S2CID_\(identifier\)) [38355565](https://api.semanticscholar.org/CorpusID:38355565).
  17. **^** Molteni M (19 November 2018). ["Now You Can Sequence Your Whole Genome For Just $200"](https://www.wired.com/story/whole-genome-sequencing-cost-200-dollars/). _Wired_.
  18. **^** Wrighton K (February 2021). ["Filling in the gaps telomere to telomere"](https://www.nature.com/articles/d42859-020-00117-1). _Nature Milestones: Genomic Sequencing_: S21.
  19. **^** Pollack A (2 June 2016). ["Scientists Announce HGP-Write, Project to Synthesize the Human Genome"](https://www.nytimes.com/2016/06/03/science/human-genome-project-write-synthetic-dna.html). _[New York Times](/wiki/New_York_Times)_. Retrieved 2 June 2016.
  20. **^** Boeke JD, Church G, Hessel A, Kelley NJ, Arkin A, Cai Y, et al. (July 2016). "The Genome Project-Write". _Science_. **353** (6295): 126–7. [Bibcode](/wiki/Bibcode_\(identifier\)):[2016Sci...353..126B](https://ui.adsabs.harvard.edu/abs/2016Sci...353..126B). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.aaf6850](https://doi.org/10.1126%2Fscience.aaf6850). [PMID](/wiki/PMID_\(identifier\)) [27256881](//pubmed.ncbi.nlm.nih.gov/27256881). [S2CID](/wiki/S2CID_\(identifier\)) [206649424](https://api.semanticscholar.org/CorpusID:206649424).
  21. **^** Zhang S (28 November 2018). ["300 Million Letters of DNA Are Missing From the Human Genome"](https://www.theatlantic.com/science/archive/2018/11/human-genome-300-million-missing-letters-dna/576481/). _The Atlantic_. Retrieved 16 August 2019.
  22. **^** Chaisson MJ, Huddleston J, Dennis MY, Sudmant PH, Malig M, Hormozdiari F, et al. (January 2015). ["Resolving the complexity of the human genome using single-molecule sequencing"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317254). _Nature_. **517** (7536): 608–11. [Bibcode](/wiki/Bibcode_\(identifier\)):[2015Natur.517..608C](https://ui.adsabs.harvard.edu/abs/2015Natur.517..608C). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature13907](https://doi.org/10.1038%2Fnature13907). [PMC](/wiki/PMC_\(identifier\)) [4317254](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317254). [PMID](/wiki/PMID_\(identifier\)) [25383537](//pubmed.ncbi.nlm.nih.gov/25383537).
  23. **^** [Miga KH](/wiki/Karen_Miga), Koren S, Rhie A, Vollger MR, Gershman A, Bzikadze A, et al. (September 2020). ["Telomere-to-telomere assembly of a complete human X chromosome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7484160). _Nature_. **585** (7823): 79–84. [Bibcode](/wiki/Bibcode_\(identifier\)):[2020Natur.585...79M](https://ui.adsabs.harvard.edu/abs/2020Natur.585...79M). [doi](/wiki/Doi_\(identifier\)):[10.1038/s41586-020-2547-7](https://doi.org/10.1038%2Fs41586-020-2547-7). [PMC](/wiki/PMC_\(identifier\)) [7484160](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7484160). [PMID](/wiki/PMID_\(identifier\)) [32663838](//pubmed.ncbi.nlm.nih.gov/32663838).
  24. **^** ["CHM13 T2T v1.1 - Genome - Assembly - NCBI"](https://www.ncbi.nlm.nih.gov/assembly/GCA_009914755.3). _www.ncbi.nlm.nih.gov_. Retrieved 26 July 2021.
  25. **^** ["Genome List - Genome - NCBI"](https://www.ncbi.nlm.nih.gov/genome/browse/#!/eukaryotes/51/). _www.ncbi.nlm.nih.gov_. Retrieved 26 July 2021.
  26. **^** [Ensembl genome browser release 87](http://useast.ensembl.org/Homo_sapiens/Location/Genome?r=Y:1-1000)[_[permanent dead link](/wiki/Wikipedia:Link_rot)_] (December 2016) for most values; [Ensembl genome browser release 68](http://jul2012.archive.ensembl.org/Homo_sapiens/Location/Chromosome?r=1:1-1000000) (July 2012) for miRNA, rRNA, snRNA, snoRNA.
  27. **^** Piovesan A, Pelleri MC, Antonaros F, Strippoli P, Caracausi M, Vitale L (February 2019). ["On the length, weight and GC content of the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6391780). _BMC Research Notes_. **12** (1): 106. [doi](/wiki/Doi_\(identifier\)):[10.1186/s13104-019-4137-z](https://doi.org/10.1186%2Fs13104-019-4137-z). [PMC](/wiki/PMC_\(identifier\)) [6391780](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6391780). [PMID](/wiki/PMID_\(identifier\)) [30813969](//pubmed.ncbi.nlm.nih.gov/30813969).
  28. **^** Salzberg SL (August 2018). ["Open questions: How many genes do we have?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6100717). _BMC Biology_. **16** (1): 94. [doi](/wiki/Doi_\(identifier\)):[10.1186/s12915-018-0564-x](https://doi.org/10.1186%2Fs12915-018-0564-x). [PMC](/wiki/PMC_\(identifier\)) [6100717](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6100717). [PMID](/wiki/PMID_\(identifier\)) [30124169](//pubmed.ncbi.nlm.nih.gov/30124169).
  29. **^** ["Gencode statistics, version 28"](https://web.archive.org/web/20180302114250/http://www.gencodegenes.org/stats/current.html). Archived from [the original](http://www.gencodegenes.org/stats/current.html) on 2 March 2018. Retrieved 12 July 2018.
  30. **^** ["Ensembl statistics for version 92.38, corresponding to Gencode v28"](http://ensembl.org/Homo_sapiens/Info/Annotation). Retrieved 12 July 2018.
  31. **^** ["NCBI Homo sapiens Annotation Release 108"](http://www.ncbi.nlm.nih.gov/genome/annotation_euk/Homo_sapiens/108/). NIH. 2016.
  32. **^** ["CHESS statistics, version 2.0"](http://ccb.jhu.edu/chess). _Center for Computational Biology_. Johns Hopkins University.
  33. **^** ["Human Genome Project Completion: Frequently Asked Questions"](https://www.genome.gov/11006943/human-genome-project-completion-frequently-asked-questions/). _National Human Genome Research Institute (NHGRI)_. Retrieved 2 February 2019.
  34. **^** Christley S, Lu Y, Li C, Xie X (January 2009). ["Human genomes as email attachments"](https://doi.org/10.1093%2Fbioinformatics%2Fbtn582). _Bioinformatics_. **25** (2): 274–5. [doi](/wiki/Doi_\(identifier\)):[10.1093/bioinformatics/btn582](https://doi.org/10.1093%2Fbioinformatics%2Fbtn582). [PMID](/wiki/PMID_\(identifier\)) [18996942](//pubmed.ncbi.nlm.nih.gov/18996942).
  35. **^** Liu Z, Venkatesh SS, Maley CC (October 2008). ["Sequence space coverage, entropy of genomes and the potential to detect non-human DNA in human samples"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2628393). _BMC Genomics_. **9**: 509. [doi](/wiki/Doi_\(identifier\)):[10.1186/1471-2164-9-509](https://doi.org/10.1186%2F1471-2164-9-509). [PMC](/wiki/PMC_\(identifier\)) [2628393](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2628393). [PMID](/wiki/PMID_\(identifier\)) [18973670](//pubmed.ncbi.nlm.nih.gov/18973670)., fig. 6, using the [Lempel-Ziv](/wiki/Lempel-Ziv) estimators of entropy rate.
  36. **^** Waters K (7 March 2007). ["Molecular Genetics"](http://plato.stanford.edu/entries/molecular-genetics/#GenSke). _Stanford Encyclopedia of Philosophy_. Retrieved 18 July 2013.
  37. **^** Gannett L (26 October 2008). ["The Human Genome Project"](http://plato.stanford.edu/entries/human-genome/#ConFouHumGenPro). _Stanford Encyclopedia of Philosophy_. Retrieved 18 July 2013.
  38. **^** [PANTHER Pie Chart](http://www.pantherdb.org/chart/summary/pantherChart.jsp?filterLevel=1&chartType=1&listType=1&type=5&species=Homo%20sapiens) at the PANTHER Classification System homepage. Retrieved 25 May 2011
  39. **^** [List of human proteins in the Uniprot Human reference proteome](https://www.uniprot.org/uniprot/?query=*&fil=reviewed%3Ayes+AND+organism%3A%22Homo+sapiens+%28Human%29+%5B9606%5D%22+AND+proteome%3Aup000005640); accessed 28 January 2015
  40. **^** Kauffman SA (March 1969). "Metabolic stability and epigenesis in randomly constructed genetic nets". _Journal of Theoretical Biology_. **22** (3): 437–67. [doi](/wiki/Doi_\(identifier\)):[10.1016/0022-5193(69)90015-0](https://doi.org/10.1016%2F0022-5193%2869%2990015-0). [PMID](/wiki/PMID_\(identifier\)) [5803332](//pubmed.ncbi.nlm.nih.gov/5803332).
  41. **^** Ohno S (1972). "An argument for the genetic simplicity of man and other mammals". _Journal of Human Evolution_. **1** (6): 651–662. [doi](/wiki/Doi_\(identifier\)):[10.1016/0047-2484(72)90011-5](https://doi.org/10.1016%2F0047-2484%2872%2990011-5).
  42. **^** Sémon M, Mouchiroud D, Duret L (February 2005). ["Relationship between gene expression and GC-content in mammals: statistical significance and biological relevance"](https://doi.org/10.1093%2Fhmg%2Fddi038). _Human Molecular Genetics_. **14** (3): 421–7. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/ddi038](https://doi.org/10.1093%2Fhmg%2Fddi038). [PMID](/wiki/PMID_\(identifier\)) [15590696](//pubmed.ncbi.nlm.nih.gov/15590696).
  43. **^** M. Huang, H. Zhu, B. Shen, G. Gao, ["A non-random gait through the human genome"](https://ieeexplore.ieee.org/document/5162209), _3rd International Conference on Bioinformatics and Biomedical Engineering_ (UCBBE, 2009), 1–3
  44. ^ _**a**_ _**b**_ Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S (2001). ["The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system"](https://doi.org/10.1161%2Fhh2301.100981). _Circulation Research_. **89** (11): 1065–72. [doi](/wiki/Doi_\(identifier\)):[10.1161/hh2301.100981](https://doi.org/10.1161%2Fhh2301.100981). [PMID](/wiki/PMID_\(identifier\)) [11717165](//pubmed.ncbi.nlm.nih.gov/11717165).
  45. ^ _**a**_ _**b**_ Piovesan A, Caracausi M, Antonaros F, Pelleri MC, Vitale L (2016). ["GeneBase 1.1: a tool to summarize data from NCBI gene datasets and its application to an update of human gene statistics"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5199132). _Database: The Journal of Biological Databases and Curation_. **2016**: baw153. [doi](/wiki/Doi_\(identifier\)):[10.1093/database/baw153](https://doi.org/10.1093%2Fdatabase%2Fbaw153). [PMC](/wiki/PMC_\(identifier\)) [5199132](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5199132). [PMID](/wiki/PMID_\(identifier\)) [28025344](//pubmed.ncbi.nlm.nih.gov/28025344).
  46. **^** [Ensembl genome browser](https://archive.today/20130414163120/http://useast.ensembl.org/Homo_sapiens/Location/Genome?r=6:133017695-133161157) (July 2012)
  47. **^** Gregory TR (September 2005). "Synergy between sequence and size in large-scale genomics". _Nature Reviews Genetics_. **6** (9): 699–708. [doi](/wiki/Doi_\(identifier\)):[10.1038/nrg1674](https://doi.org/10.1038%2Fnrg1674). [PMID](/wiki/PMID_\(identifier\)) [16151375](//pubmed.ncbi.nlm.nih.gov/16151375). [S2CID](/wiki/S2CID_\(identifier\)) [24237594](https://api.semanticscholar.org/CorpusID:24237594).
  48. ^ _**a**_ _**b**_ Palazzo AF, Akef A (June 2012). "Nuclear export as a key arbiter of "mRNA identity" in eukaryotes". _Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms_. **1819** (6): 566–77. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.bbagrm.2011.12.012](https://doi.org/10.1016%2Fj.bbagrm.2011.12.012). [PMID](/wiki/PMID_\(identifier\)) [22248619](//pubmed.ncbi.nlm.nih.gov/22248619).
  49. **^** Ludwig MZ (December 2002). "Functional evolution of noncoding DNA". _Current Opinion in Genetics & Development_. **12** (6): 634–9. [doi](/wiki/Doi_\(identifier\)):[10.1016/S0959-437X(02)00355-6](https://doi.org/10.1016%2FS0959-437X%2802%2900355-6). [PMID](/wiki/PMID_\(identifier\)) [12433575](//pubmed.ncbi.nlm.nih.gov/12433575).
  50. **^** Martens JA, Laprade L, Winston F (June 2004). "Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene". _Nature_. **429** (6991): 571–4. [Bibcode](/wiki/Bibcode_\(identifier\)):[2004Natur.429..571M](https://ui.adsabs.harvard.edu/abs/2004Natur.429..571M). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature02538](https://doi.org/10.1038%2Fnature02538). [PMID](/wiki/PMID_\(identifier\)) [15175754](//pubmed.ncbi.nlm.nih.gov/15175754). [S2CID](/wiki/S2CID_\(identifier\)) [809550](https://api.semanticscholar.org/CorpusID:809550).
  51. **^** Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, [Chang HY](/wiki/Howard_Y._Chang) (August 2010). ["Long noncoding RNA as modular scaffold of histone modification complexes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2967777). _Science_. **329** (5992): 689–93. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Sci...329..689T](https://ui.adsabs.harvard.edu/abs/2010Sci...329..689T). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1192002](https://doi.org/10.1126%2Fscience.1192002). [PMC](/wiki/PMC_\(identifier\)) [2967777](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2967777). [PMID](/wiki/PMID_\(identifier\)) [20616235](//pubmed.ncbi.nlm.nih.gov/20616235).
  52. **^** Bartolomei MS, Zemel S, Tilghman SM (May 1991). "Parental imprinting of the mouse H19 gene". _Nature_. **351** (6322): 153–5. [Bibcode](/wiki/Bibcode_\(identifier\)):[1991Natur.351..153B](https://ui.adsabs.harvard.edu/abs/1991Natur.351..153B). [doi](/wiki/Doi_\(identifier\)):[10.1038/351153a0](https://doi.org/10.1038%2F351153a0). [PMID](/wiki/PMID_\(identifier\)) [1709450](//pubmed.ncbi.nlm.nih.gov/1709450). [S2CID](/wiki/S2CID_\(identifier\)) [4364975](https://api.semanticscholar.org/CorpusID:4364975).
  53. **^** Kobayashi T, Ganley AR (September 2005). "Recombination regulation by transcription-induced cohesin dissociation in rDNA repeats". _Science_. **309** (5740): 1581–4. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Sci...309.1581K](https://ui.adsabs.harvard.edu/abs/2005Sci...309.1581K). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1116102](https://doi.org/10.1126%2Fscience.1116102). [PMID](/wiki/PMID_\(identifier\)) [16141077](//pubmed.ncbi.nlm.nih.gov/16141077). [S2CID](/wiki/S2CID_\(identifier\)) [21547462](https://api.semanticscholar.org/CorpusID:21547462).
  54. **^** Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (August 2011). ["A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3235919). _Cell_. **146** (3): 353–8. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.cell.2011.07.014](https://doi.org/10.1016%2Fj.cell.2011.07.014). [PMC](/wiki/PMC_\(identifier\)) [3235919](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3235919). [PMID](/wiki/PMID_\(identifier\)) [21802130](//pubmed.ncbi.nlm.nih.gov/21802130).
  55. **^** Pei B, Sisu C, Frankish A, Howald C, Habegger L, Mu XJ, Harte R, Balasubramanian S, Tanzer A, Diekhans M, Reymond A, Hubbard TJ, Harrow J, Gerstein MB (2012). ["The GENCODE pseudogene resource"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3491395). _Genome Biology_. **13** (9): R51. [doi](/wiki/Doi_\(identifier\)):[10.1186/gb-2012-13-9-r51](https://doi.org/10.1186%2Fgb-2012-13-9-r51). [PMC](/wiki/PMC_\(identifier\)) [3491395](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3491395). [PMID](/wiki/PMID_\(identifier\)) [22951037](//pubmed.ncbi.nlm.nih.gov/22951037).
  56. **^** Gilad Y, Man O, Pääbo S, Lancet D (March 2003). ["Human specific loss of olfactory receptor genes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC152291). _Proceedings of the National Academy of Sciences of the United States of America_. **100** (6): 3324–7. [Bibcode](/wiki/Bibcode_\(identifier\)):[2003PNAS..100.3324G](https://ui.adsabs.harvard.edu/abs/2003PNAS..100.3324G). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.0535697100](https://doi.org/10.1073%2Fpnas.0535697100). [PMC](/wiki/PMC_\(identifier\)) [152291](//www.ncbi.nlm.nih.gov/pmc/articles/PMC152291). [PMID](/wiki/PMID_\(identifier\)) [12612342](//pubmed.ncbi.nlm.nih.gov/12612342).
  57. **^** Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, Wu YM, Robinson DR, Beer DG, Feng FY, Iyer HK, Chinnaiyan AM (March 2015). ["The landscape of long noncoding RNAs in the human transcriptome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4417758). _Nature Genetics_. **47** (3): 199–208. [doi](/wiki/Doi_\(identifier\)):[10.1038/ng.3192](https://doi.org/10.1038%2Fng.3192). [PMC](/wiki/PMC_\(identifier\)) [4417758](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4417758). [PMID](/wiki/PMID_\(identifier\)) [25599403](//pubmed.ncbi.nlm.nih.gov/25599403).
  58. **^** Eddy SR (December 2001). "Non-coding RNA genes and the modern RNA world". _Nature Reviews Genetics_. **2** (12): 919–29. [doi](/wiki/Doi_\(identifier\)):[10.1038/35103511](https://doi.org/10.1038%2F35103511). [PMID](/wiki/PMID_\(identifier\)) [11733745](//pubmed.ncbi.nlm.nih.gov/11733745). [S2CID](/wiki/S2CID_\(identifier\)) [18347629](https://api.semanticscholar.org/CorpusID:18347629).
  59. **^** Managadze D, Lobkovsky AE, Wolf YI, Shabalina SA, Rogozin IB, Koonin EV (2013). ["The vast, conserved mammalian lincRNome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3585383). _PLOS Computational Biology_. **9** (2): e1002917. [Bibcode](/wiki/Bibcode_\(identifier\)):[2013PLSCB...9E2917M](https://ui.adsabs.harvard.edu/abs/2013PLSCB...9E2917M). [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pcbi.1002917](https://doi.org/10.1371%2Fjournal.pcbi.1002917). [PMC](/wiki/PMC_\(identifier\)) [3585383](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3585383). [PMID](/wiki/PMID_\(identifier\)) [23468607](//pubmed.ncbi.nlm.nih.gov/23468607).
  60. **^** Palazzo AF, Lee ES (2015). ["Non-coding RNA: what is functional and what is junk?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4306305). _Frontiers in Genetics_. **6**: 2. [doi](/wiki/Doi_\(identifier\)):[10.3389/fgene.2015.00002](https://doi.org/10.3389%2Ffgene.2015.00002). [PMC](/wiki/PMC_\(identifier\)) [4306305](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4306305). [PMID](/wiki/PMID_\(identifier\)) [25674102](//pubmed.ncbi.nlm.nih.gov/25674102).
  61. **^** Mattick JS, Makunin IV (April 2006). ["Non-coding RNA"](https://doi.org/10.1093%2Fhmg%2Fddl046). _Human Molecular Genetics_. **15** (Spec No 1): R17–29. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/ddl046](https://doi.org/10.1093%2Fhmg%2Fddl046). [PMID](/wiki/PMID_\(identifier\)) [16651366](//pubmed.ncbi.nlm.nih.gov/16651366).
  62. ^ _**a**_ _**b**_ Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M (September 2012). ["An integrated encyclopedia of DNA elements in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3439153). _Nature_. **489** (7414): 57–74. [Bibcode](/wiki/Bibcode_\(identifier\)):[2012Natur.489...57T](https://ui.adsabs.harvard.edu/abs/2012Natur.489...57T). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature11247](https://doi.org/10.1038%2Fnature11247). [PMC](/wiki/PMC_\(identifier\)) [3439153](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3439153). [PMID](/wiki/PMID_\(identifier\)) [22955616](//pubmed.ncbi.nlm.nih.gov/22955616).
  63. **^** Birney E (5 September 2012). ["ENCODE: My own thoughts"](http://genomeinformatician.blogspot.ca/2012/09/encode-my-own-thoughts.html). _Ewan's Blog: Bioinformatician at large_.
  64. **^** Stamatoyannopoulos JA (September 2012). ["What does our genome encode?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3431477). _Genome Research_. **22** (9): 1602–11. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.146506.112](https://doi.org/10.1101%2Fgr.146506.112). [PMC](/wiki/PMC_\(identifier\)) [3431477](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3431477). [PMID](/wiki/PMID_\(identifier\)) [22955972](//pubmed.ncbi.nlm.nih.gov/22955972).
  65. **^** Carroll SB, Gompel N, Prudhomme B (May 2008). "Regulating Evolution". _Scientific American_. **298** (5): 60–67. [Bibcode](/wiki/Bibcode_\(identifier\)):[2008SciAm.298e..60C](https://ui.adsabs.harvard.edu/abs/2008SciAm.298e..60C). [doi](/wiki/Doi_\(identifier\)):[10.1038/scientificamerican0508-60](https://doi.org/10.1038%2Fscientificamerican0508-60). [PMID](/wiki/PMID_\(identifier\)) [18444326](//pubmed.ncbi.nlm.nih.gov/18444326).
  66. **^** Miller JH, Ippen K, Scaife JG, Beckwith JR (1968). "The promoter-operator region of the lac operon of Escherichia coli". _J. Mol. Biol_. **38** (3): 413–20. [doi](/wiki/Doi_\(identifier\)):[10.1016/0022-2836(68)90395-1](https://doi.org/10.1016%2F0022-2836%2868%2990395-1). [PMID](/wiki/PMID_\(identifier\)) [4887877](//pubmed.ncbi.nlm.nih.gov/4887877).
  67. **^** Wright S, Rosenthal A, Flavell R, Grosveld F (1984). "DNA sequences required for regulated expression of beta-globin genes in murine erythroleukemia cells". _Cell_. **38** (1): 265–73. [doi](/wiki/Doi_\(identifier\)):[10.1016/0092-8674(84)90548-8](https://doi.org/10.1016%2F0092-8674%2884%2990548-8). [PMID](/wiki/PMID_\(identifier\)) [6088069](//pubmed.ncbi.nlm.nih.gov/6088069). [S2CID](/wiki/S2CID_\(identifier\)) [34587386](https://api.semanticscholar.org/CorpusID:34587386).
  68. **^** Nei M, Xu P, Glazko G (February 2001). ["Estimation of divergence times from multiprotein sequences for a few mammalian species and several distantly related organisms"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC30166). _Proceedings of the National Academy of Sciences of the United States of America_. **98** (5): 2497–502. [Bibcode](/wiki/Bibcode_\(identifier\)):[2001PNAS...98.2497N](https://ui.adsabs.harvard.edu/abs/2001PNAS...98.2497N). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.051611498](https://doi.org/10.1073%2Fpnas.051611498). [PMC](/wiki/PMC_\(identifier\)) [30166](//www.ncbi.nlm.nih.gov/pmc/articles/PMC30166). [PMID](/wiki/PMID_\(identifier\)) [11226267](//pubmed.ncbi.nlm.nih.gov/11226267).
  69. **^** Loots GG, Locksley RM, Blankespoor CM, Wang ZE, Miller W, Rubin EM, Frazer KA (April 2000). "Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons". _Science_. **288** (5463): 136–40. [Bibcode](/wiki/Bibcode_\(identifier\)):[2000Sci...288..136L](https://ui.adsabs.harvard.edu/abs/2000Sci...288..136L). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.288.5463.136](https://doi.org/10.1126%2Fscience.288.5463.136). [PMID](/wiki/PMID_\(identifier\)) [10753117](//pubmed.ncbi.nlm.nih.gov/10753117). [Summary](http://www.lbl.gov/Science-Articles/Archive/mouse-dna-model.html)
  70. **^** Meunier M. ["Genoscope and Whitehead announce a high sequence coverage of the Tetraodon nigroviridis genome"](https://web.archive.org/web/20061016085223/http://www.cns.fr/externe/English/Actualites/Presse/261001_1.html). Genoscope. Archived from [the original](http://www.cns.fr/externe/English/Actualites/Presse/261001_1.html) on 16 October 2006. Retrieved 12 September 2006.
  71. **^** Romero IG, Ruvinsky I, Gilad Y (July 2012). ["Comparative studies of gene expression and the evolution of gene regulation"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4034676). _Nature Reviews Genetics_. **13** (7): 505–16. [doi](/wiki/Doi_\(identifier\)):[10.1038/nrg3229](https://doi.org/10.1038%2Fnrg3229). [PMC](/wiki/PMC_\(identifier\)) [4034676](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4034676). [PMID](/wiki/PMID_\(identifier\)) [22705669](//pubmed.ncbi.nlm.nih.gov/22705669).
  72. **^** Schmidt D, Wilson MD, Ballester B, Schwalie PC, Brown GD, Marshall A, Kutter C, Watt S, Martinez-Jimenez CP, Mackay S, Talianidis I, Flicek P, Odom DT (May 2010). ["Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3008766). _Science_. **328** (5981): 1036–40. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Sci...328.1036S](https://ui.adsabs.harvard.edu/abs/2010Sci...328.1036S). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1186176](https://doi.org/10.1126%2Fscience.1186176). [PMC](/wiki/PMC_\(identifier\)) [3008766](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3008766). [PMID](/wiki/PMID_\(identifier\)) [20378774](//pubmed.ncbi.nlm.nih.gov/20378774).
  73. **^** Wilson MD, Barbosa-Morais NL, Schmidt D, Conboy CM, Vanes L, Tybulewicz VL, Fisher EM, Tavaré S, Odom DT (October 2008). ["Species-specific transcription in mice carrying human chromosome 21"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3717767). _Science_. **322** (5900): 434–8. [Bibcode](/wiki/Bibcode_\(identifier\)):[2008Sci...322..434W](https://ui.adsabs.harvard.edu/abs/2008Sci...322..434W). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1160930](https://doi.org/10.1126%2Fscience.1160930). [PMC](/wiki/PMC_\(identifier\)) [3717767](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3717767). [PMID](/wiki/PMID_\(identifier\)) [18787134](//pubmed.ncbi.nlm.nih.gov/18787134).
  74. **^** Treangen TJ, Salzberg SL (January 2012). ["Repetitive DNA and next-generation sequencing: computational challenges and solutions"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3324860). _Nature Reviews Genetics_. **13** (1): 36–46. [doi](/wiki/Doi_\(identifier\)):[10.1038/nrg3117](https://doi.org/10.1038%2Fnrg3117). [PMC](/wiki/PMC_\(identifier\)) [3324860](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3324860). [PMID](/wiki/PMID_\(identifier\)) [22124482](//pubmed.ncbi.nlm.nih.gov/22124482).
  75. **^** Duitama J, Zablotskaya A, Gemayel R, Jansen A, Belet S, Vermeesch JR, Verstrepen KJ, Froyen G (May 2014). ["Large-scale analysis of tandem repeat variability in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4027155). _Nucleic Acids Research_. **42** (9): 5728–41. [doi](/wiki/Doi_\(identifier\)):[10.1093/nar/gku212](https://doi.org/10.1093%2Fnar%2Fgku212). [PMC](/wiki/PMC_\(identifier\)) [4027155](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4027155). [PMID](/wiki/PMID_\(identifier\)) [24682812](//pubmed.ncbi.nlm.nih.gov/24682812).
  76. **^** Pierce BA (2012). _Genetics : a conceptual approach_ (4th ed.). New York: W.H. Freeman. pp. 538–540. [ISBN](/wiki/ISBN_\(identifier\)) [978-1-4292-3250-0](/wiki/Special:BookSources/978-1-4292-3250-0).
  77. **^** Bennett EA, Keller H, Mills RE, Schmidt S, Moran JV, Weichenrieder O, Devine SE (December 2008). ["Active Alu retrotransposons in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2593586). _Genome Research_. **18** (12): 1875–83. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.081737.108](https://doi.org/10.1101%2Fgr.081737.108). [PMC](/wiki/PMC_\(identifier\)) [2593586](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2593586). [PMID](/wiki/PMID_\(identifier\)) [18836035](//pubmed.ncbi.nlm.nih.gov/18836035).
  78. **^** Liang KH, Yeh CT (2013). ["A gene expression restriction network mediated by sense and antisense Alu sequences located on protein-coding messenger RNAs"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3655826). _BMC Genomics_. **14**: 325. [doi](/wiki/Doi_\(identifier\)):[10.1186/1471-2164-14-325](https://doi.org/10.1186%2F1471-2164-14-325). [PMC](/wiki/PMC_\(identifier\)) [3655826](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3655826). [PMID](/wiki/PMID_\(identifier\)) [23663499](//pubmed.ncbi.nlm.nih.gov/23663499).
  79. **^** Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH (April 2003). ["Hot L1s account for the bulk of retrotransposition in the human population"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC154336). _Proceedings of the National Academy of Sciences of the United States of America_. **100** (9): 5280–5. [Bibcode](/wiki/Bibcode_\(identifier\)):[2003PNAS..100.5280B](https://ui.adsabs.harvard.edu/abs/2003PNAS..100.5280B). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.0831042100](https://doi.org/10.1073%2Fpnas.0831042100). [PMC](/wiki/PMC_\(identifier\)) [154336](//www.ncbi.nlm.nih.gov/pmc/articles/PMC154336). [PMID](/wiki/PMID_\(identifier\)) [12682288](//pubmed.ncbi.nlm.nih.gov/12682288).
  80. **^** Barton NH, Briggs DE, Eisen JA, Goldstein DB, Patel NH (2007). _Evolution_. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. [ISBN](/wiki/ISBN_\(identifier\)) [978-0-87969-684-9](/wiki/Special:BookSources/978-0-87969-684-9).
  81. **^** [NCBI](/wiki/National_Center_for_Biotechnology_Information). ["GRCh38 – hg38 – Genome – Assembly – NCBI"](https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.26/). _ncbi.nlm.nih.gov_. Retrieved 15 March 2019.
  82. **^** ["from Bill Clinton's 2000 State of the Union address"](https://web.archive.org/web/20170221025546/https://clinton4.nara.gov/WH/SOTU00/sotu-text.html). Archived from [the original](https://clinton4.nara.gov/WH/SOTU00/sotu-text.html) on 21 February 2017. Retrieved 14 June 2007.
  83. **^** Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. (November 2006). ["Global variation in copy number in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2669898). _Nature_. **444** (7118): 444–54. [Bibcode](/wiki/Bibcode_\(identifier\)):[2006Natur.444..444R](https://ui.adsabs.harvard.edu/abs/2006Natur.444..444R). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature05329](https://doi.org/10.1038%2Fnature05329). [PMC](/wiki/PMC_\(identifier\)) [2669898](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2669898). [PMID](/wiki/PMID_\(identifier\)) [17122850](//pubmed.ncbi.nlm.nih.gov/17122850).
  84. **^** ["What's a Genome?"](http://www.genomenewsnetwork.org/resources/whats_a_genome/Chp3_1.shtml). Genomenewsnetwork.org. 15 January 2003. Retrieved 31 May 2009.
  85. **^** NCBI_user_services (29 March 2004). ["Mapping Factsheet"](https://web.archive.org/web/20100719235548/http://www.ncbi.nlm.nih.gov/About/primer/mapping.html). Ncbi.nlm.nih.gov. Archived from [the original](https://www.ncbi.nlm.nih.gov/About/primer/mapping.html) on 19 July 2010. Retrieved 31 May 2009.
  86. **^** ["About the Project"](http://www.hapmap.org/abouthapmap.html). HapMap. Retrieved 31 May 2009.
  87. **^** ["2008 Release: Researchers Produce First Sequence Map of Large-Scale Structural Variation in the Human Genome"](http://www.genome.gov/27026113). genome.gov. Retrieved 31 May 2009.
  88. **^** Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, Graves T, et al. (May 2008). ["Mapping and sequencing of structural variation from eight human genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2424287). _Nature_. **453** (7191): 56–64. [Bibcode](/wiki/Bibcode_\(identifier\)):[2008Natur.453...56K](https://ui.adsabs.harvard.edu/abs/2008Natur.453...56K). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature06862](https://doi.org/10.1038%2Fnature06862). [PMC](/wiki/PMC_\(identifier\)) [2424287](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2424287). [PMID](/wiki/PMID_\(identifier\)) [18451855](//pubmed.ncbi.nlm.nih.gov/18451855).
  89. ^ _**a**_ _**b**_ Abel HJ, Larson DE, Regier AA, Chiang C, Das I, Kanchi KL, et al. (July 2020). ["Mapping and characterization of structural variation in 17,795 human genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7547914). _Nature_. **583** (7814): 83–89. [doi](/wiki/Doi_\(identifier\)):[10.1038/s41586-020-2371-0](https://doi.org/10.1038%2Fs41586-020-2371-0). [PMC](/wiki/PMC_\(identifier\)) [7547914](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7547914). [PMID](/wiki/PMID_\(identifier\)) [32460305](//pubmed.ncbi.nlm.nih.gov/32460305).
  90. **^** Gray IC, Campbell DA, Spurr NK (2000). ["Single nucleotide polymorphisms as tools in human genetics"](https://doi.org/10.1093%2Fhmg%2F9.16.2403). _Human Molecular Genetics_. **9** (16): 2403–2408. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/9.16.2403](https://doi.org/10.1093%2Fhmg%2F9.16.2403). [PMID](/wiki/PMID_\(identifier\)) [11005795](//pubmed.ncbi.nlm.nih.gov/11005795).
  91. **^** Lai E (June 2001). ["Application of SNP technologies in medicine: lessons learned and future challenges"](https://doi.org/10.1101%2Fgr.192301). _Genome Research_. **11** (6): 927–9. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.192301](https://doi.org/10.1101%2Fgr.192301). [PMID](/wiki/PMID_\(identifier\)) [11381021](//pubmed.ncbi.nlm.nih.gov/11381021).
  92. **^** ["Human Genome Project Completion: Frequently Asked Questions"](http://www.genome.gov/11006943). genome.gov. Retrieved 31 May 2009.
  93. **^** Singer E (4 September 2007). ["Craig Venter's Genome"](http://www.technologyreview.com/biomedicine/19328/?a=f). _[MIT Technology Review](/wiki/MIT_Technology_Review)_. Retrieved 25 May 2010.
  94. **^** Pushkarev D, Neff NF, Quake SR (September 2009). ["Single-molecule sequencing of an individual human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4117198). _Nature Biotechnology_. **27** (9): 847–50. [doi](/wiki/Doi_\(identifier\)):[10.1038/nbt.1561](https://doi.org/10.1038%2Fnbt.1561). [PMC](/wiki/PMC_\(identifier\)) [4117198](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4117198). [PMID](/wiki/PMID_\(identifier\)) [19668243](//pubmed.ncbi.nlm.nih.gov/19668243).
  95. **^** Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, et al. (May 2010). ["Clinical assessment incorporating a personal genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2937184). _Lancet_. **375** (9725): 1525–35. [doi](/wiki/Doi_\(identifier\)):[10.1016/S0140-6736(10)60452-7](https://doi.org/10.1016%2FS0140-6736%2810%2960452-7). [PMC](/wiki/PMC_\(identifier\)) [2937184](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2937184). [PMID](/wiki/PMID_\(identifier\)) [20435227](//pubmed.ncbi.nlm.nih.gov/20435227).
  96. **^** Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ, et al. (September 2011). ["Phased whole-genome genetic risk in a family quartet using a major allele reference sequence"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3174201). _PLOS Genetics_. **7** (9): e1002280. [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pgen.1002280](https://doi.org/10.1371%2Fjournal.pgen.1002280). [PMC](/wiki/PMC_\(identifier\)) [3174201](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3174201). [PMID](/wiki/PMID_\(identifier\)) [21935354](//pubmed.ncbi.nlm.nih.gov/21935354).
  97. **^** ["Complete Genomics Adds 29 High-Coverage, Complete Human Genome Sequencing Datasets to Its Public Genomic Repository"](http://globenewswire.com/news-release/2011/04/06/443810/218032/en/Complete-Genomics-Adds-29-High-Coverage-Complete-Human-Genome-Sequencing-Datasets-to-Its-Public-Genomic-Repository.html?print=1).
  98. **^** Sample I (17 February 2010). ["Desmond Tutu's genome sequenced as part of genetic diversity study"](https://www.theguardian.com/science/2010/feb/17/desmond-tutu-genome-genetic-diversity). _The Guardian_.
  99. **^** Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, Kasson LR, et al. (February 2010). ["Complete Khoisan and Bantu genomes from southern Africa"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3890430). _Nature_. **463** (7283): 943–7. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Natur.463..943S](https://ui.adsabs.harvard.edu/abs/2010Natur.463..943S). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature08795](https://doi.org/10.1038%2Fnature08795). [PMC](/wiki/PMC_\(identifier\)) [3890430](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3890430). [PMID](/wiki/PMID_\(identifier\)) [20164927](//pubmed.ncbi.nlm.nih.gov/20164927).
  100. **^** Rasmussen M, Li Y, Lindgreen S, Pedersen JS, Albrechtsen A, Moltke I, et al. (February 2010). ["Ancient human genome sequence of an extinct Palaeo-Eskimo"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3951495). _Nature_. **463** (7282): 757–62. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Natur.463..757R](https://ui.adsabs.harvard.edu/abs/2010Natur.463..757R). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature08835](https://doi.org/10.1038%2Fnature08835). [PMC](/wiki/PMC_\(identifier\)) [3951495](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3951495). [PMID](/wiki/PMID_\(identifier\)) [20148029](//pubmed.ncbi.nlm.nih.gov/20148029).
  101. **^** [Corpas M](/wiki/Manuel_Corpas_\(Scientist\)), Cariaso M, Coletta A, Weiss D, Harrison AP, Moran F, Yang H (12 November 2013). "A Complete Public Domain Family Genomics Dataset". [bioRxiv](/wiki/BioRxiv_\(identifier\)) [10.1101/000216](https://doi.org/10.1101%2F000216).
  102. **^** [Corpas M](/wiki/Manuel_Corpas_\(Scientist\)) (June 2013). ["Crowdsourcing the corpasome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3706263). _Source Code for Biology and Medicine_. **8** (1): 13. [doi](/wiki/Doi_\(identifier\)):[10.1186/1751-0473-8-13](https://doi.org/10.1186%2F1751-0473-8-13). [PMC](/wiki/PMC_\(identifier\)) [3706263](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3706263). [PMID](/wiki/PMID_\(identifier\)) [23799911](//pubmed.ncbi.nlm.nih.gov/23799911).
  103. **^** Mao Q, Ciotlos S, Zhang RY, Ball MP, Chin R, Carnevali P, et al. (October 2016). ["The whole genome sequences and experimentally phased haplotypes of over 100 personal genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5057367). _GigaScience_. **5** (1): 42. [doi](/wiki/Doi_\(identifier\)):[10.1186/s13742-016-0148-z](https://doi.org/10.1186%2Fs13742-016-0148-z). [PMC](/wiki/PMC_\(identifier\)) [5057367](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5057367). [PMID](/wiki/PMID_\(identifier\)) [27724973](//pubmed.ncbi.nlm.nih.gov/27724973).
  104. **^** Cai B, Li B, Kiga N, Thusberg J, Bergquist T, Chen YC, et al. (September 2017). ["Matching phenotypes to whole genomes: Lessons learned from four iterations of the personal genome project community challenges"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5645203). _Human Mutation_. **38** (9): 1266–1276. [doi](/wiki/Doi_\(identifier\)):[10.1002/humu.23265](https://doi.org/10.1002%2Fhumu.23265). [PMC](/wiki/PMC_\(identifier\)) [5645203](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5645203). [PMID](/wiki/PMID_\(identifier\)) [28544481](//pubmed.ncbi.nlm.nih.gov/28544481).
  105. **^** Gonzaga-Jauregui C, Lupski JR, Gibbs RA (2012). ["Human genome sequencing in health and disease"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3656720). _Annual Review of Medicine_. **63**: 35–61. [doi](/wiki/Doi_\(identifier\)):[10.1146/annurev-med-051010-162644](https://doi.org/10.1146%2Fannurev-med-051010-162644). [PMC](/wiki/PMC_\(identifier\)) [3656720](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3656720). [PMID](/wiki/PMID_\(identifier\)) [22248320](//pubmed.ncbi.nlm.nih.gov/22248320).
  106. **^** Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloğlu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP (November 2009). ["Genetic diagnosis by whole exome capture and massively parallel DNA sequencing"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2768590). _Proceedings of the National Academy of Sciences of the United States of America_. **106** (45): 19096–101. [Bibcode](/wiki/Bibcode_\(identifier\)):[2009PNAS..10619096C](https://ui.adsabs.harvard.edu/abs/2009PNAS..10619096C). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.0910672106](https://doi.org/10.1073%2Fpnas.0910672106). [PMC](/wiki/PMC_\(identifier\)) [2768590](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2768590). [PMID](/wiki/PMID_\(identifier\)) [19861545](//pubmed.ncbi.nlm.nih.gov/19861545).
  107. ^ _**a**_ _**b**_ Narasimhan VM, Xue Y, Tyler-Smith C (April 2016). ["Human Knockout Carriers: Dead, Diseased, Healthy, or Improved?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4826344). _Trends in Molecular Medicine_. **22** (4): 341–351. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.molmed.2016.02.006](https://doi.org/10.1016%2Fj.molmed.2016.02.006). [PMC](/wiki/PMC_\(identifier\)) [4826344](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4826344). [PMID](/wiki/PMID_\(identifier\)) [26988438](//pubmed.ncbi.nlm.nih.gov/26988438).
  108. **^** Saleheen D, Natarajan P, Armean IM, Zhao W, Rasheed A, Khetarpal SA, et al. (April 2017). ["Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5600291). _Nature_. **544** (7649): 235–239. [Bibcode](/wiki/Bibcode_\(identifier\)):[2017Natur.544..235S](https://ui.adsabs.harvard.edu/abs/2017Natur.544..235S). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature22034](https://doi.org/10.1038%2Fnature22034). [PMC](/wiki/PMC_\(identifier\)) [5600291](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5600291). [PMID](/wiki/PMID_\(identifier\)) [28406212](//pubmed.ncbi.nlm.nih.gov/28406212).
  109. ^ _**a**_ _**b**_ Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA (January 2002). ["Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC99152). _Nucleic Acids Research_. **30** (1): 52–5. [doi](/wiki/Doi_\(identifier\)):[10.1093/nar/30.1.52](https://doi.org/10.1093%2Fnar%2F30.1.52). [PMC](/wiki/PMC_\(identifier\)) [99152](//www.ncbi.nlm.nih.gov/pmc/articles/PMC99152). [PMID](/wiki/PMID_\(identifier\)) [11752252](//pubmed.ncbi.nlm.nih.gov/11752252).
  110. **^** Katsanis N (November 2016). ["The continuum of causality in human genetic disorders"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5114767). _Genome Biology_. **17** (1): 233. [doi](/wiki/Doi_\(identifier\)):[10.1186/s13059-016-1107-9](https://doi.org/10.1186%2Fs13059-016-1107-9). [PMC](/wiki/PMC_\(identifier\)) [5114767](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5114767). [PMID](/wiki/PMID_\(identifier\)) [27855690](//pubmed.ncbi.nlm.nih.gov/27855690).
  111. **^** Wong JC (2017). "Overview of the Clinical Utility of Next Generation Sequencing in Molecular Diagnoses of Human Genetic Disorders". In Wong LJ (ed.). _Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders_. Cham: Springer International Publishing. pp. 1–11. [doi](/wiki/Doi_\(identifier\)):[10.1007/978-3-319-56418-0_1](https://doi.org/10.1007%2F978-3-319-56418-0_1). [ISBN](/wiki/ISBN_\(identifier\)) [978-3-319-56416-6](/wiki/Special:BookSources/978-3-319-56416-6).
  112. **^** Fedick A, Zhang J (2017). "Next Generation of Carrier Screening". In Wong LJ (ed.). _Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders_. Cham: Springer International Publishing. pp. 339–354. [doi](/wiki/Doi_\(identifier\)):[10.1007/978-3-319-56418-0_16](https://doi.org/10.1007%2F978-3-319-56418-0_16). [ISBN](/wiki/ISBN_\(identifier\)) [978-3-319-56416-6](/wiki/Special:BookSources/978-3-319-56416-6).
  113. **^** Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, et al. (December 2002). ["Initial sequencing and comparative analysis of the mouse genome"](https://doi.org/10.1038%2Fnature01262). _Nature_. **420** (6915): 520–62. [Bibcode](/wiki/Bibcode_\(identifier\)):[2002Natur.420..520W](https://ui.adsabs.harvard.edu/abs/2002Natur.420..520W). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature01262](https://doi.org/10.1038%2Fnature01262). [PMID](/wiki/PMID_\(identifier\)) [12466850](//pubmed.ncbi.nlm.nih.gov/12466850). the proportion of small (50–100 bp) segments in the mammalian genome that is under (purifying) selection can be estimated to be about 5%. This proportion is much higher than can be explained by protein-coding sequences alone, implying that the genome contains many additional features (such as untranslated regions, regulatory elements, non-protein-coding genes, and chromosomal structural elements) under selection for biological function.
  114. **^** Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, et al. (June 2007). ["Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2212820). _Nature_. **447** (7146): 799–816. [Bibcode](/wiki/Bibcode_\(identifier\)):[2007Natur.447..799B](https://ui.adsabs.harvard.edu/abs/2007Natur.447..799B). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature05874](https://doi.org/10.1038%2Fnature05874). [PMC](/wiki/PMC_\(identifier\)) [2212820](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2212820). [PMID](/wiki/PMID_\(identifier\)) [17571346](//pubmed.ncbi.nlm.nih.gov/17571346).
  115. **^** The Chimpanzee Sequencing Analysis Consortium (September 2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](https://doi.org/10.1038%2Fnature04072). _Nature_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). We calculate the genome-wide nucleotide divergence between human and chimpanzee to be 1.23%, confirming recent results from more limited studies.
  116. **^** The Chimpanzee Sequencing Analysis Consortium (September 2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](https://doi.org/10.1038%2Fnature04072). _Nature_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). we estimate that polymorphism accounts for 14–22% of the observed divergence rate and thus that the fixed divergence is ~1.06% or less
  117. **^** Demuth JP, De Bie T, Stajich JE, Cristianini N, Hahn MW (2006). ["The evolution of mammalian gene families"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1762380). _PLOS ONE_. **1** (1): e85. [Bibcode](/wiki/Bibcode_\(identifier\)):[2006PLoSO...1...85D](https://ui.adsabs.harvard.edu/abs/2006PLoSO...1...85D). [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pone.0000085](https://doi.org/10.1371%2Fjournal.pone.0000085). [PMC](/wiki/PMC_\(identifier\)) [1762380](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1762380). [PMID](/wiki/PMID_\(identifier\)) [17183716](//pubmed.ncbi.nlm.nih.gov/17183716). Our results imply that humans and chimpanzees differ by at least 6% (1,418 of 22,000 genes) in their complement of genes, which stands in stark contrast to the oft-cited 1.5% difference between orthologous nucleotide sequences
  118. **^** The Chimpanzee Sequencing Analysis Consortium (September 2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](https://doi.org/10.1038%2Fnature04072). _Nature_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). Human chromosome 2 resulted from a fusion of two ancestral chromosomes that remained separate in the chimpanzee lineage  
Olson MV, Varki A (January 2003). "Sequencing the chimpanzee genome: insights
into human evolution and disease". _Nature Reviews Genetics_. **4** (1): 20–8.
[doi](/wiki/Doi_\(identifier\)):[10.1038/nrg981](https://doi.org/10.1038%2Fnrg
981). [PMID](/wiki/PMID_\(identifier\))
[12509750](//pubmed.ncbi.nlm.nih.gov/12509750).
[S2CID](/wiki/S2CID_\(identifier\))
[205486561](https://api.semanticscholar.org/CorpusID:205486561). Large-scale
sequencing of the chimpanzee genome is now imminent.

  119. **^** Gilad Y, Wiebe V, Przeworski M, Lancet D, Pääbo S (January 2004). ["Loss of olfactory receptor genes coincides with the acquisition of full trichromatic vision in primates"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC314465). _PLOS Biology_. **2** (1): E5. [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pbio.0020005](https://doi.org/10.1371%2Fjournal.pbio.0020005). [PMC](/wiki/PMC_\(identifier\)) [314465](//www.ncbi.nlm.nih.gov/pmc/articles/PMC314465). [PMID](/wiki/PMID_\(identifier\)) [14737185](//pubmed.ncbi.nlm.nih.gov/14737185). Our findings suggest that the deterioration of the olfactory repertoire occurred concomitant with the acquisition of full trichromatic color vision in primates.
  120. **^** [Zimmer C](/wiki/Carl_Zimmer) (21 September 2016). ["How We Got Here: DNA Points to a Single Migration From Africa"](https://www.nytimes.com/2016/09/22/science/ancient-dna-human-history.html). _[New York Times](/wiki/New_York_Times)_. Retrieved 22 September 2016.
  121. **^** Copeland WC (January 2012). ["Defects in mitochondrial DNA replication and human disease"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3244805). _Critical Reviews in Biochemistry and Molecular Biology_. **47** (1): 64–74. [doi](/wiki/Doi_\(identifier\)):[10.3109/10409238.2011.632763](https://doi.org/10.3109%2F10409238.2011.632763). [PMC](/wiki/PMC_\(identifier\)) [3244805](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3244805). [PMID](/wiki/PMID_\(identifier\)) [22176657](//pubmed.ncbi.nlm.nih.gov/22176657).
  122. **^** Nielsen R, Akey JM, Jakobsson M, Pritchard JK, Tishkoff S, Willerslev E (January 2017). ["Tracing the peopling of the world through genomics"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5772775). _Nature_. **541** (7637): 302–310. [Bibcode](/wiki/Bibcode_\(identifier\)):[2017Natur.541..302N](https://ui.adsabs.harvard.edu/abs/2017Natur.541..302N). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature21347](https://doi.org/10.1038%2Fnature21347). [PMC](/wiki/PMC_\(identifier\)) [5772775](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5772775). [PMID](/wiki/PMID_\(identifier\)) [28102248](//pubmed.ncbi.nlm.nih.gov/28102248).
  123. **^** Sykes B (9 October 2003). ["Mitochondrial DNA and human history"](https://web.archive.org/web/20150907140051/http://genome.wellcome.ac.uk/doc_WTD020876.html). The Human Genome. Archived from [the original](http://genome.wellcome.ac.uk/doc_WTD020876.html) on 7 September 2015. Retrieved 19 September 2006.
  124. **^** Misteli T (February 2007). ["Beyond the sequence: cellular organization of genome function"](https://doi.org/10.1016%2Fj.cell.2007.01.028). _Cell_. **128** (4): 787–800. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.cell.2007.01.028](https://doi.org/10.1016%2Fj.cell.2007.01.028). [PMID](/wiki/PMID_\(identifier\)) [17320514](//pubmed.ncbi.nlm.nih.gov/17320514). [S2CID](/wiki/S2CID_\(identifier\)) [9064584](https://api.semanticscholar.org/CorpusID:9064584).
  125. **^** Bernstein BE, Meissner A, Lander ES (February 2007). ["The mammalian epigenome"](https://doi.org/10.1016%2Fj.cell.2007.01.033). _Cell_. **128** (4): 669–81. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.cell.2007.01.033](https://doi.org/10.1016%2Fj.cell.2007.01.033). [PMID](/wiki/PMID_\(identifier\)) [17320505](//pubmed.ncbi.nlm.nih.gov/17320505). [S2CID](/wiki/S2CID_\(identifier\)) [2722988](https://api.semanticscholar.org/CorpusID:2722988).
  126. **^** Scheen AJ, Junien C (May–June 2012). "[Epigenetics, interface between environment and genes: role in complex diseases]". _Revue Médicale de Liège_. **67** (5–6): 250–7. [PMID](/wiki/PMID_\(identifier\)) [22891475](//pubmed.ncbi.nlm.nih.gov/22891475).

## External
links[[edit](/w/index.php?title=Human_genome&action=edit&section=28)]

![](//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg
/34px-Wikiquote-logo.svg.png)

Wikiquote has quotations related to: _**[Human
genome](https://en.wikiquote.org/wiki/Special:Search/Human_genome)**_

![](//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-
Commons-logo.svg.png)

Wikimedia Commons has media related to [Human
chromosomes](https://commons.wikimedia.org/wiki/Category:Human_chromosomes).

  * [Ensembl](http://www.ensembl.org/) The [Ensembl](/wiki/Ensembl) Genome Browser Project
  * [National Library of Medicine human genome viewer](https://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9606)
  * [UCSC Genome Browser](http://genome.ucsc.edu/).
  * [Human Genome Project](https://web.archive.org/web/20130102065343/http://www.ornl.gov/sci/techresources/Human_Genome/project/info.shtml).
  * [The National Human Genome Research Institute](http://www.genome.gov/)
  * [The National Office of Public Health Genomics](https://www.cdc.gov/genomics/default.htm)
  * [Simple Human Genome viewer](https://grrreggg.github.io/gene/)

  * [v](/wiki/Template:Chromosomes)
  * [t](/wiki/Template_talk:Chromosomes)
  * [e](https://en.wikipedia.org/w/index.php?title=Template:Chromosomes&action=edit)

Human genome

[Nuclear genome](/wiki/Nuclear_DNA)

[Autosome](/wiki/Autosome)

  * [1](/wiki/Chromosome_1)
  * [2](/wiki/Chromosome_2)
  * [3](/wiki/Chromosome_3)
  * [4](/wiki/Chromosome_4)
  * [5](/wiki/Chromosome_5)
  * [6](/wiki/Chromosome_6)
  * [7](/wiki/Chromosome_7)
  * [8](/wiki/Chromosome_8)
  * [9](/wiki/Chromosome_9)
  * [10](/wiki/Chromosome_10)
  * [11](/wiki/Chromosome_11)
  * [12](/wiki/Chromosome_12)
  * [13](/wiki/Chromosome_13)
  * [14](/wiki/Chromosome_14)
  * [15](/wiki/Chromosome_15)
  * [16](/wiki/Chromosome_16)
  * [17](/wiki/Chromosome_17)
  * [18](/wiki/Chromosome_18)
  * [19](/wiki/Chromosome_19)
  * [20](/wiki/Chromosome_20)
  * [21](/wiki/Chromosome_21)
  * [22](/wiki/Chromosome_22)

[Sex chromosome](/wiki/Allosome)

  * [X](/wiki/X_chromosome)
  * [Y](/wiki/Y_chromosome)

[Mitochondrial genome](/wiki/Mitochondrial_DNA)

[Human mitochondrial DNA](/wiki/Human_mitochondrial_genetics)

Related topics

  * Human genome
    * [Human Genome Project](/wiki/Human_Genome_Project)
  * [List of human genes](/wiki/List_of_human_genes)

  * [v](/wiki/Template:Human_genetics)
  * [t](/wiki/Template_talk:Human_genetics)
  * [e](https://en.wikipedia.org/w/index.php?title=Template:Human_genetics&action=edit)

[Human genetics](/wiki/Human_genetics)

Sub-topics

  * Human genome
    * [Human Genome Project](/wiki/Human_Genome_Project)
  * [Evolutionary genetics](/wiki/Human_evolutionary_genetics)
    * [Human-chimp MRCA](/wiki/Chimpanzee%E2%80%93human_last_common_ancestor)
    * [Neanderthal genetics](/wiki/Neanderthal_genetics)
      * [Neanderthal genome project](/wiki/Neanderthal_genome_project)
    * [Timeline](/wiki/Timeline_of_human_evolution)
  * [Genetic variation](/wiki/Human_genetic_variation)
    * [Blood type distribution by country](/wiki/Blood_type_distribution_by_country)
    * [Genealogical DNA test](/wiki/Genealogical_DNA_test)
    * [Genetic genealogy](/wiki/Genetic_genealogy)
    * [Race and genetics](/wiki/Race_and_genetics)
    * [Recent evolution](/wiki/Recent_human_evolution)
    * [Surname DNA project](/wiki/Surname_DNA_project)
  * [Genetic enhancement](/wiki/Human_genetic_enhancement)

[Genetic history](/wiki/Archaeogenetics)  
by region

  * [Sub-Saharan African](/wiki/Genetic_history_of_Sub-Saharan_Africa)
  * [South Asian](/wiki/Genetics_and_archaeogenetics_of_South_Asia)
  * [North African](/wiki/Genetic_history_of_North_Africa)
  * [Middle Eastern](/wiki/Genetic_history_of_the_Middle_East)
    * [Early Anatolian Farmers](/wiki/Early_Anatolian_Farmers)
  * [Caucasus](/wiki/Genetic_history_of_the_Caucasus)
    * [Caucasus hunter-gatherer](/wiki/Caucasus_hunter-gatherer)
  * [Europe](/wiki/Genetic_history_of_Europe)
    * [Western Hunter-Gatherer](/wiki/Western_Hunter-Gatherer)
    * [British Isles](/wiki/Genetic_history_of_the_British_Isles)
    * [Iberia](/wiki/Genetic_history_of_the_Iberian_Peninsula)
    * [Italy](/wiki/Genetic_history_of_Italy)
    * [Eastern Hunter-Gatherer](/wiki/Eastern_Hunter-Gatherer)
  * [Central Asian](/wiki/Genetic_history_of_Central_Asia)
    * [Ancient North Eurasian](/wiki/Ancient_North_Eurasian)
  * [East Asian](/wiki/Genetic_history_of_East_Asians)
  * [Southeast Asian](/wiki/Peopling_of_Southeast_Asia)
  * [American](/wiki/Genetic_history_of_indigenous_peoples_of_the_Americas)
    * [Ancient Beringian](/wiki/Ancient_Beringian)

[Population genetics](/wiki/Population_genetics)  
by group

  * Europe 
    * [Albanians](/wiki/Origin_of_the_Albanians#Genetic_studies)
    * [Basques](/wiki/Origin_of_the_Basques)
    * [Bosniaks](/wiki/Genetic_studies_on_Bosniaks)
    * [Bulgarians](/wiki/Genetic_studies_on_Bulgarians)
    * [Croats](/wiki/Genetic_studies_on_Croats)
    * [Romanians](/wiki/Genetic_studies_on_Romanians)
    * [Russians](/wiki/Genetic_studies_on_Russians)
    * [Sami](/wiki/Genetic_studies_on_Sami)
    * [Serbs](/wiki/Genetic_studies_on_Serbs)
  * [Azerbaijanis](/wiki/Origin_of_the_Azerbaijanis)
  * [Jews](/wiki/Genetic_studies_on_Jews)
  * [Turks](/wiki/Genetic_studies_on_Turkish_people)
  * MENA 
    * [Arabs](/wiki/Genetic_studies_on_Arabs)
    * [Egyptians](/wiki/DNA_history_of_Egypt)
    * [Moroccans](/wiki/Genetic_studies_on_Moroccans)
  * South Asia 
    * [Gujaratis](/wiki/Genetic_studies_on_Gujarati_people)
    * [Sinhalese](/wiki/Genetic_studies_on_Sinhalese)
    * [Tamils (Sri Lankan)](/wiki/Genetic_studies_on_Sri_Lankan_Tamils)
  * East Asia 
    * [Han Chinese](/wiki/Genetic_studies_on_Han_Chinese)
    * [Japanese](/wiki/Genetic_and_anthropometric_studies_on_Japanese_people)
  * Sub-Saharan Africa 
    * [Hutu/Tutsi](/wiki/Genetic_studies_on_Hutu_and_Tutsi)
    * [Khoisan](/wiki/Khoisan#Genetics)
    * [Pygmies](/wiki/African_Pygmies#Genetics)

  * ![Category](//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/16px-Symbol_category_class.svg.png)**[Category](/wiki/Category:Human_genetics)**

[Authority control](/wiki/Help:Authority_control) ![Edit this at
Wikidata](//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-
ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)

National libraries

  * [Japan](https://id.ndl.go.jp/auth/ndlna/01009113)

Other

  * [Microsoft Academic](https://academic.microsoft.com/v2/detail/197077220)
    * [2](https://academic.microsoft.com/v2/detail/2909424303)

![](//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1)

Retrieved from "[https://en.wikipedia.org/w/index.php?title=Human_genome&oldid
=1042301099](https://en.wikipedia.org/w/index.php?title=Human_genome&oldid=104
2301099)"

[Categories](/wiki/Help:Category):

  * [Genetic mapping](/wiki/Category:Genetic_mapping)
  * [Genomics](/wiki/Category:Genomics)
  * [Human genetics](/wiki/Category:Human_genetics)
  * [Human evolution](/wiki/Category:Human_evolution)
  * [Chromosomes (human)](/wiki/Category:Chromosomes_\(human\))

Hidden categories:

  * [All articles with dead external links](/wiki/Category:All_articles_with_dead_external_links)
  * [Articles with dead external links from January 2020](/wiki/Category:Articles_with_dead_external_links_from_January_2020)
  * [Articles with permanently dead external links](/wiki/Category:Articles_with_permanently_dead_external_links)
  * [Articles with short description](/wiki/Category:Articles_with_short_description)
  * [Short description is different from Wikidata](/wiki/Category:Short_description_is_different_from_Wikidata)
  * [All articles with unsourced statements](/wiki/Category:All_articles_with_unsourced_statements)
  * [Articles with unsourced statements from January 2020](/wiki/Category:Articles_with_unsourced_statements_from_January_2020)
  * [Commons category link from Wikidata](/wiki/Category:Commons_category_link_from_Wikidata)
  * [Use dmy dates from August 2019](/wiki/Category:Use_dmy_dates_from_August_2019)
  * [Articles with NDL identifiers](/wiki/Category:Articles_with_NDL_identifiers)
  * [Articles with MA identifiers](/wiki/Category:Articles_with_MA_identifiers)
  * [Articles with multiple identifiers](/wiki/Category:Articles_with_multiple_identifiers)

## Navigation menu

### Personal tools

  * Not logged in
  * [Talk](/wiki/Special:MyTalk)
  * [Contributions](/wiki/Special:MyContributions)
  * [Create account](/w/index.php?title=Special:CreateAccount&returnto=Human+genome)
  * [Log in](/w/index.php?title=Special:UserLogin&returnto=Human+genome)

### Namespaces

  * [Article](/wiki/Human_genome)
  * [Talk](/wiki/Talk:Human_genome)

### Variants

### Views

  * [Read](/wiki/Human_genome)
  * [Edit](/w/index.php?title=Human_genome&action=edit)
  * [View history](/w/index.php?title=Human_genome&action=history)

### More

###  Search

### Navigation

  * [Main page](/wiki/Main_Page)
  * [Contents](/wiki/Wikipedia:Contents)
  * [Current events](/wiki/Portal:Current_events)
  * [Random article](/wiki/Special:Random)
  * [About Wikipedia](/wiki/Wikipedia:About)
  * [Contact us](//en.wikipedia.org/wiki/Wikipedia:Contact_us)
  * [Donate](https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en)

### Contribute

  * [Help](/wiki/Help:Contents)
  * [Learn to edit](/wiki/Help:Introduction)
  * [Community portal](/wiki/Wikipedia:Community_portal)
  * [Recent changes](/wiki/Special:RecentChanges)
  * [Upload file](/wiki/Wikipedia:File_Upload_Wizard)

### Tools

  * [What links here](/wiki/Special:WhatLinksHere/Human_genome)
  * [Related changes](/wiki/Special:RecentChangesLinked/Human_genome)
  * [Upload file](/wiki/Wikipedia:File_Upload_Wizard)
  * [Special pages](/wiki/Special:SpecialPages)
  * [Permanent link](/w/index.php?title=Human_genome&oldid=1042301099)
  * [Page information](/w/index.php?title=Human_genome&action=info)
  * [Cite this page](/w/index.php?title=Special:CiteThisPage&page=Human_genome&id=1042301099&wpFormIdentifier=titleform)
  * [Wikidata item](https://www.wikidata.org/wiki/Special:EntityPage/Q720988)

### Print/export

  * [Download as PDF](/w/index.php?title=Special:DownloadAsPdf&page=Human_genome&action=show-download-screen)
  * [Printable version](/w/index.php?title=Human_genome&printable=yes)

### In other projects

  * [Wikimedia Commons](https://commons.wikimedia.org/wiki/Category:Human_genome)
  * [Wikiquote](https://en.wikiquote.org/wiki/Human_genome)

### Languages

  * [العربية](https://ar.wikipedia.org/wiki/%D8%AC%D9%8A%D9%86%D9%88%D9%85_%D8%A8%D8%B4%D8%B1%D9%8A)
  * [Asturianu](https://ast.wikipedia.org/wiki/Xenoma_humanu)
  * [বাংলা](https://bn.wikipedia.org/wiki/%E0%A6%AE%E0%A6%A8%E0%A7%81%E0%A6%B7%E0%A7%8D%E0%A6%AF_%E0%A6%9C%E0%A6%BF%E0%A6%A8%E0%A6%B8%E0%A6%AE%E0%A6%B7%E0%A7%8D%E0%A6%9F%E0%A6%BF)
  * [Български](https://bg.wikipedia.org/wiki/%D0%A7%D0%BE%D0%B2%D0%B5%D1%88%D0%BA%D0%B8_%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC)
  * [Bosanski](https://bs.wikipedia.org/wiki/Ljudski_genom)
  * [Català](https://ca.wikipedia.org/wiki/Genoma_hum%C3%A0)
  * [Чӑвашла](https://cv.wikipedia.org/wiki/%C3%87%D1%8B%D0%BD_%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC%C4%95)
  * [Čeština](https://cs.wikipedia.org/wiki/Lidsk%C3%BD_genom)
  * [Cymraeg](https://cy.wikipedia.org/wiki/Y_Genom_Dynol)
  * [Eesti](https://et.wikipedia.org/wiki/Inimese_genoom)
  * [Ελληνικά](https://el.wikipedia.org/wiki/%CE%91%CE%BD%CE%B8%CF%81%CF%8E%CF%80%CE%B9%CE%BD%CE%BF_%CE%B3%CE%BF%CE%BD%CE%B9%CE%B4%CE%AF%CF%89%CE%BC%CE%B1)
  * [Español](https://es.wikipedia.org/wiki/Genoma_humano)
  * [Euskara](https://eu.wikipedia.org/wiki/Giza_genoma)
  * [فارسی](https://fa.wikipedia.org/wiki/%DA%98%D9%86%D9%88%D9%85_%D8%A7%D9%86%D8%B3%D8%A7%D9%86)
  * [Gaeilge](https://ga.wikipedia.org/wiki/G%C3%A9an%C3%B3m_daonna)
  * [Galego](https://gl.wikipedia.org/wiki/Xenoma_humano)
  * [한국어](https://ko.wikipedia.org/wiki/%EC%9D%B8%EA%B0%84_%EC%9C%A0%EC%A0%84%EC%B2%B4)
  * [Hrvatski](https://hr.wikipedia.org/wiki/Ljudski_genom)
  * [Bahasa Indonesia](https://id.wikipedia.org/wiki/Genom_manusia)
  * [Italiano](https://it.wikipedia.org/wiki/Genoma_umano)
  * [עברית](https://he.wikipedia.org/wiki/%D7%92%D7%A0%D7%95%D7%9D_%D7%94%D7%90%D7%93%D7%9D)
  * [Kreyòl ayisyen](https://ht.wikipedia.org/wiki/Jen%C3%B2m_imen)
  * [Magyar](https://hu.wikipedia.org/wiki/Hum%C3%A1n_genom)
  * [日本語](https://ja.wikipedia.org/wiki/%E3%83%92%E3%83%88%E3%82%B2%E3%83%8E%E3%83%A0)
  * [Polski](https://pl.wikipedia.org/wiki/Genom_cz%C5%82owieka)
  * [Português](https://pt.wikipedia.org/wiki/Genoma_humano)
  * [Română](https://ro.wikipedia.org/wiki/Genomul_uman)
  * [Русский](https://ru.wikipedia.org/wiki/%D0%93%D0%B5%D0%BD%D0%BE%D0%BC_%D1%87%D0%B5%D0%BB%D0%BE%D0%B2%D0%B5%D0%BA%D0%B0)
  * [Simple English](https://simple.wikipedia.org/wiki/Human_genome)
  * [Српски / srpski](https://sr.wikipedia.org/wiki/%D0%A5%D1%83%D0%BC%D0%B0%D0%BD%D0%B8_%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC)
  * [Srpskohrvatski / српскохрватски](https://sh.wikipedia.org/wiki/Ljudski_genom)
  * [Suomi](https://fi.wikipedia.org/wiki/Ihmisen_perim%C3%A4)
  * [Tagalog](https://tl.wikipedia.org/wiki/Genome_ng_tao)
  * [தமிழ்](https://ta.wikipedia.org/wiki/%E0%AE%AE%E0%AE%A9%E0%AE%BF%E0%AE%A4_%E0%AE%AE%E0%AE%B0%E0%AE%AA%E0%AE%A3%E0%AF%81%E0%AE%A4%E0%AF%8D%E0%AE%A4%E0%AF%8A%E0%AE%95%E0%AF%88)
  * [ไทย](https://th.wikipedia.org/wiki/%E0%B8%88%E0%B8%B5%E0%B9%82%E0%B8%99%E0%B8%A1%E0%B8%A1%E0%B8%99%E0%B8%B8%E0%B8%A9%E0%B8%A2%E0%B9%8C)
  * [Türkçe](https://tr.wikipedia.org/wiki/%C4%B0nsan_genomu)
  * [Українська](https://uk.wikipedia.org/wiki/%D0%93%D0%B5%D0%BD%D0%BE%D0%BC_%D0%BB%D1%8E%D0%B4%D0%B8%D0%BD%D0%B8)
  * [Tiếng Việt](https://vi.wikipedia.org/wiki/B%E1%BB%99_gen_ng%C6%B0%E1%BB%9Di)
  * [Zazaki](https://diq.wikipedia.org/wiki/C%C3%AAnom%C3%AA_merdumi)
  * [中文](https://zh.wikipedia.org/wiki/%E4%BA%BA%E9%A1%9E%E5%9F%BA%E5%9B%A0%E7%B5%84)

[Edit links](https://www.wikidata.org/wiki/Special:EntityPage/Q720988
#sitelinks-wikipedia)

  * This page was last edited on 4 September 2021, at 07:40 (UTC).
  * Text is available under the [Creative Commons Attribution-ShareAlike License](//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License); additional terms may apply. By using this site, you agree to the [Terms of Use](//foundation.wikimedia.org/wiki/Terms_of_Use) and [Privacy Policy](//foundation.wikimedia.org/wiki/Privacy_policy). Wikipedia® is a registered trademark of the [Wikimedia Foundation, Inc.](//www.wikimediafoundation.org/), a non-profit organization.
  * [Privacy policy](https://foundation.wikimedia.org/wiki/Privacy_policy)
  * [About Wikipedia](/wiki/Wikipedia:About)
  * [Disclaimers](/wiki/Wikipedia:General_disclaimer)
  * [Contact Wikipedia](//en.wikipedia.org/wiki/Wikipedia:Contact_us)
  * [Mobile view](//en.m.wikipedia.org/w/index.php?title=Human_genome&mobileaction=toggle_view_mobile)
  * [Developers](https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute)
  * [Statistics](https://stats.wikimedia.org/#/en.wikipedia.org)
  * [Cookie statement](https://foundation.wikimedia.org/wiki/Cookie_statement)
  * ![Wikimedia Foundation](/static/images/footer/wikimedia-button.png)
  * ![Powered by MediaWiki](/static/images/footer/poweredby_mediawiki_88x31.png)
  *[[v]: View this template
  *[[e]: Edit this template
  *[[t]: Discuss this template

# Human genome

From Wikipedia, the free encyclopedia

Jump to navigation Jump to search

For a non-technical introduction to the topic, see [Introduction to
genetics](/wiki/Introduction_to_genetics).

Complete set of nucleic acid sequences for humans

Genomic information

![Karyotype.png](//upload.wikimedia.org/wikipedia/commons/thumb/b/b2/Karyotype
.png/260px-Karyotype.png)

Graphical representation of the idealized human diploid
[karyotype](/wiki/Karyotype), showing the organization of the genome into
chromosomes. This drawing shows both the female (XX) and male (XY) versions of
the 23rd chromosome pair. Chromosomes are shown aligned at their
[centromeres](/wiki/Centromeres). The mitochondrial DNA is not shown.

[NCBI](/wiki/National_Center_for_Biotechnology_Information) genome ID

[51](https://www.ncbi.nlm.nih.gov/genome/?term=51)

[Ploidy](/wiki/Ploidy)

diploid

[Genome size](/wiki/Genome_size)

3,100 Mbp[1] (mega-basepairs) per haploid genome  
6,200 Mbp total (diploid).

Number of [chromosomes](/wiki/Chromosome)

23 pairs

The **human genome** is a complete set of [nucleic acid
sequences](/wiki/Nucleic_acid_sequence) for [humans](/wiki/Humans), encoded as
[DNA](/wiki/DNA) within the 23 [chromosome](/wiki/Chromosome) pairs in [cell
nuclei](/wiki/Cell_nuclei) and in a small DNA molecule found within individual
[mitochondria](/wiki/Mitochondrial_DNA). These are usually treated separately
as the nuclear genome and the [mitochondrial
genome](/wiki/Human_mitochondrial_genetics).[2] Human [genomes](/wiki/Genome)
include both protein-coding DNA genes and [noncoding
DNA](/wiki/Noncoding_DNA). [Haploid](/wiki/Haploid) human genomes, which are
contained in [germ cells](/wiki/Germ_cells) (the [egg](/wiki/Egg) and
[sperm](/wiki/Sperm) [gamete](/wiki/Gamete) cells created in the
[meiosis](/wiki/Meiosis) phase of [sexual
reproduction](/wiki/Sexual_reproduction) before
[fertilization](/wiki/Fertilization) creates a [zygote](/wiki/Zygote)) consist
of three billion [DNA](/wiki/DNA) [base pairs](/wiki/Base_pair), while
[diploid](/wiki/Diploid) genomes (found in [somatic
cells](/wiki/Somatic_cells)) have twice the DNA content. While there are
significant differences among the genomes of human individuals (on the order
of 0.1% due to [single-nucleotide variants](/wiki/Single-
nucleotide_variant)[3] and 0.6% when considering [indels](/wiki/Indel)),[4]
these are considerably smaller than the differences between humans and their
closest living relatives, the [bonobos](/wiki/Bonobo) and
[chimpanzees](/wiki/Common_chimpanzee) (~1.1%
[fixed](/wiki/Fixation_\(population_genetics\)) single-nucleotide variants [5]
and 4% when including indels).[6]

Although the sequence of the human genome has been (almost) completely
determined by DNA sequencing, it is not yet fully understood. Most (though
probably not all) [genes](/wiki/Gene) have been identified by a combination of
high throughput experimental and [bioinformatics](/wiki/Bioinformatics)
approaches, yet much work still needs to be done to further elucidate the
biological functions of their protein and [RNA](/wiki/RNA) products. Recent
results suggest that most of the vast quantities of noncoding DNA within the
genome have associated biochemical activities, including [regulation of gene
expression](/wiki/Regulation_of_gene_expression), organization of [chromosome
architecture](/wiki/Chromatin), and signals controlling [epigenetic
inheritance](/wiki/Epigenetic_inheritance).

Prior to the acquisition of the full genome sequence, estimates of the number
of human genes ranged from 50,000 to 140,000 (with occasional vagueness about
whether these estimates included non-protein coding genes).[7] As genome
sequence quality and the methods for identifying protein-coding genes
improved,[8] the count of recognized protein-coding genes dropped to
19,000-20,000.[9] However, a fuller understanding of the role played by
sequences that do not encode proteins, but instead express regulatory RNA, has
raised the total number of genes to at least 46,831,[10] plus another 2300
[micro-RNA](/wiki/Micro-RNA) genes.[11] By 2012, functional DNA elements that
encode neither RNA nor proteins have been noted.[12] A 2018 population survey
found another 300 million bases of human genome that was not in the reference
sequence.[13]

[Protein](/wiki/Protein)-coding sequences account for only a very small
fraction of the genome (approximately 1.5%), and the rest is associated with
[non-coding RNA](/wiki/Non-coding_RNA) genes, [regulatory DNA
sequences](/wiki/Regulatory_sequences), [LINEs](/wiki/LINEs),
[SINEs](/wiki/Short_interspersed_nuclear_element), [introns](/wiki/Intron),
and sequences for which as yet [no function](/wiki/Noncoding_DNA) has been
determined.[14]

## Contents

  * 1 Sequencing
  * 2 Completeness
  * 3 Molecular organization and gene content
    * 3.1 Information content
  * 4 Coding vs. noncoding DNA
  * 5 Coding sequences (protein-coding genes)
  * 6 Noncoding DNA (ncDNA)
    * 6.1 Pseudogenes
    * 6.2 Genes for noncoding RNA (ncRNA)
    * 6.3 Introns and untranslated regions of mRNA
    * 6.4 Regulatory DNA sequences
    * 6.5 Repetitive DNA sequences
    * 6.6 Mobile genetic elements (transposons) and their relics
  * 7 Genomic variation in humans
    * 7.1 Human reference genome
    * 7.2 Measuring human genetic variation
      * 7.2.1 Mapping human genomic variation
    * 7.3 Structural variation
    * 7.4 SNP frequency across the human genome
    * 7.5 Personal genomes
    * 7.6 Human knockouts
  * 8 Human genetic disorders
  * 9 Evolution
  * 10 Mitochondrial DNA
  * 11 Epigenome
  * 12 See also
  * 13 References
  * 14 External links

## Sequencing[[edit](/w/index.php?title=Human_genome&action=edit&section=1)]

The first human genome sequences were published in nearly complete draft form
in February 2001 by the [Human Genome Project](/wiki/Human_Genome_Project)[15]
and [Celera Corporation](/wiki/Celera_Corporation).[16] Completion of the
Human Genome Project's sequencing effort was announced in 2004 with the
publication of a draft genome sequence, leaving just 341 gaps in the sequence,
representing highly-repetitive and other DNA that could not be sequenced with
the technology available at the time.[8] The human genome was the first of all
vertebrates to be sequenced to such near-completion, and as of 2018, the
diploid genomes of over a million individual humans had been determined using
[next-generation sequencing](/wiki/Next-generation_sequencing).[17] In 2021 it
was reported that the T2T consortium had filled in all of the gaps. Thus there
came into existence a complete human genome with no gaps.[18]

These data are used worldwide in [biomedical
science](/wiki/Biomedical_science),
[anthropology](/wiki/Biological_anthropology), [forensics](/wiki/Forensic_DNA)
and other branches of science. Such genomic studies have led to advances in
the diagnosis and treatment of diseases, and to new insights in many fields of
biology, including [human evolution](/wiki/Human_evolution).

In June 2016, scientists formally announced [HGP-Write](/wiki
/Human_Genome_Project_-_Write), a plan to synthesize the human genome.[19][20]

## Completeness[[edit](/w/index.php?title=Human_genome&action=edit&section=2)]

Main article: [Human Genome Project § State of
completion](/wiki/Human_Genome_Project#State_of_completion)

Although the 'completion' of the human genome project was announced in
2001,[14] there remained hundreds of gaps, with about 5–10% of the total
sequence remaining undetermined. The missing genetic information was mostly in
repetitive [heterochromatic](/wiki/Heterochromatin) regions and near the
[centromeres](/wiki/Centromere) and [telomeres](/wiki/Telomere), but also some
gene-encoding [euchromatic](/wiki/Euchromatin) regions.[21] There remained 160
euchromatic gaps in 2015 when the sequences spanning another 50 formerly-
unsequenced regions were determined.[22] Only in 2020 was the first truly
complete telomere-to-telomere sequence of a human chromosome determined,
namely of the [X chromosome](/wiki/X_chromosome).[23] Level "complete genome"
(without Y chromosome) was achieved in May 2021.[24][25]

## Molecular organization and gene
content[[edit](/w/index.php?title=Human_genome&action=edit&section=3)]

See also: [Lists of human genes](/wiki/Lists_of_human_genes)

The total length of the human [reference genome](/wiki/Reference_genome), that
does not represent the sequence of any specific individual, is over 3 billion
base pairs. The genome is organized into 22 paired chromosomes, termed
[autosomes](/wiki/Autosome), plus the 23rd pair of [sex
chromosomes](/wiki/Sex_chromosome) (XX) in the female, and (XY) in the male.
These are all large linear DNA molecules contained within the cell nucleus.
The genome also includes the [mitochondrial DNA](/wiki/Mitochondrial_DNA), a
comparatively small circular molecule present in multiple copies in each the
[mitochondrion](/wiki/Mitochondrion).

Human reference genome data, by chromosome[26]

Chromosome Length  
([mm](/wiki/Millimetre)) Base  
pairs Variations Protein-  
coding  
genes Pseudo-  
genes Total  
long  
ncRNA Total  
small  
ncRNA miRNA rRNA snRNA snoRNA Misc  
ncRNA Links Centromere  
position  
([Mbp](/wiki/Mega_base_pairs)) Cumulative  
(%)

[1](/wiki/Chromosome_1_\(human\))

85

248,956,422

12,151,146

2058

1220

1200

496

134

66

221

145

192

[EBI](https://archive.today/20130414235101/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=1)

125

7.9

[2](/wiki/Chromosome_2_\(human\))

83

242,193,529

12,945,965

1309

1023

1037

375

115

40

161

117

176

[EBI](https://archive.today/20130414170207/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=2)

93.3

16.2

[3](/wiki/Chromosome_3_\(human\))

67

198,295,559

10,638,715

1078

763

711

298

99

29

138

87

134

[EBI](https://archive.today/20130414155057/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=3)

91

23

[4](/wiki/Chromosome_4_\(human\))

65

190,214,555

10,165,685

752

727

657

228

92

24

120

56

104

[EBI](https://archive.today/20130414184734/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=4)

50.4

29.6

[5](/wiki/Chromosome_5_\(human\))

62

181,538,259

9,519,995

876

721

844

235

83

25

106

61

119

[EBI](https://archive.today/20130414165438/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=5)

48.4

35.8

[6](/wiki/Chromosome_6_\(human\))

58

170,805,979

9,130,476

1048

801

639

234

81

26

111

73

105

[EBI](https://archive.today/20130414210620/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=6)

61

41.6

[7](/wiki/Chromosome_7_\(human\))

54

159,345,973

8,613,298

989

885

605

208

90

24

90

76

143

[EBI](https://archive.today/20130414191348/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=7)

59.9

47.1

[8](/wiki/Chromosome_8_\(human\))

50

145,138,636

8,221,520

677

613

735

214

80

28

86

52

82

[EBI](https://archive.today/20130414151536/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=8)

45.6

52

[9](/wiki/Chromosome_9_\(human\))

48

138,394,717

6,590,811

786

661

491

190

69

19

66

51

96

[EBI](https://archive.today/20130414154313/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=9)

49

56.3

[10](/wiki/Chromosome_10_\(human\))

46

133,797,422

7,223,944

733

568

579

204

64

32

87

56

89

[EBI](https://archive.today/20130414155104/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=10)

40.2

60.9

[11](/wiki/Chromosome_11_\(human\))

46

135,086,622

7,535,370

1298

821

710

233

63

24

74

76

97

[EBI](https://archive.today/20130414155450/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=11)

53.7

65.4

[12](/wiki/Chromosome_12_\(human\))

45

133,275,309

7,228,129

1034

617

848

227

72

27

106

62

115

[EBI](https://archive.today/20130414163842/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=12)

35.8

70

[13](/wiki/Chromosome_13_\(human\))

39

114,364,328

5,082,574

327

372

397

104

42

16

45

34

75

[EBI](https://archive.today/20130414153908/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=13)

17.9

73.4

[14](/wiki/Chromosome_14_\(human\))

36

107,043,718

4,865,950

830

523

533

239

92

10

65

97

79

[EBI](https://archive.today/20130414221716/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=14)

17.6

76.4

[15](/wiki/Chromosome_15_\(human\))

35

101,991,189

4,515,076

613

510

639

250

78

13

63

136

93

[EBI](https://archive.today/20130414185000/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=15)

19

79.3

[16](/wiki/Chromosome_16_\(human\))

31

90,338,345

5,101,702

873

465

799

187

52

32

53

58

51

[EBI](https://archive.today/20130414182905/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=16)

36.6

82

[17](/wiki/Chromosome_17_\(human\))

28

83,257,441

4,614,972

1197

531

834

235

61

15

80

71

99

[EBI](https://archive.today/20130414171249/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=17)

24

84.8

[18](/wiki/Chromosome_18_\(human\))

27

80,373,285

4,035,966

270

247

453

109

32

13

51

36

41

[EBI](https://archive.today/20130414160719/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=18)

17.2

87.4

[19](/wiki/Chromosome_19_\(human\))

20

58,617,616

3,858,269

1472

512

628

179

110

13

29

31

61

[EBI](https://archive.today/20130414165626/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=19)

26.5

89.3

[20](/wiki/Chromosome_20_\(human\))

21

64,444,167

3,439,621

544

249

384

131

57

15

46

37

68

[EBI](https://archive.today/20130414185621/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=20)

27.5

91.4

[21](/wiki/Chromosome_21_\(human\))

16

46,709,983

2,049,697

234

185

305

71

16

5

21

19

24

[EBI](https://archive.today/20130414191700/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=21)

13.2

92.6

[22](/wiki/Chromosome_22_\(human\))

17

50,818,468

2,135,311

488

324

357

78

31

5

23

23

62

[EBI](https://archive.today/20130414213655/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=22)

14.7

93.8

[X](/wiki/X_chromosome)

53

156,040,895

5,753,881

842

874

271

258

128

22

85

64

100

[EBI](https://archive.today/20130414192751/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=X)

60.6

99.1

[Y](/wiki/Y_chromosome)

20

57,227,415

211,643

71

388

71

30

15

7

17

3

8

[EBI](https://archive.today/20130414161928/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=Y)

10.4

100

[mtDNA](/wiki/Mitochondrial_DNA)

0.0054

16,569

929

13

0

0

24

0

2

0

0

0

[EBI](https://archive.today/20130414220526/http://useast.ensembl.org/Homo_sapi
ens/Location/Chromosome?r=MT)

N/A

100

total

3,088,286,401

155,630,645

20412

14600

14727

5037

1756

532

1944

1521

2213

_Original analysis published in the [Ensembl](/wiki/Ensembl) database at the
[European Bioinformatics Institute](/wiki/European_Bioinformatics_Institute)
(EBI) and [Wellcome Trust Sanger
Institute](/wiki/Wellcome_Trust_Sanger_Institute). Chromosome lengths
estimated by multiplying the number of base pairs by 0.34 nanometers (distance
between base pairs in the most common structure of the [DNA double
helix](/wiki/DNA#Properties); a recent estimate of human chromosome lengths
based on updated data reports 205.00 cm for the diploid male genome and 208.23
cm for female, corresponding to weights of 6.41 and 6.51 picograms (pg),
respectively[27]). Number of proteins is based on the number of initial
[precursor mRNA](/wiki/Precursor_mRNA) transcripts, and does not include
products of [alternative pre-mRNA splicing](/wiki/Alternative_splicing), or
modifications to protein structure that occur after
[translation](/wiki/Translation_\(biology\))._

_[Variations](/wiki/Human_genetic_variation) are unique DNA sequence
differences that have been identified in the individual human genome sequences
analyzed by Ensembl as of December 2016. The number of identified variations
is expected to increase as further [personal genomes](/wiki/Personal_genomics)
are sequenced and analyzed. In addition to the gene content shown in this
table, a large number of non-expressed functional sequences have been
identified throughout the human genome (see below). Links open windows to the
reference chromosome sequences in the EBI genome browser._

_Small [non-coding RNAs](/wiki/Non-coding_RNA) are RNAs of as many as 200
bases that do not have protein-coding potential. These include:
[microRNAs](/wiki/MicroRNA), or miRNAs (post-transcriptional regulators of
gene expression), [small nuclear RNAs](/wiki/Small_nuclear_RNA), or snRNAs
(the RNA components of [spliceosomes](/wiki/Spliceosome)), and [small
nucleolar RNAs](/wiki/Small_nucleolar_RNA), or snoRNA (involved in guiding
chemical modifications to other RNA molecules). [Long non-coding RNAs](/wiki
/Long_non-coding_RNA) are RNA molecules longer than 200 bases that do not have
protein-coding potential. These include: [ribosomal
RNAs](/wiki/Ribosomal_RNA), or rRNAs (the RNA components of
[ribosomes](/wiki/Ribosome)), and a variety of other long RNAs that are
involved in [regulation of gene
expression](/wiki/Regulation_of_gene_expression),
[epigenetic](/wiki/Epigenetic) modifications of DNA nucleotides and
[histone](/wiki/Histone) proteins, and regulation of the activity of protein-
coding genes. Small discrepancies between total-small-ncRNA numbers and the
numbers of specific types of small ncNRAs result from the former values being
sourced from Ensembl release 87 and the latter from Ensembl release 68._

_The number of genes in the human genome is not entirely clear because the
function of numerous [transcripts](/wiki/Transcription_\(biology\)) remains
unclear. This is especially true for [non-coding RNA](/wiki/Non-coding_RNA).
The number of protein-coding genes is better known but there are still on the
order of 1,400 questionable genes which may or may not encode functional
proteins, usually encoded by short [open reading
frames](/wiki/Open_reading_frame)._

Discrepancies in human gene number estimates among different databases, as of
July 2018[28]

Gencode[29] Ensembl[30] Refseq[31] CHESS[32]

protein-coding genes

19,901

20,376

20,345

21,306

lncRNA genes

15,779

14,720

17,712

18,484

antisense RNA

5501

28

2694

miscellaneous RNA

2213

2222

13,899

4347

Pseudogenes

14,723

1740

15,952

total transcripts

203,835

203,903

154,484

328,827

![](//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Genes_and_base_pairs_o
n_chromosomes.svg/400px-Genes_and_base_pairs_on_chromosomes.svg.png)

Number of genes (orange) and base pairs (green, in millions) on each
chromosome.

### Information
content[[edit](/w/index.php?title=Human_genome&action=edit&section=4)]

The [haploid](/wiki/Haploid) human genome (23
[chromosomes](/wiki/Chromosomes)) is about 3 billion base pairs long and
contains around 30,000 genes.[33] Since every base pair can be coded by 2
bits, this is about 750 [megabytes](/wiki/Megabyte) of data. An individual
somatic ([diploid](/wiki/Diploid)) cell contains twice this amount, that is,
about 6 billion base pairs. Men have fewer than women because the Y chromosome
is about 57 million base pairs whereas the X is about 156 million. Since
individual genomes vary in sequence by less than 1% from each other, the
variations of a given human's genome from a common reference can be
[losslessly compressed](/wiki/Lossless_data_compression) to roughly 4
megabytes.[34]

The [entropy rate](/wiki/Entropy_rate) of the genome differs significantly
between coding and non-coding sequences. It is close to the maximum of 2 bits
per base pair for the coding sequences (about 45 million base pairs), but less
for the non-coding parts. It ranges between 1.5 and 1.9 bits per base pair for
the individual chromosome, except for the Y-chromosome, which has an entropy
rate below 0.9 bits per base pair.[35]

## Coding vs. noncoding
DNA[[edit](/w/index.php?title=Human_genome&action=edit&section=5)]

The content of the human genome is commonly divided into coding and noncoding
DNA sequences. [Coding DNA](/wiki/Coding_region) is defined as those sequences
that can be transcribed into [mRNA](/wiki/MRNA) and
[translated](/wiki/Translation_\(biology\)) into proteins during the human
life cycle; these sequences occupy only a small fraction of the genome (<2%).
[Noncoding DNA](/wiki/Noncoding_DNA) is made up of all of those sequences (ca.
98% of the genome) that are not used to encode proteins.

Some noncoding DNA contains genes for RNA molecules with important biological
functions ([noncoding RNA](/wiki/Noncoding_RNA), for example [ribosomal
RNA](/wiki/Ribosomal_RNA) and [transfer RNA](/wiki/Transfer_RNA)). The
exploration of the function and evolutionary origin of noncoding DNA is an
important goal of contemporary genome research, including the
[ENCODE](/wiki/ENCODE) (Encyclopedia of DNA Elements) project, which aims to
survey the entire human genome, using a variety of experimental tools whose
results are indicative of molecular activity.

Because non-coding DNA greatly outnumbers coding DNA, the concept of the
sequenced genome has become a more focused analytical concept than the
classical concept of the DNA-coding gene.[36][37]

## Coding sequences (protein-coding genes)
[[edit](/w/index.php?title=Human_genome&action=edit&section=6)]

For a comprehensive list, see [List of human protein-coding genes 1](/wiki
/List_of_human_protein-coding_genes_1), [List of human protein-coding genes
2](/wiki/List_of_human_protein-coding_genes_2), [List of human protein-coding
genes 3](/wiki/List_of_human_protein-coding_genes_3), and [List of human
protein-coding genes 4](/wiki/List_of_human_protein-coding_genes_4).

![](//upload.wikimedia.org/wikipedia/commons/thumb/6/6b/Human_genome_by_functi
ons.svg/480px-Human_genome_by_functions.svg.png)

Human genes categorized by function of the transcribed proteins, given both as
number of encoding genes and percentage of all genes.[38]

Protein-coding sequences represent the most widely studied and best understood
component of the human genome. These sequences ultimately lead to the
production of all human [proteins](/wiki/Protein), although several biological
processes (e.g. [DNA rearrangements](/wiki/V\(D\)J_recombination) and
[alternative pre-mRNA splicing](/wiki/Alternative_splicing)) can lead to the
production of many more unique proteins than the number of protein-coding
genes. The complete modular protein-coding capacity of the genome is contained
within the [exome](/wiki/Exome), and consists of DNA sequences encoded by
[exons](/wiki/Exon) that can be translated into proteins. Because of its
biological importance, and the fact that it constitutes less than 2% of the
genome, sequencing of the exome was the first major milepost of the Human
Genome Project.

**Number of protein-coding genes**. About 20,000 human proteins have been annotated in databases such as [Uniprot](/wiki/Uniprot).[39] Historically, estimates for the number of protein genes have varied widely, ranging up to 2,000,000 in the late 1960s,[40] but several researchers pointed out in the early 1970s that the estimated [mutational load](/wiki/Genetic_load) from deleterious mutations placed an upper limit of approximately 40,000 for the total number of functional loci (this includes protein-coding and functional non-coding genes).[41] The number of human protein-coding genes is not significantly larger than that of many less complex organisms, such as the [roundworm](/wiki/Caenorhabditis_elegans) and the [fruit fly](/wiki/Drosophila_melanogaster). This difference may result from the extensive use of [alternative pre-mRNA splicing](/wiki/Alternative_splicing) in humans, which provides the ability to build a very large number of modular proteins through the selective incorporation of exons. 

**Protein-coding capacity per chromosome**. Protein-coding genes are distributed unevenly across the chromosomes, ranging from a few dozen to more than 2000, with an especially high [gene density](/wiki/Gene_density) within chromosomes 1, 11, and 19. Each chromosome contains various gene-rich and gene-poor regions, which may be correlated with [chromosome bands](/wiki/Cytogenetics) and [GC-content](/wiki/GC-content).[42] The significance of these nonrandom patterns of gene density is not well understood.[43]

**Size of protein-coding genes**. The size of protein-coding genes within the human genome shows enormous variability. For example, the gene for [histone H1a](/wiki/Histone_H1) (HIST1HIA) is relatively small and simple, lacking introns and encoding an 781 nucleotide-long mRNA that produces a 215 amino acid protein from its 648 nucleotide [open reading frame](/wiki/Open_reading_frame). [Dystrophin](/wiki/Dystrophin) (DMD) was the largest protein-coding gene in the 2001 human reference genome, spanning a total of 2.2 million nucleotides,[44] while more recent systematic meta-analysis of updated human genome data identified an even larger protein-coding gene, _RBFOX1_ (RNA binding protein, fox-1 homolog 1), spanning a total of 2.47 million nucleotides.[45] [Titin](/wiki/Titin) (TTN) has the longest coding sequence (114,414 nucleotides), the largest number of [exons](/wiki/Exons) (363),[44] and the longest single exon (17,106 nucleotides). As estimated based on a curated set of protein-coding genes over the whole genome, the median size is 26,288 nucleotides (mean = 66,577), the median exon size, 133 nucleotides (mean = 309), the median number of exons, 8 (mean = 11), and the median encoded protein is 425 amino acids (mean = 553) in length.[45]

Examples of human protein-coding genes[46]__

Protein Chrom Gene Length Exons Exon length Intron length Alt splicing

[Breast cancer type 2 susceptibility protein](/wiki/BRCA2)

13

[BRCA2](http://omim.org/entry/600185)

83,736

27

11,386

72,350

yes

[Cystic fibrosis transmembrane conductance
regulator](/wiki/Cystic_fibrosis_transmembrane_conductance_regulator)

7

[CFTR](http://omim.org/entry/602421)

202,881

27

4,440

198,441

yes

[Cytochrome b](/wiki/Cytochrome_b)

MT

[MTCYB](http://omim.org/entry/516020)

1,140

1

1,140

0

no

[Dystrophin](/wiki/Dystrophin)

X

[DMD](http://omim.org/entry/300377)

2,220,381

79

10,500

2,209,881

yes

[Glyceraldehyde-3-phosphate
dehydrogenase](/wiki/Glyceraldehyde-3-phosphate_dehydrogenase)

12

[GAPDH](http://omim.org/entry/138400)

4,444

9

1,425

3,019

yes

[Hemoglobin beta subunit](/wiki/Hemoglobin)

11

[HBB](http://omim.org/entry/141900?search=hbb%20gene&highlight=gene%20hbb)

1,605

3

626

979

no

[Histone H1A](/wiki/Histone_H1)

6

[HIST1H1A](http://omim.org/entry/142709?search=histone%20h1&highlight=h1%20his
tone)

781

1

781

0

no

[Titin](/wiki/Titin)

2

[TTN](http://omim.org/entry/188840?search=ttn&highlight=ttn)

281,434

364

104,301

177,133

yes

## Noncoding DNA
(ncDNA)[[edit](/w/index.php?title=Human_genome&action=edit&section=7)]

Main article: [Noncoding DNA](/wiki/Noncoding_DNA)

Noncoding DNA is defined as all of the DNA sequences within a genome that are
not found within protein-coding exons, and so are never represented within the
amino acid sequence of expressed proteins. By this definition, more than 98%
of the human genomes is composed of ncDNA.

Numerous classes of noncoding DNA have been identified, including genes for
noncoding RNA (e.g. tRNA and rRNA), pseudogenes, introns, untranslated regions
of mRNA, regulatory DNA sequences, repetitive DNA sequences, and sequences
related to mobile genetic elements.

Numerous sequences that are included within genes are also defined as
noncoding DNA. These include genes for noncoding RNA (e.g. tRNA, rRNA), and
untranslated components of protein-coding genes (e.g. introns, and 5' and 3'
untranslated regions of mRNA).

Protein-coding sequences (specifically, coding [exons](/wiki/Exon)) constitute
less than 1.5% of the human genome.[14] In addition, about 26% of the human
genome is [introns](/wiki/Introns).[47] Aside from genes (exons and introns)
and known regulatory sequences (8–20%), the human genome contains regions of
noncoding DNA. The exact amount of noncoding DNA that plays a role in cell
physiology has been hotly debated. Recent analysis by the
[ENCODE](/wiki/ENCODE) project indicates that 80% of the entire human genome
is either transcribed, binds to regulatory proteins, or is associated with
some other biochemical activity.[12]

It however remains controversial whether all of this biochemical activity
contributes to cell physiology, or whether a substantial portion of this is
the result transcriptional and biochemical noise, which must be actively
filtered out by the organism.[48] Excluding protein-coding sequences, introns,
and regulatory regions, much of the non-coding DNA is composed of: Many DNA
sequences that do not play a role in [gene expression](/wiki/Gene_expression)
have important biological functions. [Comparative
genomics](/wiki/Comparative_genomics) studies indicate that about 5% of the
genome contains sequences of noncoding DNA that are highly
[conserved](/wiki/Conserved_sequence), sometimes on time-scales representing
hundreds of millions of years, implying that these noncoding regions are under
strong [evolutionary](/wiki/Evolution) pressure and [positive
selection](/wiki/Natural_selection).[49]

Many of these sequences regulate the structure of chromosomes by limiting the
regions of [heterochromatin](/wiki/Heterochromatin) formation and regulating
structural features of the chromosomes, such as the
[telomeres](/wiki/Telomeres) and [centromeres](/wiki/Centromeres). Other
noncoding regions serve as [origins of DNA
replication](/wiki/DNA_replication#Origins). Finally several regions are
transcribed into functional noncoding RNA that regulate the expression of
protein-coding genes (for example[50] ), mRNA translation and stability (see
[miRNA](/wiki/MiRNA)), chromatin structure (including [histone](/wiki/Histone)
modifications, for example[51] ), DNA methylation (for example[52] ), DNA
recombination (for example[53] ), and cross-regulate other noncoding RNAs (for
example[54] ). It is also likely that many transcribed noncoding regions do
not serve any role and that this transcription is the product of non-specific
[RNA Polymerase](/wiki/RNA_Polymerase) activity.[48]

### Pseudogenes[[edit](/w/index.php?title=Human_genome&action=edit&section=8)]

Main article: [Pseudogene](/wiki/Pseudogene)

Pseudogenes are inactive copies of protein-coding genes, often generated by
[gene duplication](/wiki/Gene_duplication), that have become nonfunctional
through the accumulation of inactivating mutations. The number of pseudogenes
in the human genome is on the order of 13,000,[55] and in some chromosomes is
nearly the same as the number of functional protein-coding genes. Gene
duplication is a major mechanism through which new genetic material is
generated during [molecular evolution](/wiki/Molecular_evolution).

For example, the [olfactory receptor](/wiki/Olfactory_receptor) gene family is
one of the best-documented examples of pseudogenes in the human genome. More
than 60 percent of the genes in this family are non-functional pseudogenes in
humans. By comparison, only 20 percent of genes in the mouse olfactory
receptor gene family are pseudogenes. Research suggests that this is a
species-specific characteristic, as the most closely related primates all have
proportionally fewer pseudogenes. This genetic discovery helps to explain the
less acute sense of smell in humans relative to other mammals.[56]

### Genes for noncoding RNA
(ncRNA)[[edit](/w/index.php?title=Human_genome&action=edit&section=9)]

Main article: [Noncoding RNA](/wiki/Noncoding_RNA)

Noncoding RNA molecules play many essential roles in cells, especially in the
many reactions of [protein synthesis](/wiki/Translation_\(biology\)) and [RNA
processing](/wiki/Post-transcriptional_modification). Noncoding RNA include
[tRNA](/wiki/TRNA), [ribosomal](/wiki/Ribosome) RNA,
[microRNA](/wiki/MicroRNA), [snRNA](/wiki/SnRNA) and other non-coding RNA
genes including about 60,000 [long non-coding RNAs](/wiki/LncRNA)
(lncRNAs).[12][57][58][59] Although the number of reported lncRNA genes
continues to rise and the exact number in the human genome is yet to be
defined, many of them are argued to be non-functional.[60]

Many ncRNAs are critical elements in gene regulation and expression. Noncoding
RNA also contributes to epigenetics, transcription, RNA splicing, and the
translational machinery. The role of RNA in genetic regulation and disease
offers a new potential level of unexplored genomic complexity.[61]

### Introns and untranslated regions of
mRNA[[edit](/w/index.php?title=Human_genome&action=edit&section=10)]

In addition to the ncRNA molecules that are encoded by discrete genes, the
initial transcripts of protein coding genes usually contain extensive
noncoding sequences, in the form of [introns](/wiki/Introns), [5'-untranslated
regions](/wiki/Five_prime_untranslated_region) (5'-UTR), and [3'-untranslated
regions](/wiki/Three_prime_untranslated_region) (3'-UTR). Within most protein-
coding genes of the human genome, the length of intron sequences is 10- to
100-times the length of exon sequences.

### Regulatory DNA
sequences[[edit](/w/index.php?title=Human_genome&action=edit&section=11)]

The human genome has many different [regulatory
sequences](/wiki/Regulatory_regions) which are crucial to controlling [gene
expression](/wiki/Gene_expression). Conservative estimates indicate that these
sequences make up 8% of the genome,[62] however extrapolations from the
[ENCODE](/wiki/ENCODE) project give that 20[63]-40%[64] of the genome is gene
regulatory sequence. Some types of non-coding DNA are genetic "switches" that
do not encode proteins, but do regulate when and where genes are expressed
(called [enhancers](/wiki/Enhancer_\(genetics\))).[65]

Regulatory sequences have been known since the late 1960s.[66] The first
identification of regulatory sequences in the human genome relied on
recombinant DNA technology.[67] Later with the advent of genomic sequencing,
the identification of these sequences could be inferred by evolutionary
conservation. The evolutionary branch between the [primates](/wiki/Primates)
and [mouse](/wiki/Mouse), for example, occurred 70–90 million years ago.[68]
So computer comparisons of gene sequences that identify [conserved non-coding
sequences](/wiki/Conserved_non-coding_sequence) will be an indication of their
importance in duties such as gene regulation.[69]

Other genomes have been sequenced with the same intention of aiding
conservation-guided methods, for exampled the [pufferfish](/wiki/Pufferfish)
genome.[70] However, regulatory sequences disappear and re-evolve during
evolution at a high rate.[71][72][73]

As of 2012, the efforts have shifted toward finding interactions between DNA
and regulatory proteins by the technique [ChIP-Seq](/wiki/ChIP-Seq), or gaps
where the DNA is not packaged by [histones](/wiki/Histone) ([DNase
hypersensitive sites](/wiki/Hypersensitive_site)), both of which tell where
there are active regulatory sequences in the investigated cell type.[62]

### Repetitive DNA
sequences[[edit](/w/index.php?title=Human_genome&action=edit&section=12)]

[Repetitive DNA sequences](/wiki/Repetitive_DNA) comprise approximately 50% of
the human genome.[74]

About 8% of the human genome consists of tandem DNA arrays or tandem repeats,
low complexity repeat sequences that have multiple adjacent copies (e.g.
"CAGCAGCAG...").[75] The tandem sequences may be of variable lengths, from two
nucleotides to tens of nucleotides. These sequences are highly variable, even
among closely related individuals, and so are used for [genealogical DNA
testing](/wiki/Genealogical_DNA_testing) and [forensic DNA
analysis](/wiki/Forensic_DNA).[76]

Repeated sequences of fewer than ten nucleotides (e.g. the dinucleotide repeat
(AC)n) are termed microsatellite sequences. Among the microsatellite
sequences, trinucleotide repeats are of particular importance, as sometimes
occur within [coding regions](/wiki/Coding_region) of genes for proteins and
may lead to genetic disorders. For example, Huntington's disease results from
an expansion of the trinucleotide repeat (CAG)n within the
_[Huntingtin](/wiki/Huntingtin)_ gene on human chromosome 4.
[Telomeres](/wiki/Telomeres) (the ends of linear chromosomes) end with a
microsatellite hexanucleotide repeat of the sequence (TTAGGG)n.

Tandem repeats of longer sequences (arrays of repeated sequences 10–60
nucleotides long) are termed [minisatellites](/wiki/Minisatellite).

### Mobile genetic elements (transposons) and their
relics[[edit](/w/index.php?title=Human_genome&action=edit&section=13)]

[Transposable genetic elements](/wiki/Transposable_element), DNA sequences
that can replicate and insert copies of themselves at other locations within a
host genome, are an abundant component in the human genome. The most abundant
transposon lineage, _Alu_, has about 50,000 active copies,[77] and can be
inserted into intragenic and intergenic regions.[78] One other lineage,
LINE-1, has about 100 active copies per genome (the number varies between
people).[79] Together with non-functional relics of old transposons, they
account for over half of total human DNA.[80] Sometimes called "jumping
genes", transposons have played a major role in sculpting the human genome.
Some of these sequences represent [endogenous
retroviruses](/wiki/Endogenous_retroviruses), DNA copies of viral sequences
that have become permanently integrated into the genome and are now passed on
to succeeding generations.

Mobile elements within the human genome can be classified into [LTR
retrotransposons](/wiki/Retrotransposon#LTR_retrotransposons) (8.3% of total
genome), [SINEs](/wiki/Short_interspersed_nuclear_element) (13.1% of total
genome) including [Alu elements](/wiki/Alu_elements),
[LINEs](/wiki/Long_interspersed_nuclear_element) (20.4% of total genome), SVAs
and [Class II DNA transposons](/wiki/Transposable_element#Classification)
(2.9% of total genome).

## Genomic variation in
humans[[edit](/w/index.php?title=Human_genome&action=edit&section=14)]

Main article: [Human genetic variation](/wiki/Human_genetic_variation)

### Human reference
genome[[edit](/w/index.php?title=Human_genome&action=edit&section=15)]

With the exception of identical twins, all humans show significant variation
in genomic DNA sequences. The human [reference genome](/wiki/Reference_genome)
(HRG) is used as a standard sequence reference.

There are several important points concerning the human reference genome:

  * The HRG is a haploid sequence. Each chromosome is represented once.
  * The HRG is a composite sequence, and does not correspond to any actual human individual.
  * The HRG is periodically updated to correct errors, ambiguities, and unknown "gaps".
  * The HRG in no way represents an "ideal" or "perfect" human individual. It is simply a standardized representation or model that is used for comparative purposes.

The [Genome Reference Consortium](/wiki/Genome_Reference_Consortium) is
responsible for updating the HRG. Version 38 was released in December
2013.[81]

### Measuring human genetic
variation[[edit](/w/index.php?title=Human_genome&action=edit&section=16)]

Most studies of human genetic variation have focused on [single-nucleotide
polymorphisms](/wiki/Single-nucleotide_polymorphism) (SNPs), which are
substitutions in individual bases along a chromosome. Most analyses estimate
that SNPs occur 1 in 1000 base pairs, on average, in the
[euchromatic](/wiki/Euchromatin) human genome, although they do not occur at a
uniform density. Thus follows the popular statement that "we are all,
regardless of [race](/wiki/Race_\(classification_of_human_beings\)),
genetically 99.9% the same",[82] although this would be somewhat qualified by
most geneticists. For example, a much larger fraction of the genome is now
thought to be involved in [copy number
variation](/wiki/Copy_number_variation).[83] A large-scale collaborative
effort to catalog SNP variations in the human genome is being undertaken by
the [International HapMap Project](/wiki/International_HapMap_Project).

The genomic loci and length of certain types of small [repetitive
sequences](/wiki/Repeated_sequence_\(DNA\)) are highly variable from person to
person, which is the basis of [DNA fingerprinting](/wiki/DNA_fingerprinting)
and [DNA paternity testing](/wiki/DNA_paternity_testing) technologies. The
[heterochromatic](/wiki/Heterochromatin) portions of the human genome, which
total several hundred million base pairs, are also thought to be quite
variable within the human population (they are so repetitive and so long that
they cannot be accurately sequenced with current technology). These regions
contain few genes, and it is unclear whether any significant
[phenotypic](/wiki/Phenotype) effect results from typical variation in repeats
or heterochromatin.

Most gross genomic mutations in [gamete](/wiki/Gamete) germ cells probably
result in inviable embryos; however, a number of human diseases are related to
large-scale genomic abnormalities. [Down syndrome](/wiki/Down_syndrome),
[Turner Syndrome](/wiki/Turner_Syndrome), and a number of other diseases
result from [nondisjunction](/wiki/Nondisjunction) of entire chromosomes.
[Cancer](/wiki/Cancer) cells frequently have [aneuploidy](/wiki/Aneuploidy) of
chromosomes and chromosome arms, although a [cause and
effect](/wiki/Causality) relationship between aneuploidy and cancer has not
been established.

#### Mapping human genomic
variation[[edit](/w/index.php?title=Human_genome&action=edit&section=17)]

Whereas a genome sequence lists the order of every DNA base in a genome, a
genome map identifies the landmarks. A genome map is less detailed than a
genome sequence and aids in navigating around the genome.[84][85]

An example of a variation map is the HapMap being developed by the
[International HapMap Project](/wiki/International_HapMap_Project). The HapMap
is a [haplotype](/wiki/Haplotype) map of the human genome, "which will
describe the common patterns of human DNA sequence variation."[86] It catalogs
the patterns of small-scale variations in the genome that involve single DNA
letters, or bases.

Researchers published the first sequence-based map of large-scale structural
variation across the human genome in the journal
_[Nature](/wiki/Nature_\(journal\))_ in May 2008.[87][88] Large-scale
structural variations are differences in the genome among people that range
from a few thousand to a few million DNA bases; some are gains or losses of
stretches of genome sequence and others appear as re-arrangements of stretches
of sequence. These variations include [differences in the number of
copies](/wiki/Copy_number_variation) individuals have of a particular gene,
deletions, translocations and inversions.

### Structural
variation[[edit](/w/index.php?title=Human_genome&action=edit&section=18)]

Structural variation refers to genetic variants that affect larger segments of
the human genome, as opposed to point mutations. Often, structural variants
(SVs) are defined as variants of 50 base pairs (bp) or greater, such as
deletions, duplications, insertions, inversions and other rearrangements.
About 90% of structural variants are noncoding deletions but most individuals
have more than a thousand such deletions; the size of deletions ranges from
dozens of base pairs to tens of thousands of bp.[89] On average, individuals
carry ~3 rare structural variants that alter coding regions, e.g. delete
[exons](/wiki/Exon). About 2% of individuals carry ultra-rare megabase-scale
structural variants, especially rearrangements. That is, millions of base
pairs may be inverted within a chromosome; ultra-rare means that they are only
found in individuals or their family members and thus have arisen very
recently.[89]

### SNP frequency across the human
genome[[edit](/w/index.php?title=Human_genome&action=edit&section=19)]

Single-nucleotide polymorphisms (SNPs) do not occur homogeneously across the
human genome. In fact, there is enormous diversity in [SNP](/wiki/Single-
nucleotide_polymorphism) frequency between genes, reflecting different
selective pressures on each gene as well as different mutation and
recombination rates across the genome. However, studies on SNPs are biased
towards coding regions, the data generated from them are unlikely to reflect
the overall distribution of SNPs throughout the genome. Therefore, the [SNP
Consortium](/wiki/SNP_Consortium) protocol was designed to identify SNPs with
no bias towards coding regions and the Consortium's 100,000 SNPs generally
reflect sequence diversity across the human chromosomes. The [SNP
Consortium](/wiki/SNP_Consortium) aims to expand the number of SNPs identified
across the genome to 300 000 by the end of the first quarter of 2001.[90]

![](//upload.wikimedia.org/wikipedia/commons/thumb/5/55/TSC_SNP_Distribution.j
pg/220px-TSC_SNP_Distribution.jpg)

TSC SNP distribution along the long arm of chromosome 22 (from
<https://web.archive.org/web/20130903043223/http://snp.cshl.org/> ). Each
column represents a 1 Mb interval; the approximate cytogenetic position is
given on the x-axis. Clear peaks and troughs of SNP density can be seen,
possibly reflecting different rates of mutation, recombination and selection.

Changes in **non-coding sequence** and synonymous changes in **coding
sequence** are generally more common than non-synonymous changes, reflecting
greater selective pressure reducing diversity at positions dictating amino
acid identity. Transitional changes are more common than transversions, with
CpG dinucleotides showing the highest mutation rate, presumably due to
deamination.

### Personal
genomes[[edit](/w/index.php?title=Human_genome&action=edit&section=20)]

See also: [Personal genomics](/wiki/Personal_genomics)

A personal genome sequence is a (nearly) complete
[sequence](/wiki/DNA_sequencing) of the chemical base pairs that make up the
[DNA](/wiki/DNA) of a single person. Because medical treatments have different
effects on different people due to genetic variations such as [single-
nucleotide polymorphisms](/wiki/Single-nucleotide_polymorphisms) (SNPs), the
analysis of personal genomes may lead to personalized medical treatment based
on individual genotypes.[91]

The first personal genome sequence to be determined was that of [Craig
Venter](/wiki/Craig_Venter) in 2007. Personal genomes had not been sequenced
in the public Human Genome Project to protect the identity of volunteers who
provided DNA samples. That sequence was derived from the DNA of several
volunteers from a diverse population.[92] However, early in the Venter-led
[Celera Genomics](/wiki/Celera_Genomics) genome sequencing effort the decision
was made to switch from sequencing a composite sample to using DNA from a
single individual, later revealed to have been Venter himself. Thus the Celera
human genome sequence released in 2000 was largely that of one man. Subsequent
replacement of the early composite-derived data and determination of the
diploid sequence, representing both sets of [chromosomes](/wiki/Chromosomes),
rather than a haploid sequence originally reported, allowed the release of the
first personal genome.[93] In April 2008, that of [James
Watson](/wiki/James_Watson) was also completed. In 2009, Stephen Quake
published his own genome sequence derived from a sequencer of his own design,
the Heliscope.[94] A Stanford team led by [Euan Ashley](/wiki/Euan_Ashley)
published a framework for the medical interpretation of human genomes
implemented on Quake’s genome and made whole genome-informed medical decisions
for the first time.[95] That team further extended the approach to the West
family, the first family sequenced as part of Illumina’s Personal Genome
Sequencing program.[96] Since then hundreds of personal genome sequences have
been released,[97] including those of [Desmond
Tutu](/wiki/Desmond_Tutu),[98][99] and of a [Paleo-Eskimo](/wiki/Paleo-
Eskimo).[100] In 2012, the whole genome sequences of two family trios among
1092 genomes was made public.[3] In November 2013, a Spanish family made four
personal exome datasets (about 1% of the genome) publicly available under a
[Creative Commons public domain
license](/wiki/CC0#Zero_.2F_Public_domain).[101][102] The [Personal Genome
Project](/wiki/Personal_Genome_Project) (started in 2005) is among the few to
make both genome sequences and corresponding medical phenotypes publicly
available.[103][104]

The sequencing of individual genomes further unveiled levels of genetic
complexity that had not been appreciated before. Personal genomics helped
reveal the significant level of diversity in the human genome attributed not
only to SNPs but structural variations as well. However, the application of
such knowledge to the treatment of disease and in the medical field is only in
its very beginnings.[105] [Exome sequencing](/wiki/Exome_sequencing) has
become increasingly popular as a tool to aid in diagnosis of genetic disease
because the exome contributes only 1% of the genomic sequence but accounts for
roughly 85% of mutations that contribute significantly to disease.[106]

### Human
knockouts[[edit](/w/index.php?title=Human_genome&action=edit&section=21)]

In humans, [gene knockouts](/wiki/Gene_knockouts) naturally occur as
[heterozygous](/wiki/Heterozygous) or [homozygous](/wiki/Homozygous) [loss-of-
function](/wiki/Loss-of-function) gene knockouts. These knockouts are often
difficult to distinguish, especially within
[heterogeneous](/wiki/Heterogeneous) genetic backgrounds. They are also
difficult to find as they occur in low frequencies.

![](//upload.wikimedia.org/wikipedia/commons/thumb/9/96/Gene_Knockouts_in_Outb
red_vs._Parentally-related_populations.jpg/220px-Gene_Knockouts_in_Outbred_vs
._Parentally-related_populations.jpg)

Populations with a high level of parental-relatedness result in a larger
number of homozygous gene knockouts as compared to outbred populations.[107]

Populations with high rates of [consanguinity](/wiki/Consanguinity), such as
countries with high rates of first-cousin marriages, display the highest
frequencies of homozygous gene knockouts. Such populations include Pakistan,
Iceland, and Amish populations. These populations with a high level of
parental-relatedness have been subjects of human knock out research which has
helped to determine the function of specific genes in humans. By
distinguishing specific knockouts, researchers are able to use phenotypic
analyses of these individuals to help characterize the gene that has been
knocked out.

![](//upload.wikimedia.org/wikipedia/commons/thumb/d/d4/Consanguineous_Mating_
resulting_in_Knockout.jpg/220px-
Consanguineous_Mating_resulting_in_Knockout.jpg)

A pedigree displaying a first-cousin mating (carriers both carrying
heterozygous knockouts mating as marked by double line) leading to offspring
possessing a homozygous gene knockout.

Knockouts in specific genes can cause genetic diseases, potentially have
beneficial effects, or even result in no phenotypic effect at all. However,
determining a knockout's phenotypic effect and in humans can be challenging.
Challenges to characterizing and clinically interpreting knockouts include
difficulty calling of DNA variants, determining disruption of protein function
(annotation), and considering the amount of influence
[mosaicism](/wiki/Mosaicism) has on the phenotype.[107]

One major study that investigated human knockouts is the Pakistan Risk of
Myocardial Infarction study. It was found that individuals possessing a
heterozygous loss-of-function gene knockout for the [APOC3](/wiki/APOC3) gene
had lower triglycerides in the blood after consuming a high fat meal as
compared to individuals without the mutation. However, individuals possessing
homozygous loss-of-function gene knockouts of the APOC3 gene displayed the
lowest level of triglycerides in the blood after the fat load test, as they
produce no functional APOC3 protein.[108]

## Human genetic
disorders[[edit](/w/index.php?title=Human_genome&action=edit&section=22)]

Further information: [Genetic disorder](/wiki/Genetic_disorder)

Most aspects of human biology involve both genetic (inherited) and non-genetic
(environmental) factors. Some inherited variation influences aspects of our
biology that are not medical in nature (height, eye color, ability to taste or
smell certain compounds, etc.). Moreover, some genetic disorders only cause
disease in combination with the appropriate environmental factors (such as
diet). With these caveats, genetic disorders may be described as clinically
defined diseases caused by genomic DNA sequence variation. In the most
straightforward cases, the disorder can be associated with variation in a
single gene. For example, [cystic fibrosis](/wiki/Cystic_fibrosis) is caused
by mutations in the CFTR gene and is the most common recessive disorder in
caucasian populations with over 1,300 different mutations known.[109]

Disease-causing mutations in specific genes are usually severe in terms of
gene function and are fortunately rare, thus genetic disorders are similarly
individually rare. However, since there are many genes that can vary to cause
genetic disorders, in aggregate they constitute a significant component of
known medical conditions, especially in pediatric medicine. Molecularly
characterized genetic disorders are those for which the underlying causal gene
has been identified. Currently there are approximately 2,200 such disorders
annotated in the [OMIM](/wiki/Online_Mendelian_Inheritance_in_Man)
database.[109]

Studies of genetic disorders are often performed by means of family-based
studies. In some instances, population based approaches are employed,
particularly in the case of so-called founder populations such as those in
Finland, French-Canada, Utah, Sardinia, etc. Diagnosis and treatment of
genetic disorders are usually performed by a
[geneticist](/wiki/Geneticist)-physician trained in clinical/medical genetics.
The results of the [Human Genome Project](/wiki/Human_Genome_Project) are
likely to provide increased availability of [genetic
testing](/wiki/Genetic_testing) for gene-related disorders, and eventually
improved treatment. Parents can be screened for hereditary conditions and
[counselled](/wiki/Genetic_counseling) on the consequences, the probability of
inheritance, and how to avoid or ameliorate it in their offspring.

There are many different kinds of DNA sequence variation, ranging from
complete extra or missing chromosomes down to single nucleotide changes. It is
generally presumed that much naturally occurring genetic variation in human
populations is phenotypically neutral, i.e., has little or no detectable
effect on the physiology of the individual (although there may be fractional
differences in fitness defined over evolutionary time frames). Genetic
disorders can be caused by any or all known types of sequence variation. To
molecularly characterize a new genetic disorder, it is necessary to establish
a causal link between a particular genomic sequence variant and the clinical
disease under investigation. Such studies constitute the realm of human
molecular genetics.

With the advent of the Human Genome and [International HapMap
Project](/wiki/International_HapMap_Project), it has become feasible to
explore subtle genetic influences on many common disease conditions such as
diabetes, asthma, migraine, schizophrenia, etc. Although some causal links
have been made between genomic sequence variants in particular genes and some
of these diseases, often with much publicity in the general media, these are
usually not considered to be genetic disorders _per se_ as their causes are
complex, involving many different genetic and environmental factors. Thus
there may be disagreement in particular cases whether a specific medical
condition should be termed a genetic disorder.

Additional genetic disorders of mention are [Kallman
syndrome](/wiki/Kallmann_syndrome) and [Pfeiffer
syndrome](/wiki/Pfeiffer_syndrome) (gene FGFR1), [Fuchs corneal
dystrophy](/wiki/Fuchs%27_dystrophy) (gene TCF4), [Hirschsprung's
disease](/wiki/Hirschsprung%27s_disease) (genes RET and FECH), Bardet-Biedl
syndrome 1 (genes CCDC28B and BBS1), Bardet-Biedl syndrome 10 (gene BBS10),
and facioscapulohumeral muscular dystrophy type 2 (genes D4Z4 and
SMCHD1).[110]

Genome sequencing is now able to narrow the genome down to specific locations
to more accurately find mutations that will result in a genetic disorder.
[Copy number variants](/wiki/Copy-number_variation) (CNVs) and [single
nucleotide variants](/wiki/Single-nucleotide_polymorphism) (SNVs) are also
able to be detected at the same time as genome sequencing with newer
sequencing procedures available, called [Next Generation
Sequencing](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944141/) (NGS). This
only analyzes a small portion of the genome, around 1-2%. The results of this
sequencing can be used for clinical diagnosis of a genetic condition,
including [Usher syndrome](/wiki/Usher_syndrome), retinal disease, hearing
impairments, diabetes, epilepsy, [Leigh disease](/wiki/Leigh_syndrome),
hereditary cancers, neuromuscular diseases, primary immunodeficiencies,
[severe combined immunodeficiency](/wiki/Severe_combined_immunodeficiency)
(SCID), and diseases of the mitochondria.[111] NGS can also be used to
identify carriers of diseases before conception. The diseases that can be
detected in this sequencing include [Tay-Sachs
disease](/wiki/Tay%E2%80%93Sachs_disease), [Bloom
syndrome](/wiki/Bloom_syndrome), [Gaucher disease](/wiki/Gaucher%27s_disease),
[Canavan disease](/wiki/Canavan_disease), [familial
dysautonomia](/wiki/Familial_dysautonomia), cystic fibrosis, [spinal muscular
atrophy](/wiki/Spinal_muscular_atrophy), and [fragile-X
syndrome](/wiki/Fragile_X_syndrome). The Next Genome Sequencing can be
narrowed down to specifically look for diseases more prevalent in certain
ethnic populations.[112]

Prevalence and associated gene/chromosome for some human genetic disorders

Disorder  Prevalence  Chromosome or gene involved

Chromosomal conditions

[Down syndrome](/wiki/Down_syndrome)

1:600

Chromosome 21

[Klinefelter syndrome](/wiki/Klinefelter_syndrome)

1:500–1000 males

Additional X chromosome

[Turner syndrome](/wiki/Turner_syndrome)

1:2000 females

Loss of X chromosome

[Sickle cell anemia](/wiki/Sickle_cell_anemia)

1 in 50 births in parts of Africa; rarer elsewhere

[β-globin (on chromosome 11)](/wiki/HBB)

[Bloom syndrome](/wiki/Bloom_syndrome)

1:48000 Ashkenazi Jews

BLM

Cancers

[Breast](/wiki/Breast_cancer)/[Ovarian cancer](/wiki/Ovarian_cancer)
(susceptibility)

~5% of cases of these cancer types

BRCA1, BRCA2

[FAP](/wiki/Familial_adenomatous_polyposis) (hereditary nonpolyposis coli)

1:3500

[APC](/wiki/Adenomatous_polyposis_coli)

[Lynch syndrome](/wiki/Lynch_syndrome)

5–10% of all cases of bowel cancer

MLH1, MSH2, MSH6, PMS2

[Fanconi anemia](/wiki/Fanconi_anemia)

1:130000 births

FANCC

Neurological conditions

[Huntington disease](/wiki/Huntington_disease)

1:20000

Huntingtin

[Alzheimer disease](/wiki/Alzheimer_disease) ‐ early onset

1:2500

PS1, PS2, APP

[Tay-Sachs](/wiki/Tay%E2%80%93Sachs_disease)

1:3600 births in Ashkenazi Jews

[HEXA gene (on chromosome 15)](/wiki/HEXA)

[Canavan disease](/wiki/Canavan_disease)

2.5% Eastern European Jewish ancestry

[ASPA](/wiki/Aspartoacylase) gene (on chromosome 17)

[Familial dysautonomia](/wiki/Familial_dysautonomia)

600 known cases worldwide since discovery

IKBKAP gene (on chromosome 9)

[Fragile X syndrome](/wiki/Fragile_X_syndrome)

1.4:10000 in males, 0.9:10000 in females

FMR1 gene (on X chromosome)

[Mucolipidosis type IV](/wiki/Mucolipidosis_type_IV)

1:90 to 1:100 in Ashkenazi Jews

MCOLN1

Other conditions

[Cystic fibrosis](/wiki/Cystic_fibrosis)

1:2500

CFTR

[Duchenne muscular dystrophy](/wiki/Duchenne_muscular_dystrophy)

1:3500 boys

Dystrophin

[Becker muscular dystrophy](/wiki/Becker_muscular_dystrophy)

1.5-6:100000 males

DMD

[Beta thalassemia](/wiki/Beta_thalassemia)

1:100000

HBB

[Congenital adrenal hyperplasia](/wiki/Congenital_adrenal_hyperplasia)

1:280 in Native Americans and Yupik Eskimos

1:15000 in American Caucasians

CYP21A2

[Glycogen storage disease type I](/wiki/Glycogen_storage_disease_type_I)

1:100000 births in America

G6PC

[Maple syrup urine disease](/wiki/Maple_syrup_urine_disease)

1:180000 in the U.S.

1:176 in Mennonite/Amish communities

1:250000 in Austria

BCKDHA, BCKDHB, DBT, DLD

[Niemann–Pick disease,
SMPD1-associated](/wiki/Niemann%E2%80%93Pick_disease,_SMPD1-associated)

1,200 cases worldwide

SMPD1

[Usher syndrome](/wiki/Usher_syndrome)

1:23000 in the U.S.

1:28000 in Norway

1:12500 in Germany

CDH23, CLRN1, DFNB31, GPR98, MYO7A, PCDH15, USH1C, USH1G, USH2A

## Evolution[[edit](/w/index.php?title=Human_genome&action=edit&section=23)]

[Hominin timeline](/wiki/Timeline_of_human_evolution)

This box:

  * [view](/wiki/Template:Human_timeline)
  * [talk](/wiki/Template_talk:Human_timeline)
  * [edit](https://en.wikipedia.org/w/index.php?title=Template:Human_timeline&action=edit)

−10 --

-

−9.5 --

-

−9 --

-

−8.5 --

-

−8 --

-

−7.5 --

-

−7 --

-

−6.5 --

-

−6 --

-

−5.5 --

-

−5 --

-

−4.5 --

-

−4 --

-

−3.5 --

-

−3 --

-

−2.5 --

-

−2 --

-

−1.5 --

-

−1 --

-

−0.5 --

-

0 --

**

[Miocene

](/wiki/Miocene)**

**

[Pliocene

](/wiki/Pliocene)**

**

[Pleistocene

](/wiki/Pleistocene)**

**[Hominini](/wiki/Hominini)**

_[Nakalipithecus](/wiki/Nakalipithecus)_

_[Ouranopithecus](/wiki/Ouranopithecus)_

_[Oreopithecus](/wiki/Oreopithecus)_

_[Sahelanthropus](/wiki/Sahelanthropus)_

_[Orrorin](/wiki/Orrorin)_

_[Ardipithecus](/wiki/Ardipithecus)_

_[Australopithecus](/wiki/Australopithecus)_

_[Homo habilis](/wiki/Homo_habilis)_

_[Homo erectus](/wiki/Homo_erectus)_

_[Homo heidelbergensis](/wiki/Homo_heidelbergensis)_

_[Homo sapiens](/wiki/Anatomically_modern_human)_

[Neanderthals](/wiki/Neanderthal),[Denisovans](/wiki/Denisovan)

<-

[Earlier apes](/wiki/Timeline_of_human_evolution#Hominidae)

<-

[Gorilla split](/wiki/Gorilla%E2%80%93human_last_common_ancestor)

<-

[Chimpanzee split](/wiki/Chimpanzee%E2%80%93human_last_common_ancestor)

<-

[Earliest bipedal](/wiki/Human_skeletal_changes_due_to_bipedalism)

<-

[Stone tools](/wiki/Stone_Age#Beginning_of_the_Stone_Age)

<-

[Dispersal beyond Africa](/wiki/Early_expansions_of_hominins_out_of_Africa)

<-

[Earliest fire](/wiki/Control_of_fire_by_early_humans) /
[cooking](/wiki/Cooking#History)

<-

[Earliest clothes](/wiki/Clothing#Early_use)

<-

[Modern humans](/wiki/Behavioral_modernity)

**  
[H  
  
o  
  
m  
  
i  
  
n  
  
i  
  
d  
  
s](/wiki/Hominidae)**

([million years ago](/wiki/Myr))

See also: [Human evolution](/wiki/Human_evolution) and [Chimpanzee Genome
Project](/wiki/Chimpanzee_Genome_Project)

[Comparative genomics](/wiki/Comparative_genomics) studies of mammalian
genomes suggest that approximately 5% of the human genome has been conserved
by evolution since the divergence of extant lineages approximately 200 million
years ago, containing the vast majority of genes.[113][114] The published
[chimpanzee](/wiki/Common_chimpanzee) genome differs from that of the human
genome by 1.23% in direct sequence comparisons.[115] Around 20% of this figure
is accounted for by variation within each species, leaving only ~1.06%
consistent sequence divergence between humans and chimps at shared genes.[116]
This nucleotide by nucleotide difference is dwarfed, however, by the portion
of each genome that is not shared, including around 6% of functional genes
that are unique to either humans or chimps.[117]

In other words, the considerable observable differences between humans and
chimps may be due as much or more to genome level variation in the number,
function and expression of genes rather than DNA sequence changes in shared
genes. Indeed, even within humans, there has been found to be a previously
unappreciated amount of copy number variation (CNV) which can make up as much
as 5 – 15% of the human genome. In other words, between humans, there could be
+/- 500,000,000 base pairs of DNA, some being active genes, others
inactivated, or active at different levels. The full significance of this
finding remains to be seen. On average, a typical human protein-coding gene
differs from its chimpanzee [ortholog](/wiki/Ortholog) by only two [amino
acid](/wiki/Amino_acid) substitutions; nearly one third of human genes have
exactly the same protein translation as their chimpanzee orthologs. A major
difference between the two genomes is human [chromosome
2](/wiki/Chromosome_2_\(human\)), which is equivalent to a fusion product of
chimpanzee chromosomes 12 and 13.[118] (later renamed to chromosomes 2A and
2B, respectively).

Humans have undergone an extraordinary loss of [olfactory
receptor](/wiki/Olfactory_receptor) genes during our recent evolution, which
explains our relatively crude sense of [smell](/wiki/Olfaction) compared to
most other mammals. Evolutionary evidence suggests that the emergence of
[color vision](/wiki/Color_vision) in humans and several other
[primate](/wiki/Primate) species has diminished the need for the sense of
smell.[119]

In September 2016, scientists reported that, based on human DNA genetic
studies, all [non-Africans in the world today](/wiki/Behavioral_modernity) can
be traced to a [single population](/wiki/Anatomically_modern_human) that
[exited Africa](/wiki/Recent_African_origin_of_modern_humans) between 50,000
and 80,000 years ago.[120]

## Mitochondrial
DNA[[edit](/w/index.php?title=Human_genome&action=edit&section=24)]

The human [mitochondrial DNA](/wiki/Mitochondrial_DNA) is of tremendous
interest to geneticists, since it undoubtedly plays a role in [mitochondrial
disease](/wiki/Mitochondrial_disease). It also sheds light on human evolution;
for example, analysis of variation in the human mitochondrial genome has led
to the postulation of a recent common ancestor for all humans on the maternal
line of descent (see [Mitochondrial Eve](/wiki/Mitochondrial_Eve)).

Due to the lack of a system for checking for copying errors,[121]
mitochondrial DNA (mtDNA) has a more rapid rate of variation than nuclear DNA.
This 20-fold higher mutation rate allows mtDNA to be used for more accurate
tracing of maternal ancestry.[_[citation
needed](/wiki/Wikipedia:Citation_needed)_] Studies of mtDNA in populations
have allowed ancient migration paths to be traced, such as the migration of
[Native Americans](/wiki/Indigenous_peoples_of_the_Americas) from
[Siberia](/wiki/Siberia)[122] or [Polynesians](/wiki/Polynesia) from
southeastern [Asia](/wiki/Asia).[_[citation
needed](/wiki/Wikipedia:Citation_needed)_] It has also been used to show that
there is no trace of [Neanderthal](/wiki/Neanderthal) DNA in the European gene
mixture inherited through purely maternal lineage.[123] Due to the restrictive
all or none manner of mtDNA inheritance, this result (no trace of Neanderthal
mtDNA) would be likely unless there were a large percentage of Neanderthal
ancestry, or there was strong positive selection for that mtDNA. For example,
going back 5 generations, only 1 of a person's 32 ancestors contributed to
that person's mtDNA, so if one of these 32 was pure Neanderthal an expected
~3% of that person's autosomal DNA would be of Neanderthal origin, yet they
would have a ~97% chance of having no trace of Neanderthal mtDNA.[_[citation
needed](/wiki/Wikipedia:Citation_needed)_]

## Epigenome[[edit](/w/index.php?title=Human_genome&action=edit&section=25)]

See also: [Epigenetics](/wiki/Epigenetics)

Epigenetics describes a variety of features of the human genome that transcend
its primary DNA sequence, such as [chromatin](/wiki/Chromatin) packaging,
[histone](/wiki/Histone) modifications and [DNA
methylation](/wiki/DNA_methylation), and which are important in regulating
gene expression, genome replication and other cellular processes. Epigenetic
markers strengthen and weaken transcription of certain genes but do not affect
the actual sequence of DNA nucleotides. DNA methylation is a major form of
epigenetic control over gene expression and one of the most highly studied
topics in epigenetics. During development, the human DNA methylation profile
experiences dramatic changes. In early germ line cells, the genome has very
low methylation levels. These low levels generally describe active genes. As
development progresses, parental imprinting tags lead to increased methylation
activity.[124][125]

Epigenetic patterns can be identified between tissues within an individual as
well as between individuals themselves. Identical genes that have differences
only in their epigenetic state are called **epialleles**. Epialleles can be
placed into three categories: those directly determined by an individual's
genotype, those influenced by genotype, and those entirely independent of
genotype. The epigenome is also influenced significantly by environmental
factors. Diet, toxins, and hormones impact the epigenetic state. Studies in
dietary manipulation have demonstrated that methyl-deficient diets are
associated with hypomethylation of the epigenome. Such studies establish
epigenetics as an important interface between the environment and the
genome.[126]

## See also[[edit](/w/index.php?title=Human_genome&action=edit&section=26)]

  * [Human Genome Organisation](/wiki/Human_Genome_Organisation)
  * [Genome Reference Consortium](/wiki/Genome_Reference_Consortium)
  * [Human Genome Project](/wiki/Human_Genome_Project)
  * [Genetics](/wiki/Genetics)
  * [Genomics](/wiki/Genomics)
  * [Genographic Project](/wiki/Genographic_Project)
  * [Genomic organization](/wiki/Genomic_organization)
  * [Low copy repeats](/wiki/Low_copy_repeats)
  * [Non-coding DNA](/wiki/Non-coding_DNA)
  * [Whole genome sequencing](/wiki/Whole_genome_sequencing)
  * [Universal Declaration on the Human Genome and Human Rights](/wiki/Universal_Declaration_on_the_Human_Genome_and_Human_Rights)

## References[[edit](/w/index.php?title=Human_genome&action=edit&section=27)]

  1. **^** ["GRCh38.p13"](https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.39). _ncbi_. Genome Reference Consortium. Retrieved 8 June 2020.
  2. **^** Brown TA (2002). _[The Human Genome_](https://www.ncbi.nlm.nih.gov/books/NBK21134/) (2nd ed.). Oxford: Wiley-Liss.
  3. ^ _**a**_ _**b**_ Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA (November 2012). ["An integrated map of genetic variation from 1,092 human genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3498066). _Nature_. **491** (7422): 56–65. [Bibcode](/wiki/Bibcode_\(identifier\)):[2012Natur.491...56T](https://ui.adsabs.harvard.edu/abs/2012Natur.491...56T). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature11632](https://doi.org/10.1038%2Fnature11632). [PMC](/wiki/PMC_\(identifier\)) [3498066](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3498066). [PMID](/wiki/PMID_\(identifier\)) [23128226](//pubmed.ncbi.nlm.nih.gov/23128226).
  4. **^** Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. (October 2015). ["A global reference for human genetic variation"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4750478). _Nature_. **526** (7571): 68–74. [Bibcode](/wiki/Bibcode_\(identifier\)):[2015Natur.526...68T](https://ui.adsabs.harvard.edu/abs/2015Natur.526...68T). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature15393](https://doi.org/10.1038%2Fnature15393). [PMC](/wiki/PMC_\(identifier\)) [4750478](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4750478). [PMID](/wiki/PMID_\(identifier\)) [26432245](//pubmed.ncbi.nlm.nih.gov/26432245).
  5. **^** Chimpanzee Sequencing Analysis Consortium (2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](http://www.genome.gov/Pages/Research/DIR/Chimp_Analysis.pdf) (PDF). _[Nature](/wiki/Nature_\(journal\))_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). [S2CID](/wiki/S2CID_\(identifier\)) [2638825](https://api.semanticscholar.org/CorpusID:2638825).
  6. **^** Varki A, Altheide TK (December 2005). ["Comparing the human and chimpanzee genomes: searching for needles in a haystack"](https://doi.org/10.1101%2Fgr.3737405). _Genome Research_. **15** (12): 1746–58. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.3737405](https://doi.org/10.1101%2Fgr.3737405). [PMID](/wiki/PMID_\(identifier\)) [16339373](//pubmed.ncbi.nlm.nih.gov/16339373).
  7. **^** Wade N (23 September 1999). ["Number of Human Genes Is Put at 140,000, a Significant Gain"](https://archive.nytimes.com/www.nytimes.com/library/national/science/092399sci-human-genome.html). _The New York Times_.
  8. ^ _**a**_ _**b**_ International Human Genome Sequencing Consortium (October 2004). ["Finishing the euchromatic sequence of the human genome"](https://doi.org/10.1038%2Fnature03001). _Nature_. **431** (7011): 931–45. [Bibcode](/wiki/Bibcode_\(identifier\)):[2004Natur.431..931H](https://ui.adsabs.harvard.edu/abs/2004Natur.431..931H). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature03001](https://doi.org/10.1038%2Fnature03001). [PMID](/wiki/PMID_\(identifier\)) [15496913](//pubmed.ncbi.nlm.nih.gov/15496913).
  9. **^** Ezkurdia I, Juan D, Rodriguez JM, Frankish A, Diekhans M, Harrow J, Vazquez J, Valencia A, Tress ML (November 2014). ["Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4204768). _Human Molecular Genetics_. **23** (22): 5866–78. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/ddu309](https://doi.org/10.1093%2Fhmg%2Fddu309). [PMC](/wiki/PMC_\(identifier\)) [4204768](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4204768). [PMID](/wiki/PMID_\(identifier\)) [24939910](//pubmed.ncbi.nlm.nih.gov/24939910).
  10. **^** Saey TH (17 September 2018). ["A recount of human genes ups the number to at least 46,831"](https://www.sciencenews.org/article/recount-human-genes-ups-number-least-46831). _Science News_.
  11. **^** Alles J, Fehlmann T, Fischer U, Backes C, Galata V, Minet M, et al. (April 2019). ["An estimate of the total number of true human miRNAs"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6468295). _Nucleic Acids Research_. **47** (7): 3353–3364. [doi](/wiki/Doi_\(identifier\)):[10.1093/nar/gkz097](https://doi.org/10.1093%2Fnar%2Fgkz097). [PMC](/wiki/PMC_\(identifier\)) [6468295](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6468295). [PMID](/wiki/PMID_\(identifier\)) [30820533](//pubmed.ncbi.nlm.nih.gov/30820533).
  12. ^ _**a**_ _**b**_ _**c**_ Pennisi E (September 2012). "Genomics. ENCODE project writes eulogy for junk DNA". _Science_. **337** (6099): 1159–1161. [doi](/wiki/Doi_\(identifier\)):[10.1126/science.337.6099.1159](https://doi.org/10.1126%2Fscience.337.6099.1159). [PMID](/wiki/PMID_\(identifier\)) [22955811](//pubmed.ncbi.nlm.nih.gov/22955811).
  13. **^** Zhang S (28 November 2018). "300 Million Letters of DNA Are Missing From the Human Genome". _The Atlantic_.
  14. ^ _**a**_ _**b**_ _**c**_ International Human Genome Sequencing Consortium (February 2001). ["Initial sequencing and analysis of the human genome"](https://doi.org/10.1038%2F35057062). _Nature_. **409** (6822): 860–921. [Bibcode](/wiki/Bibcode_\(identifier\)):[2001Natur.409..860L](https://ui.adsabs.harvard.edu/abs/2001Natur.409..860L). [doi](/wiki/Doi_\(identifier\)):[10.1038/35057062](https://doi.org/10.1038%2F35057062). [PMID](/wiki/PMID_\(identifier\)) [11237011](//pubmed.ncbi.nlm.nih.gov/11237011).
  15. **^** [International Human Genome Sequencing Consortium Publishes Sequence and Analysis of the Human Genome](https://www.genome.gov/10002192)
  16. **^** Pennisi E (February 2001). "The human genome". _Science_. **291** (5507): 1177–80. [doi](/wiki/Doi_\(identifier\)):[10.1126/science.291.5507.1177](https://doi.org/10.1126%2Fscience.291.5507.1177). [PMID](/wiki/PMID_\(identifier\)) [11233420](//pubmed.ncbi.nlm.nih.gov/11233420). [S2CID](/wiki/S2CID_\(identifier\)) [38355565](https://api.semanticscholar.org/CorpusID:38355565).
  17. **^** Molteni M (19 November 2018). ["Now You Can Sequence Your Whole Genome For Just $200"](https://www.wired.com/story/whole-genome-sequencing-cost-200-dollars/). _Wired_.
  18. **^** Wrighton K (February 2021). ["Filling in the gaps telomere to telomere"](https://www.nature.com/articles/d42859-020-00117-1). _Nature Milestones: Genomic Sequencing_: S21.
  19. **^** Pollack A (2 June 2016). ["Scientists Announce HGP-Write, Project to Synthesize the Human Genome"](https://www.nytimes.com/2016/06/03/science/human-genome-project-write-synthetic-dna.html). _[New York Times](/wiki/New_York_Times)_. Retrieved 2 June 2016.
  20. **^** Boeke JD, Church G, Hessel A, Kelley NJ, Arkin A, Cai Y, et al. (July 2016). "The Genome Project-Write". _Science_. **353** (6295): 126–7. [Bibcode](/wiki/Bibcode_\(identifier\)):[2016Sci...353..126B](https://ui.adsabs.harvard.edu/abs/2016Sci...353..126B). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.aaf6850](https://doi.org/10.1126%2Fscience.aaf6850). [PMID](/wiki/PMID_\(identifier\)) [27256881](//pubmed.ncbi.nlm.nih.gov/27256881). [S2CID](/wiki/S2CID_\(identifier\)) [206649424](https://api.semanticscholar.org/CorpusID:206649424).
  21. **^** Zhang S (28 November 2018). ["300 Million Letters of DNA Are Missing From the Human Genome"](https://www.theatlantic.com/science/archive/2018/11/human-genome-300-million-missing-letters-dna/576481/). _The Atlantic_. Retrieved 16 August 2019.
  22. **^** Chaisson MJ, Huddleston J, Dennis MY, Sudmant PH, Malig M, Hormozdiari F, et al. (January 2015). ["Resolving the complexity of the human genome using single-molecule sequencing"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317254). _Nature_. **517** (7536): 608–11. [Bibcode](/wiki/Bibcode_\(identifier\)):[2015Natur.517..608C](https://ui.adsabs.harvard.edu/abs/2015Natur.517..608C). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature13907](https://doi.org/10.1038%2Fnature13907). [PMC](/wiki/PMC_\(identifier\)) [4317254](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4317254). [PMID](/wiki/PMID_\(identifier\)) [25383537](//pubmed.ncbi.nlm.nih.gov/25383537).
  23. **^** [Miga KH](/wiki/Karen_Miga), Koren S, Rhie A, Vollger MR, Gershman A, Bzikadze A, et al. (September 2020). ["Telomere-to-telomere assembly of a complete human X chromosome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7484160). _Nature_. **585** (7823): 79–84. [Bibcode](/wiki/Bibcode_\(identifier\)):[2020Natur.585...79M](https://ui.adsabs.harvard.edu/abs/2020Natur.585...79M). [doi](/wiki/Doi_\(identifier\)):[10.1038/s41586-020-2547-7](https://doi.org/10.1038%2Fs41586-020-2547-7). [PMC](/wiki/PMC_\(identifier\)) [7484160](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7484160). [PMID](/wiki/PMID_\(identifier\)) [32663838](//pubmed.ncbi.nlm.nih.gov/32663838).
  24. **^** ["CHM13 T2T v1.1 - Genome - Assembly - NCBI"](https://www.ncbi.nlm.nih.gov/assembly/GCA_009914755.3). _www.ncbi.nlm.nih.gov_. Retrieved 26 July 2021.
  25. **^** ["Genome List - Genome - NCBI"](https://www.ncbi.nlm.nih.gov/genome/browse/#!/eukaryotes/51/). _www.ncbi.nlm.nih.gov_. Retrieved 26 July 2021.
  26. **^** [Ensembl genome browser release 87](http://useast.ensembl.org/Homo_sapiens/Location/Genome?r=Y:1-1000)[_[permanent dead link](/wiki/Wikipedia:Link_rot)_] (December 2016) for most values; [Ensembl genome browser release 68](http://jul2012.archive.ensembl.org/Homo_sapiens/Location/Chromosome?r=1:1-1000000) (July 2012) for miRNA, rRNA, snRNA, snoRNA.
  27. **^** Piovesan A, Pelleri MC, Antonaros F, Strippoli P, Caracausi M, Vitale L (February 2019). ["On the length, weight and GC content of the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6391780). _BMC Research Notes_. **12** (1): 106. [doi](/wiki/Doi_\(identifier\)):[10.1186/s13104-019-4137-z](https://doi.org/10.1186%2Fs13104-019-4137-z). [PMC](/wiki/PMC_\(identifier\)) [6391780](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6391780). [PMID](/wiki/PMID_\(identifier\)) [30813969](//pubmed.ncbi.nlm.nih.gov/30813969).
  28. **^** Salzberg SL (August 2018). ["Open questions: How many genes do we have?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6100717). _BMC Biology_. **16** (1): 94. [doi](/wiki/Doi_\(identifier\)):[10.1186/s12915-018-0564-x](https://doi.org/10.1186%2Fs12915-018-0564-x). [PMC](/wiki/PMC_\(identifier\)) [6100717](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6100717). [PMID](/wiki/PMID_\(identifier\)) [30124169](//pubmed.ncbi.nlm.nih.gov/30124169).
  29. **^** ["Gencode statistics, version 28"](https://web.archive.org/web/20180302114250/http://www.gencodegenes.org/stats/current.html). Archived from [the original](http://www.gencodegenes.org/stats/current.html) on 2 March 2018. Retrieved 12 July 2018.
  30. **^** ["Ensembl statistics for version 92.38, corresponding to Gencode v28"](http://ensembl.org/Homo_sapiens/Info/Annotation). Retrieved 12 July 2018.
  31. **^** ["NCBI Homo sapiens Annotation Release 108"](http://www.ncbi.nlm.nih.gov/genome/annotation_euk/Homo_sapiens/108/). NIH. 2016.
  32. **^** ["CHESS statistics, version 2.0"](http://ccb.jhu.edu/chess). _Center for Computational Biology_. Johns Hopkins University.
  33. **^** ["Human Genome Project Completion: Frequently Asked Questions"](https://www.genome.gov/11006943/human-genome-project-completion-frequently-asked-questions/). _National Human Genome Research Institute (NHGRI)_. Retrieved 2 February 2019.
  34. **^** Christley S, Lu Y, Li C, Xie X (January 2009). ["Human genomes as email attachments"](https://doi.org/10.1093%2Fbioinformatics%2Fbtn582). _Bioinformatics_. **25** (2): 274–5. [doi](/wiki/Doi_\(identifier\)):[10.1093/bioinformatics/btn582](https://doi.org/10.1093%2Fbioinformatics%2Fbtn582). [PMID](/wiki/PMID_\(identifier\)) [18996942](//pubmed.ncbi.nlm.nih.gov/18996942).
  35. **^** Liu Z, Venkatesh SS, Maley CC (October 2008). ["Sequence space coverage, entropy of genomes and the potential to detect non-human DNA in human samples"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2628393). _BMC Genomics_. **9**: 509. [doi](/wiki/Doi_\(identifier\)):[10.1186/1471-2164-9-509](https://doi.org/10.1186%2F1471-2164-9-509). [PMC](/wiki/PMC_\(identifier\)) [2628393](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2628393). [PMID](/wiki/PMID_\(identifier\)) [18973670](//pubmed.ncbi.nlm.nih.gov/18973670)., fig. 6, using the [Lempel-Ziv](/wiki/Lempel-Ziv) estimators of entropy rate.
  36. **^** Waters K (7 March 2007). ["Molecular Genetics"](http://plato.stanford.edu/entries/molecular-genetics/#GenSke). _Stanford Encyclopedia of Philosophy_. Retrieved 18 July 2013.
  37. **^** Gannett L (26 October 2008). ["The Human Genome Project"](http://plato.stanford.edu/entries/human-genome/#ConFouHumGenPro). _Stanford Encyclopedia of Philosophy_. Retrieved 18 July 2013.
  38. **^** [PANTHER Pie Chart](http://www.pantherdb.org/chart/summary/pantherChart.jsp?filterLevel=1&chartType=1&listType=1&type=5&species=Homo%20sapiens) at the PANTHER Classification System homepage. Retrieved 25 May 2011
  39. **^** [List of human proteins in the Uniprot Human reference proteome](https://www.uniprot.org/uniprot/?query=*&fil=reviewed%3Ayes+AND+organism%3A%22Homo+sapiens+%28Human%29+%5B9606%5D%22+AND+proteome%3Aup000005640); accessed 28 January 2015
  40. **^** Kauffman SA (March 1969). "Metabolic stability and epigenesis in randomly constructed genetic nets". _Journal of Theoretical Biology_. **22** (3): 437–67. [doi](/wiki/Doi_\(identifier\)):[10.1016/0022-5193(69)90015-0](https://doi.org/10.1016%2F0022-5193%2869%2990015-0). [PMID](/wiki/PMID_\(identifier\)) [5803332](//pubmed.ncbi.nlm.nih.gov/5803332).
  41. **^** Ohno S (1972). "An argument for the genetic simplicity of man and other mammals". _Journal of Human Evolution_. **1** (6): 651–662. [doi](/wiki/Doi_\(identifier\)):[10.1016/0047-2484(72)90011-5](https://doi.org/10.1016%2F0047-2484%2872%2990011-5).
  42. **^** Sémon M, Mouchiroud D, Duret L (February 2005). ["Relationship between gene expression and GC-content in mammals: statistical significance and biological relevance"](https://doi.org/10.1093%2Fhmg%2Fddi038). _Human Molecular Genetics_. **14** (3): 421–7. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/ddi038](https://doi.org/10.1093%2Fhmg%2Fddi038). [PMID](/wiki/PMID_\(identifier\)) [15590696](//pubmed.ncbi.nlm.nih.gov/15590696).
  43. **^** M. Huang, H. Zhu, B. Shen, G. Gao, ["A non-random gait through the human genome"](https://ieeexplore.ieee.org/document/5162209), _3rd International Conference on Bioinformatics and Biomedical Engineering_ (UCBBE, 2009), 1–3
  44. ^ _**a**_ _**b**_ Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S (2001). ["The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system"](https://doi.org/10.1161%2Fhh2301.100981). _Circulation Research_. **89** (11): 1065–72. [doi](/wiki/Doi_\(identifier\)):[10.1161/hh2301.100981](https://doi.org/10.1161%2Fhh2301.100981). [PMID](/wiki/PMID_\(identifier\)) [11717165](//pubmed.ncbi.nlm.nih.gov/11717165).
  45. ^ _**a**_ _**b**_ Piovesan A, Caracausi M, Antonaros F, Pelleri MC, Vitale L (2016). ["GeneBase 1.1: a tool to summarize data from NCBI gene datasets and its application to an update of human gene statistics"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5199132). _Database: The Journal of Biological Databases and Curation_. **2016**: baw153. [doi](/wiki/Doi_\(identifier\)):[10.1093/database/baw153](https://doi.org/10.1093%2Fdatabase%2Fbaw153). [PMC](/wiki/PMC_\(identifier\)) [5199132](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5199132). [PMID](/wiki/PMID_\(identifier\)) [28025344](//pubmed.ncbi.nlm.nih.gov/28025344).
  46. **^** [Ensembl genome browser](https://archive.today/20130414163120/http://useast.ensembl.org/Homo_sapiens/Location/Genome?r=6:133017695-133161157) (July 2012)
  47. **^** Gregory TR (September 2005). "Synergy between sequence and size in large-scale genomics". _Nature Reviews Genetics_. **6** (9): 699–708. [doi](/wiki/Doi_\(identifier\)):[10.1038/nrg1674](https://doi.org/10.1038%2Fnrg1674). [PMID](/wiki/PMID_\(identifier\)) [16151375](//pubmed.ncbi.nlm.nih.gov/16151375). [S2CID](/wiki/S2CID_\(identifier\)) [24237594](https://api.semanticscholar.org/CorpusID:24237594).
  48. ^ _**a**_ _**b**_ Palazzo AF, Akef A (June 2012). "Nuclear export as a key arbiter of "mRNA identity" in eukaryotes". _Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms_. **1819** (6): 566–77. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.bbagrm.2011.12.012](https://doi.org/10.1016%2Fj.bbagrm.2011.12.012). [PMID](/wiki/PMID_\(identifier\)) [22248619](//pubmed.ncbi.nlm.nih.gov/22248619).
  49. **^** Ludwig MZ (December 2002). "Functional evolution of noncoding DNA". _Current Opinion in Genetics & Development_. **12** (6): 634–9. [doi](/wiki/Doi_\(identifier\)):[10.1016/S0959-437X(02)00355-6](https://doi.org/10.1016%2FS0959-437X%2802%2900355-6). [PMID](/wiki/PMID_\(identifier\)) [12433575](//pubmed.ncbi.nlm.nih.gov/12433575).
  50. **^** Martens JA, Laprade L, Winston F (June 2004). "Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene". _Nature_. **429** (6991): 571–4. [Bibcode](/wiki/Bibcode_\(identifier\)):[2004Natur.429..571M](https://ui.adsabs.harvard.edu/abs/2004Natur.429..571M). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature02538](https://doi.org/10.1038%2Fnature02538). [PMID](/wiki/PMID_\(identifier\)) [15175754](//pubmed.ncbi.nlm.nih.gov/15175754). [S2CID](/wiki/S2CID_\(identifier\)) [809550](https://api.semanticscholar.org/CorpusID:809550).
  51. **^** Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, [Chang HY](/wiki/Howard_Y._Chang) (August 2010). ["Long noncoding RNA as modular scaffold of histone modification complexes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2967777). _Science_. **329** (5992): 689–93. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Sci...329..689T](https://ui.adsabs.harvard.edu/abs/2010Sci...329..689T). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1192002](https://doi.org/10.1126%2Fscience.1192002). [PMC](/wiki/PMC_\(identifier\)) [2967777](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2967777). [PMID](/wiki/PMID_\(identifier\)) [20616235](//pubmed.ncbi.nlm.nih.gov/20616235).
  52. **^** Bartolomei MS, Zemel S, Tilghman SM (May 1991). "Parental imprinting of the mouse H19 gene". _Nature_. **351** (6322): 153–5. [Bibcode](/wiki/Bibcode_\(identifier\)):[1991Natur.351..153B](https://ui.adsabs.harvard.edu/abs/1991Natur.351..153B). [doi](/wiki/Doi_\(identifier\)):[10.1038/351153a0](https://doi.org/10.1038%2F351153a0). [PMID](/wiki/PMID_\(identifier\)) [1709450](//pubmed.ncbi.nlm.nih.gov/1709450). [S2CID](/wiki/S2CID_\(identifier\)) [4364975](https://api.semanticscholar.org/CorpusID:4364975).
  53. **^** Kobayashi T, Ganley AR (September 2005). "Recombination regulation by transcription-induced cohesin dissociation in rDNA repeats". _Science_. **309** (5740): 1581–4. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Sci...309.1581K](https://ui.adsabs.harvard.edu/abs/2005Sci...309.1581K). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1116102](https://doi.org/10.1126%2Fscience.1116102). [PMID](/wiki/PMID_\(identifier\)) [16141077](//pubmed.ncbi.nlm.nih.gov/16141077). [S2CID](/wiki/S2CID_\(identifier\)) [21547462](https://api.semanticscholar.org/CorpusID:21547462).
  54. **^** Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (August 2011). ["A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3235919). _Cell_. **146** (3): 353–8. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.cell.2011.07.014](https://doi.org/10.1016%2Fj.cell.2011.07.014). [PMC](/wiki/PMC_\(identifier\)) [3235919](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3235919). [PMID](/wiki/PMID_\(identifier\)) [21802130](//pubmed.ncbi.nlm.nih.gov/21802130).
  55. **^** Pei B, Sisu C, Frankish A, Howald C, Habegger L, Mu XJ, Harte R, Balasubramanian S, Tanzer A, Diekhans M, Reymond A, Hubbard TJ, Harrow J, Gerstein MB (2012). ["The GENCODE pseudogene resource"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3491395). _Genome Biology_. **13** (9): R51. [doi](/wiki/Doi_\(identifier\)):[10.1186/gb-2012-13-9-r51](https://doi.org/10.1186%2Fgb-2012-13-9-r51). [PMC](/wiki/PMC_\(identifier\)) [3491395](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3491395). [PMID](/wiki/PMID_\(identifier\)) [22951037](//pubmed.ncbi.nlm.nih.gov/22951037).
  56. **^** Gilad Y, Man O, Pääbo S, Lancet D (March 2003). ["Human specific loss of olfactory receptor genes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC152291). _Proceedings of the National Academy of Sciences of the United States of America_. **100** (6): 3324–7. [Bibcode](/wiki/Bibcode_\(identifier\)):[2003PNAS..100.3324G](https://ui.adsabs.harvard.edu/abs/2003PNAS..100.3324G). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.0535697100](https://doi.org/10.1073%2Fpnas.0535697100). [PMC](/wiki/PMC_\(identifier\)) [152291](//www.ncbi.nlm.nih.gov/pmc/articles/PMC152291). [PMID](/wiki/PMID_\(identifier\)) [12612342](//pubmed.ncbi.nlm.nih.gov/12612342).
  57. **^** Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, Wu YM, Robinson DR, Beer DG, Feng FY, Iyer HK, Chinnaiyan AM (March 2015). ["The landscape of long noncoding RNAs in the human transcriptome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4417758). _Nature Genetics_. **47** (3): 199–208. [doi](/wiki/Doi_\(identifier\)):[10.1038/ng.3192](https://doi.org/10.1038%2Fng.3192). [PMC](/wiki/PMC_\(identifier\)) [4417758](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4417758). [PMID](/wiki/PMID_\(identifier\)) [25599403](//pubmed.ncbi.nlm.nih.gov/25599403).
  58. **^** Eddy SR (December 2001). "Non-coding RNA genes and the modern RNA world". _Nature Reviews Genetics_. **2** (12): 919–29. [doi](/wiki/Doi_\(identifier\)):[10.1038/35103511](https://doi.org/10.1038%2F35103511). [PMID](/wiki/PMID_\(identifier\)) [11733745](//pubmed.ncbi.nlm.nih.gov/11733745). [S2CID](/wiki/S2CID_\(identifier\)) [18347629](https://api.semanticscholar.org/CorpusID:18347629).
  59. **^** Managadze D, Lobkovsky AE, Wolf YI, Shabalina SA, Rogozin IB, Koonin EV (2013). ["The vast, conserved mammalian lincRNome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3585383). _PLOS Computational Biology_. **9** (2): e1002917. [Bibcode](/wiki/Bibcode_\(identifier\)):[2013PLSCB...9E2917M](https://ui.adsabs.harvard.edu/abs/2013PLSCB...9E2917M). [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pcbi.1002917](https://doi.org/10.1371%2Fjournal.pcbi.1002917). [PMC](/wiki/PMC_\(identifier\)) [3585383](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3585383). [PMID](/wiki/PMID_\(identifier\)) [23468607](//pubmed.ncbi.nlm.nih.gov/23468607).
  60. **^** Palazzo AF, Lee ES (2015). ["Non-coding RNA: what is functional and what is junk?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4306305). _Frontiers in Genetics_. **6**: 2. [doi](/wiki/Doi_\(identifier\)):[10.3389/fgene.2015.00002](https://doi.org/10.3389%2Ffgene.2015.00002). [PMC](/wiki/PMC_\(identifier\)) [4306305](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4306305). [PMID](/wiki/PMID_\(identifier\)) [25674102](//pubmed.ncbi.nlm.nih.gov/25674102).
  61. **^** Mattick JS, Makunin IV (April 2006). ["Non-coding RNA"](https://doi.org/10.1093%2Fhmg%2Fddl046). _Human Molecular Genetics_. **15** (Spec No 1): R17–29. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/ddl046](https://doi.org/10.1093%2Fhmg%2Fddl046). [PMID](/wiki/PMID_\(identifier\)) [16651366](//pubmed.ncbi.nlm.nih.gov/16651366).
  62. ^ _**a**_ _**b**_ Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M (September 2012). ["An integrated encyclopedia of DNA elements in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3439153). _Nature_. **489** (7414): 57–74. [Bibcode](/wiki/Bibcode_\(identifier\)):[2012Natur.489...57T](https://ui.adsabs.harvard.edu/abs/2012Natur.489...57T). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature11247](https://doi.org/10.1038%2Fnature11247). [PMC](/wiki/PMC_\(identifier\)) [3439153](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3439153). [PMID](/wiki/PMID_\(identifier\)) [22955616](//pubmed.ncbi.nlm.nih.gov/22955616).
  63. **^** Birney E (5 September 2012). ["ENCODE: My own thoughts"](http://genomeinformatician.blogspot.ca/2012/09/encode-my-own-thoughts.html). _Ewan's Blog: Bioinformatician at large_.
  64. **^** Stamatoyannopoulos JA (September 2012). ["What does our genome encode?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3431477). _Genome Research_. **22** (9): 1602–11. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.146506.112](https://doi.org/10.1101%2Fgr.146506.112). [PMC](/wiki/PMC_\(identifier\)) [3431477](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3431477). [PMID](/wiki/PMID_\(identifier\)) [22955972](//pubmed.ncbi.nlm.nih.gov/22955972).
  65. **^** Carroll SB, Gompel N, Prudhomme B (May 2008). "Regulating Evolution". _Scientific American_. **298** (5): 60–67. [Bibcode](/wiki/Bibcode_\(identifier\)):[2008SciAm.298e..60C](https://ui.adsabs.harvard.edu/abs/2008SciAm.298e..60C). [doi](/wiki/Doi_\(identifier\)):[10.1038/scientificamerican0508-60](https://doi.org/10.1038%2Fscientificamerican0508-60). [PMID](/wiki/PMID_\(identifier\)) [18444326](//pubmed.ncbi.nlm.nih.gov/18444326).
  66. **^** Miller JH, Ippen K, Scaife JG, Beckwith JR (1968). "The promoter-operator region of the lac operon of Escherichia coli". _J. Mol. Biol_. **38** (3): 413–20. [doi](/wiki/Doi_\(identifier\)):[10.1016/0022-2836(68)90395-1](https://doi.org/10.1016%2F0022-2836%2868%2990395-1). [PMID](/wiki/PMID_\(identifier\)) [4887877](//pubmed.ncbi.nlm.nih.gov/4887877).
  67. **^** Wright S, Rosenthal A, Flavell R, Grosveld F (1984). "DNA sequences required for regulated expression of beta-globin genes in murine erythroleukemia cells". _Cell_. **38** (1): 265–73. [doi](/wiki/Doi_\(identifier\)):[10.1016/0092-8674(84)90548-8](https://doi.org/10.1016%2F0092-8674%2884%2990548-8). [PMID](/wiki/PMID_\(identifier\)) [6088069](//pubmed.ncbi.nlm.nih.gov/6088069). [S2CID](/wiki/S2CID_\(identifier\)) [34587386](https://api.semanticscholar.org/CorpusID:34587386).
  68. **^** Nei M, Xu P, Glazko G (February 2001). ["Estimation of divergence times from multiprotein sequences for a few mammalian species and several distantly related organisms"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC30166). _Proceedings of the National Academy of Sciences of the United States of America_. **98** (5): 2497–502. [Bibcode](/wiki/Bibcode_\(identifier\)):[2001PNAS...98.2497N](https://ui.adsabs.harvard.edu/abs/2001PNAS...98.2497N). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.051611498](https://doi.org/10.1073%2Fpnas.051611498). [PMC](/wiki/PMC_\(identifier\)) [30166](//www.ncbi.nlm.nih.gov/pmc/articles/PMC30166). [PMID](/wiki/PMID_\(identifier\)) [11226267](//pubmed.ncbi.nlm.nih.gov/11226267).
  69. **^** Loots GG, Locksley RM, Blankespoor CM, Wang ZE, Miller W, Rubin EM, Frazer KA (April 2000). "Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons". _Science_. **288** (5463): 136–40. [Bibcode](/wiki/Bibcode_\(identifier\)):[2000Sci...288..136L](https://ui.adsabs.harvard.edu/abs/2000Sci...288..136L). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.288.5463.136](https://doi.org/10.1126%2Fscience.288.5463.136). [PMID](/wiki/PMID_\(identifier\)) [10753117](//pubmed.ncbi.nlm.nih.gov/10753117). [Summary](http://www.lbl.gov/Science-Articles/Archive/mouse-dna-model.html)
  70. **^** Meunier M. ["Genoscope and Whitehead announce a high sequence coverage of the Tetraodon nigroviridis genome"](https://web.archive.org/web/20061016085223/http://www.cns.fr/externe/English/Actualites/Presse/261001_1.html). Genoscope. Archived from [the original](http://www.cns.fr/externe/English/Actualites/Presse/261001_1.html) on 16 October 2006. Retrieved 12 September 2006.
  71. **^** Romero IG, Ruvinsky I, Gilad Y (July 2012). ["Comparative studies of gene expression and the evolution of gene regulation"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4034676). _Nature Reviews Genetics_. **13** (7): 505–16. [doi](/wiki/Doi_\(identifier\)):[10.1038/nrg3229](https://doi.org/10.1038%2Fnrg3229). [PMC](/wiki/PMC_\(identifier\)) [4034676](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4034676). [PMID](/wiki/PMID_\(identifier\)) [22705669](//pubmed.ncbi.nlm.nih.gov/22705669).
  72. **^** Schmidt D, Wilson MD, Ballester B, Schwalie PC, Brown GD, Marshall A, Kutter C, Watt S, Martinez-Jimenez CP, Mackay S, Talianidis I, Flicek P, Odom DT (May 2010). ["Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3008766). _Science_. **328** (5981): 1036–40. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Sci...328.1036S](https://ui.adsabs.harvard.edu/abs/2010Sci...328.1036S). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1186176](https://doi.org/10.1126%2Fscience.1186176). [PMC](/wiki/PMC_\(identifier\)) [3008766](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3008766). [PMID](/wiki/PMID_\(identifier\)) [20378774](//pubmed.ncbi.nlm.nih.gov/20378774).
  73. **^** Wilson MD, Barbosa-Morais NL, Schmidt D, Conboy CM, Vanes L, Tybulewicz VL, Fisher EM, Tavaré S, Odom DT (October 2008). ["Species-specific transcription in mice carrying human chromosome 21"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3717767). _Science_. **322** (5900): 434–8. [Bibcode](/wiki/Bibcode_\(identifier\)):[2008Sci...322..434W](https://ui.adsabs.harvard.edu/abs/2008Sci...322..434W). [doi](/wiki/Doi_\(identifier\)):[10.1126/science.1160930](https://doi.org/10.1126%2Fscience.1160930). [PMC](/wiki/PMC_\(identifier\)) [3717767](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3717767). [PMID](/wiki/PMID_\(identifier\)) [18787134](//pubmed.ncbi.nlm.nih.gov/18787134).
  74. **^** Treangen TJ, Salzberg SL (January 2012). ["Repetitive DNA and next-generation sequencing: computational challenges and solutions"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3324860). _Nature Reviews Genetics_. **13** (1): 36–46. [doi](/wiki/Doi_\(identifier\)):[10.1038/nrg3117](https://doi.org/10.1038%2Fnrg3117). [PMC](/wiki/PMC_\(identifier\)) [3324860](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3324860). [PMID](/wiki/PMID_\(identifier\)) [22124482](//pubmed.ncbi.nlm.nih.gov/22124482).
  75. **^** Duitama J, Zablotskaya A, Gemayel R, Jansen A, Belet S, Vermeesch JR, Verstrepen KJ, Froyen G (May 2014). ["Large-scale analysis of tandem repeat variability in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4027155). _Nucleic Acids Research_. **42** (9): 5728–41. [doi](/wiki/Doi_\(identifier\)):[10.1093/nar/gku212](https://doi.org/10.1093%2Fnar%2Fgku212). [PMC](/wiki/PMC_\(identifier\)) [4027155](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4027155). [PMID](/wiki/PMID_\(identifier\)) [24682812](//pubmed.ncbi.nlm.nih.gov/24682812).
  76. **^** Pierce BA (2012). _Genetics : a conceptual approach_ (4th ed.). New York: W.H. Freeman. pp. 538–540. [ISBN](/wiki/ISBN_\(identifier\)) [978-1-4292-3250-0](/wiki/Special:BookSources/978-1-4292-3250-0).
  77. **^** Bennett EA, Keller H, Mills RE, Schmidt S, Moran JV, Weichenrieder O, Devine SE (December 2008). ["Active Alu retrotransposons in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2593586). _Genome Research_. **18** (12): 1875–83. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.081737.108](https://doi.org/10.1101%2Fgr.081737.108). [PMC](/wiki/PMC_\(identifier\)) [2593586](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2593586). [PMID](/wiki/PMID_\(identifier\)) [18836035](//pubmed.ncbi.nlm.nih.gov/18836035).
  78. **^** Liang KH, Yeh CT (2013). ["A gene expression restriction network mediated by sense and antisense Alu sequences located on protein-coding messenger RNAs"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3655826). _BMC Genomics_. **14**: 325. [doi](/wiki/Doi_\(identifier\)):[10.1186/1471-2164-14-325](https://doi.org/10.1186%2F1471-2164-14-325). [PMC](/wiki/PMC_\(identifier\)) [3655826](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3655826). [PMID](/wiki/PMID_\(identifier\)) [23663499](//pubmed.ncbi.nlm.nih.gov/23663499).
  79. **^** Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH (April 2003). ["Hot L1s account for the bulk of retrotransposition in the human population"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC154336). _Proceedings of the National Academy of Sciences of the United States of America_. **100** (9): 5280–5. [Bibcode](/wiki/Bibcode_\(identifier\)):[2003PNAS..100.5280B](https://ui.adsabs.harvard.edu/abs/2003PNAS..100.5280B). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.0831042100](https://doi.org/10.1073%2Fpnas.0831042100). [PMC](/wiki/PMC_\(identifier\)) [154336](//www.ncbi.nlm.nih.gov/pmc/articles/PMC154336). [PMID](/wiki/PMID_\(identifier\)) [12682288](//pubmed.ncbi.nlm.nih.gov/12682288).
  80. **^** Barton NH, Briggs DE, Eisen JA, Goldstein DB, Patel NH (2007). _Evolution_. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. [ISBN](/wiki/ISBN_\(identifier\)) [978-0-87969-684-9](/wiki/Special:BookSources/978-0-87969-684-9).
  81. **^** [NCBI](/wiki/National_Center_for_Biotechnology_Information). ["GRCh38 – hg38 – Genome – Assembly – NCBI"](https://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.26/). _ncbi.nlm.nih.gov_. Retrieved 15 March 2019.
  82. **^** ["from Bill Clinton's 2000 State of the Union address"](https://web.archive.org/web/20170221025546/https://clinton4.nara.gov/WH/SOTU00/sotu-text.html). Archived from [the original](https://clinton4.nara.gov/WH/SOTU00/sotu-text.html) on 21 February 2017. Retrieved 14 June 2007.
  83. **^** Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. (November 2006). ["Global variation in copy number in the human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2669898). _Nature_. **444** (7118): 444–54. [Bibcode](/wiki/Bibcode_\(identifier\)):[2006Natur.444..444R](https://ui.adsabs.harvard.edu/abs/2006Natur.444..444R). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature05329](https://doi.org/10.1038%2Fnature05329). [PMC](/wiki/PMC_\(identifier\)) [2669898](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2669898). [PMID](/wiki/PMID_\(identifier\)) [17122850](//pubmed.ncbi.nlm.nih.gov/17122850).
  84. **^** ["What's a Genome?"](http://www.genomenewsnetwork.org/resources/whats_a_genome/Chp3_1.shtml). Genomenewsnetwork.org. 15 January 2003. Retrieved 31 May 2009.
  85. **^** NCBI_user_services (29 March 2004). ["Mapping Factsheet"](https://web.archive.org/web/20100719235548/http://www.ncbi.nlm.nih.gov/About/primer/mapping.html). Ncbi.nlm.nih.gov. Archived from [the original](https://www.ncbi.nlm.nih.gov/About/primer/mapping.html) on 19 July 2010. Retrieved 31 May 2009.
  86. **^** ["About the Project"](http://www.hapmap.org/abouthapmap.html). HapMap. Retrieved 31 May 2009.
  87. **^** ["2008 Release: Researchers Produce First Sequence Map of Large-Scale Structural Variation in the Human Genome"](http://www.genome.gov/27026113). genome.gov. Retrieved 31 May 2009.
  88. **^** Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, Graves T, et al. (May 2008). ["Mapping and sequencing of structural variation from eight human genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2424287). _Nature_. **453** (7191): 56–64. [Bibcode](/wiki/Bibcode_\(identifier\)):[2008Natur.453...56K](https://ui.adsabs.harvard.edu/abs/2008Natur.453...56K). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature06862](https://doi.org/10.1038%2Fnature06862). [PMC](/wiki/PMC_\(identifier\)) [2424287](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2424287). [PMID](/wiki/PMID_\(identifier\)) [18451855](//pubmed.ncbi.nlm.nih.gov/18451855).
  89. ^ _**a**_ _**b**_ Abel HJ, Larson DE, Regier AA, Chiang C, Das I, Kanchi KL, et al. (July 2020). ["Mapping and characterization of structural variation in 17,795 human genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7547914). _Nature_. **583** (7814): 83–89. [doi](/wiki/Doi_\(identifier\)):[10.1038/s41586-020-2371-0](https://doi.org/10.1038%2Fs41586-020-2371-0). [PMC](/wiki/PMC_\(identifier\)) [7547914](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7547914). [PMID](/wiki/PMID_\(identifier\)) [32460305](//pubmed.ncbi.nlm.nih.gov/32460305).
  90. **^** Gray IC, Campbell DA, Spurr NK (2000). ["Single nucleotide polymorphisms as tools in human genetics"](https://doi.org/10.1093%2Fhmg%2F9.16.2403). _Human Molecular Genetics_. **9** (16): 2403–2408. [doi](/wiki/Doi_\(identifier\)):[10.1093/hmg/9.16.2403](https://doi.org/10.1093%2Fhmg%2F9.16.2403). [PMID](/wiki/PMID_\(identifier\)) [11005795](//pubmed.ncbi.nlm.nih.gov/11005795).
  91. **^** Lai E (June 2001). ["Application of SNP technologies in medicine: lessons learned and future challenges"](https://doi.org/10.1101%2Fgr.192301). _Genome Research_. **11** (6): 927–9. [doi](/wiki/Doi_\(identifier\)):[10.1101/gr.192301](https://doi.org/10.1101%2Fgr.192301). [PMID](/wiki/PMID_\(identifier\)) [11381021](//pubmed.ncbi.nlm.nih.gov/11381021).
  92. **^** ["Human Genome Project Completion: Frequently Asked Questions"](http://www.genome.gov/11006943). genome.gov. Retrieved 31 May 2009.
  93. **^** Singer E (4 September 2007). ["Craig Venter's Genome"](http://www.technologyreview.com/biomedicine/19328/?a=f). _[MIT Technology Review](/wiki/MIT_Technology_Review)_. Retrieved 25 May 2010.
  94. **^** Pushkarev D, Neff NF, Quake SR (September 2009). ["Single-molecule sequencing of an individual human genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4117198). _Nature Biotechnology_. **27** (9): 847–50. [doi](/wiki/Doi_\(identifier\)):[10.1038/nbt.1561](https://doi.org/10.1038%2Fnbt.1561). [PMC](/wiki/PMC_\(identifier\)) [4117198](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4117198). [PMID](/wiki/PMID_\(identifier\)) [19668243](//pubmed.ncbi.nlm.nih.gov/19668243).
  95. **^** Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, et al. (May 2010). ["Clinical assessment incorporating a personal genome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2937184). _Lancet_. **375** (9725): 1525–35. [doi](/wiki/Doi_\(identifier\)):[10.1016/S0140-6736(10)60452-7](https://doi.org/10.1016%2FS0140-6736%2810%2960452-7). [PMC](/wiki/PMC_\(identifier\)) [2937184](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2937184). [PMID](/wiki/PMID_\(identifier\)) [20435227](//pubmed.ncbi.nlm.nih.gov/20435227).
  96. **^** Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ, et al. (September 2011). ["Phased whole-genome genetic risk in a family quartet using a major allele reference sequence"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3174201). _PLOS Genetics_. **7** (9): e1002280. [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pgen.1002280](https://doi.org/10.1371%2Fjournal.pgen.1002280). [PMC](/wiki/PMC_\(identifier\)) [3174201](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3174201). [PMID](/wiki/PMID_\(identifier\)) [21935354](//pubmed.ncbi.nlm.nih.gov/21935354).
  97. **^** ["Complete Genomics Adds 29 High-Coverage, Complete Human Genome Sequencing Datasets to Its Public Genomic Repository"](http://globenewswire.com/news-release/2011/04/06/443810/218032/en/Complete-Genomics-Adds-29-High-Coverage-Complete-Human-Genome-Sequencing-Datasets-to-Its-Public-Genomic-Repository.html?print=1).
  98. **^** Sample I (17 February 2010). ["Desmond Tutu's genome sequenced as part of genetic diversity study"](https://www.theguardian.com/science/2010/feb/17/desmond-tutu-genome-genetic-diversity). _The Guardian_.
  99. **^** Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, Kasson LR, et al. (February 2010). ["Complete Khoisan and Bantu genomes from southern Africa"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3890430). _Nature_. **463** (7283): 943–7. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Natur.463..943S](https://ui.adsabs.harvard.edu/abs/2010Natur.463..943S). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature08795](https://doi.org/10.1038%2Fnature08795). [PMC](/wiki/PMC_\(identifier\)) [3890430](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3890430). [PMID](/wiki/PMID_\(identifier\)) [20164927](//pubmed.ncbi.nlm.nih.gov/20164927).
  100. **^** Rasmussen M, Li Y, Lindgreen S, Pedersen JS, Albrechtsen A, Moltke I, et al. (February 2010). ["Ancient human genome sequence of an extinct Palaeo-Eskimo"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3951495). _Nature_. **463** (7282): 757–62. [Bibcode](/wiki/Bibcode_\(identifier\)):[2010Natur.463..757R](https://ui.adsabs.harvard.edu/abs/2010Natur.463..757R). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature08835](https://doi.org/10.1038%2Fnature08835). [PMC](/wiki/PMC_\(identifier\)) [3951495](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3951495). [PMID](/wiki/PMID_\(identifier\)) [20148029](//pubmed.ncbi.nlm.nih.gov/20148029).
  101. **^** [Corpas M](/wiki/Manuel_Corpas_\(Scientist\)), Cariaso M, Coletta A, Weiss D, Harrison AP, Moran F, Yang H (12 November 2013). "A Complete Public Domain Family Genomics Dataset". [bioRxiv](/wiki/BioRxiv_\(identifier\)) [10.1101/000216](https://doi.org/10.1101%2F000216).
  102. **^** [Corpas M](/wiki/Manuel_Corpas_\(Scientist\)) (June 2013). ["Crowdsourcing the corpasome"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3706263). _Source Code for Biology and Medicine_. **8** (1): 13. [doi](/wiki/Doi_\(identifier\)):[10.1186/1751-0473-8-13](https://doi.org/10.1186%2F1751-0473-8-13). [PMC](/wiki/PMC_\(identifier\)) [3706263](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3706263). [PMID](/wiki/PMID_\(identifier\)) [23799911](//pubmed.ncbi.nlm.nih.gov/23799911).
  103. **^** Mao Q, Ciotlos S, Zhang RY, Ball MP, Chin R, Carnevali P, et al. (October 2016). ["The whole genome sequences and experimentally phased haplotypes of over 100 personal genomes"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5057367). _GigaScience_. **5** (1): 42. [doi](/wiki/Doi_\(identifier\)):[10.1186/s13742-016-0148-z](https://doi.org/10.1186%2Fs13742-016-0148-z). [PMC](/wiki/PMC_\(identifier\)) [5057367](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5057367). [PMID](/wiki/PMID_\(identifier\)) [27724973](//pubmed.ncbi.nlm.nih.gov/27724973).
  104. **^** Cai B, Li B, Kiga N, Thusberg J, Bergquist T, Chen YC, et al. (September 2017). ["Matching phenotypes to whole genomes: Lessons learned from four iterations of the personal genome project community challenges"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5645203). _Human Mutation_. **38** (9): 1266–1276. [doi](/wiki/Doi_\(identifier\)):[10.1002/humu.23265](https://doi.org/10.1002%2Fhumu.23265). [PMC](/wiki/PMC_\(identifier\)) [5645203](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5645203). [PMID](/wiki/PMID_\(identifier\)) [28544481](//pubmed.ncbi.nlm.nih.gov/28544481).
  105. **^** Gonzaga-Jauregui C, Lupski JR, Gibbs RA (2012). ["Human genome sequencing in health and disease"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3656720). _Annual Review of Medicine_. **63**: 35–61. [doi](/wiki/Doi_\(identifier\)):[10.1146/annurev-med-051010-162644](https://doi.org/10.1146%2Fannurev-med-051010-162644). [PMC](/wiki/PMC_\(identifier\)) [3656720](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3656720). [PMID](/wiki/PMID_\(identifier\)) [22248320](//pubmed.ncbi.nlm.nih.gov/22248320).
  106. **^** Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloğlu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP (November 2009). ["Genetic diagnosis by whole exome capture and massively parallel DNA sequencing"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2768590). _Proceedings of the National Academy of Sciences of the United States of America_. **106** (45): 19096–101. [Bibcode](/wiki/Bibcode_\(identifier\)):[2009PNAS..10619096C](https://ui.adsabs.harvard.edu/abs/2009PNAS..10619096C). [doi](/wiki/Doi_\(identifier\)):[10.1073/pnas.0910672106](https://doi.org/10.1073%2Fpnas.0910672106). [PMC](/wiki/PMC_\(identifier\)) [2768590](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2768590). [PMID](/wiki/PMID_\(identifier\)) [19861545](//pubmed.ncbi.nlm.nih.gov/19861545).
  107. ^ _**a**_ _**b**_ Narasimhan VM, Xue Y, Tyler-Smith C (April 2016). ["Human Knockout Carriers: Dead, Diseased, Healthy, or Improved?"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4826344). _Trends in Molecular Medicine_. **22** (4): 341–351. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.molmed.2016.02.006](https://doi.org/10.1016%2Fj.molmed.2016.02.006). [PMC](/wiki/PMC_\(identifier\)) [4826344](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4826344). [PMID](/wiki/PMID_\(identifier\)) [26988438](//pubmed.ncbi.nlm.nih.gov/26988438).
  108. **^** Saleheen D, Natarajan P, Armean IM, Zhao W, Rasheed A, Khetarpal SA, et al. (April 2017). ["Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5600291). _Nature_. **544** (7649): 235–239. [Bibcode](/wiki/Bibcode_\(identifier\)):[2017Natur.544..235S](https://ui.adsabs.harvard.edu/abs/2017Natur.544..235S). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature22034](https://doi.org/10.1038%2Fnature22034). [PMC](/wiki/PMC_\(identifier\)) [5600291](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5600291). [PMID](/wiki/PMID_\(identifier\)) [28406212](//pubmed.ncbi.nlm.nih.gov/28406212).
  109. ^ _**a**_ _**b**_ Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA (January 2002). ["Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC99152). _Nucleic Acids Research_. **30** (1): 52–5. [doi](/wiki/Doi_\(identifier\)):[10.1093/nar/30.1.52](https://doi.org/10.1093%2Fnar%2F30.1.52). [PMC](/wiki/PMC_\(identifier\)) [99152](//www.ncbi.nlm.nih.gov/pmc/articles/PMC99152). [PMID](/wiki/PMID_\(identifier\)) [11752252](//pubmed.ncbi.nlm.nih.gov/11752252).
  110. **^** Katsanis N (November 2016). ["The continuum of causality in human genetic disorders"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5114767). _Genome Biology_. **17** (1): 233. [doi](/wiki/Doi_\(identifier\)):[10.1186/s13059-016-1107-9](https://doi.org/10.1186%2Fs13059-016-1107-9). [PMC](/wiki/PMC_\(identifier\)) [5114767](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5114767). [PMID](/wiki/PMID_\(identifier\)) [27855690](//pubmed.ncbi.nlm.nih.gov/27855690).
  111. **^** Wong JC (2017). "Overview of the Clinical Utility of Next Generation Sequencing in Molecular Diagnoses of Human Genetic Disorders". In Wong LJ (ed.). _Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders_. Cham: Springer International Publishing. pp. 1–11. [doi](/wiki/Doi_\(identifier\)):[10.1007/978-3-319-56418-0_1](https://doi.org/10.1007%2F978-3-319-56418-0_1). [ISBN](/wiki/ISBN_\(identifier\)) [978-3-319-56416-6](/wiki/Special:BookSources/978-3-319-56416-6).
  112. **^** Fedick A, Zhang J (2017). "Next Generation of Carrier Screening". In Wong LJ (ed.). _Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders_. Cham: Springer International Publishing. pp. 339–354. [doi](/wiki/Doi_\(identifier\)):[10.1007/978-3-319-56418-0_16](https://doi.org/10.1007%2F978-3-319-56418-0_16). [ISBN](/wiki/ISBN_\(identifier\)) [978-3-319-56416-6](/wiki/Special:BookSources/978-3-319-56416-6).
  113. **^** Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, et al. (December 2002). ["Initial sequencing and comparative analysis of the mouse genome"](https://doi.org/10.1038%2Fnature01262). _Nature_. **420** (6915): 520–62. [Bibcode](/wiki/Bibcode_\(identifier\)):[2002Natur.420..520W](https://ui.adsabs.harvard.edu/abs/2002Natur.420..520W). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature01262](https://doi.org/10.1038%2Fnature01262). [PMID](/wiki/PMID_\(identifier\)) [12466850](//pubmed.ncbi.nlm.nih.gov/12466850). the proportion of small (50–100 bp) segments in the mammalian genome that is under (purifying) selection can be estimated to be about 5%. This proportion is much higher than can be explained by protein-coding sequences alone, implying that the genome contains many additional features (such as untranslated regions, regulatory elements, non-protein-coding genes, and chromosomal structural elements) under selection for biological function.
  114. **^** Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, et al. (June 2007). ["Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2212820). _Nature_. **447** (7146): 799–816. [Bibcode](/wiki/Bibcode_\(identifier\)):[2007Natur.447..799B](https://ui.adsabs.harvard.edu/abs/2007Natur.447..799B). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature05874](https://doi.org/10.1038%2Fnature05874). [PMC](/wiki/PMC_\(identifier\)) [2212820](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2212820). [PMID](/wiki/PMID_\(identifier\)) [17571346](//pubmed.ncbi.nlm.nih.gov/17571346).
  115. **^** The Chimpanzee Sequencing Analysis Consortium (September 2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](https://doi.org/10.1038%2Fnature04072). _Nature_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). We calculate the genome-wide nucleotide divergence between human and chimpanzee to be 1.23%, confirming recent results from more limited studies.
  116. **^** The Chimpanzee Sequencing Analysis Consortium (September 2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](https://doi.org/10.1038%2Fnature04072). _Nature_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). we estimate that polymorphism accounts for 14–22% of the observed divergence rate and thus that the fixed divergence is ~1.06% or less
  117. **^** Demuth JP, De Bie T, Stajich JE, Cristianini N, Hahn MW (2006). ["The evolution of mammalian gene families"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1762380). _PLOS ONE_. **1** (1): e85. [Bibcode](/wiki/Bibcode_\(identifier\)):[2006PLoSO...1...85D](https://ui.adsabs.harvard.edu/abs/2006PLoSO...1...85D). [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pone.0000085](https://doi.org/10.1371%2Fjournal.pone.0000085). [PMC](/wiki/PMC_\(identifier\)) [1762380](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1762380). [PMID](/wiki/PMID_\(identifier\)) [17183716](//pubmed.ncbi.nlm.nih.gov/17183716). Our results imply that humans and chimpanzees differ by at least 6% (1,418 of 22,000 genes) in their complement of genes, which stands in stark contrast to the oft-cited 1.5% difference between orthologous nucleotide sequences
  118. **^** The Chimpanzee Sequencing Analysis Consortium (September 2005). ["Initial sequence of the chimpanzee genome and comparison with the human genome"](https://doi.org/10.1038%2Fnature04072). _Nature_. **437** (7055): 69–87. [Bibcode](/wiki/Bibcode_\(identifier\)):[2005Natur.437...69.](https://ui.adsabs.harvard.edu/abs/2005Natur.437...69.). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature04072](https://doi.org/10.1038%2Fnature04072). [PMID](/wiki/PMID_\(identifier\)) [16136131](//pubmed.ncbi.nlm.nih.gov/16136131). Human chromosome 2 resulted from a fusion of two ancestral chromosomes that remained separate in the chimpanzee lineage  
Olson MV, Varki A (January 2003). "Sequencing the chimpanzee genome: insights
into human evolution and disease". _Nature Reviews Genetics_. **4** (1): 20–8.
[doi](/wiki/Doi_\(identifier\)):[10.1038/nrg981](https://doi.org/10.1038%2Fnrg
981). [PMID](/wiki/PMID_\(identifier\))
[12509750](//pubmed.ncbi.nlm.nih.gov/12509750).
[S2CID](/wiki/S2CID_\(identifier\))
[205486561](https://api.semanticscholar.org/CorpusID:205486561). Large-scale
sequencing of the chimpanzee genome is now imminent.

  119. **^** Gilad Y, Wiebe V, Przeworski M, Lancet D, Pääbo S (January 2004). ["Loss of olfactory receptor genes coincides with the acquisition of full trichromatic vision in primates"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC314465). _PLOS Biology_. **2** (1): E5. [doi](/wiki/Doi_\(identifier\)):[10.1371/journal.pbio.0020005](https://doi.org/10.1371%2Fjournal.pbio.0020005). [PMC](/wiki/PMC_\(identifier\)) [314465](//www.ncbi.nlm.nih.gov/pmc/articles/PMC314465). [PMID](/wiki/PMID_\(identifier\)) [14737185](//pubmed.ncbi.nlm.nih.gov/14737185). Our findings suggest that the deterioration of the olfactory repertoire occurred concomitant with the acquisition of full trichromatic color vision in primates.
  120. **^** [Zimmer C](/wiki/Carl_Zimmer) (21 September 2016). ["How We Got Here: DNA Points to a Single Migration From Africa"](https://www.nytimes.com/2016/09/22/science/ancient-dna-human-history.html). _[New York Times](/wiki/New_York_Times)_. Retrieved 22 September 2016.
  121. **^** Copeland WC (January 2012). ["Defects in mitochondrial DNA replication and human disease"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3244805). _Critical Reviews in Biochemistry and Molecular Biology_. **47** (1): 64–74. [doi](/wiki/Doi_\(identifier\)):[10.3109/10409238.2011.632763](https://doi.org/10.3109%2F10409238.2011.632763). [PMC](/wiki/PMC_\(identifier\)) [3244805](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3244805). [PMID](/wiki/PMID_\(identifier\)) [22176657](//pubmed.ncbi.nlm.nih.gov/22176657).
  122. **^** Nielsen R, Akey JM, Jakobsson M, Pritchard JK, Tishkoff S, Willerslev E (January 2017). ["Tracing the peopling of the world through genomics"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5772775). _Nature_. **541** (7637): 302–310. [Bibcode](/wiki/Bibcode_\(identifier\)):[2017Natur.541..302N](https://ui.adsabs.harvard.edu/abs/2017Natur.541..302N). [doi](/wiki/Doi_\(identifier\)):[10.1038/nature21347](https://doi.org/10.1038%2Fnature21347). [PMC](/wiki/PMC_\(identifier\)) [5772775](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5772775). [PMID](/wiki/PMID_\(identifier\)) [28102248](//pubmed.ncbi.nlm.nih.gov/28102248).
  123. **^** Sykes B (9 October 2003). ["Mitochondrial DNA and human history"](https://web.archive.org/web/20150907140051/http://genome.wellcome.ac.uk/doc_WTD020876.html). The Human Genome. Archived from [the original](http://genome.wellcome.ac.uk/doc_WTD020876.html) on 7 September 2015. Retrieved 19 September 2006.
  124. **^** Misteli T (February 2007). ["Beyond the sequence: cellular organization of genome function"](https://doi.org/10.1016%2Fj.cell.2007.01.028). _Cell_. **128** (4): 787–800. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.cell.2007.01.028](https://doi.org/10.1016%2Fj.cell.2007.01.028). [PMID](/wiki/PMID_\(identifier\)) [17320514](//pubmed.ncbi.nlm.nih.gov/17320514). [S2CID](/wiki/S2CID_\(identifier\)) [9064584](https://api.semanticscholar.org/CorpusID:9064584).
  125. **^** Bernstein BE, Meissner A, Lander ES (February 2007). ["The mammalian epigenome"](https://doi.org/10.1016%2Fj.cell.2007.01.033). _Cell_. **128** (4): 669–81. [doi](/wiki/Doi_\(identifier\)):[10.1016/j.cell.2007.01.033](https://doi.org/10.1016%2Fj.cell.2007.01.033). [PMID](/wiki/PMID_\(identifier\)) [17320505](//pubmed.ncbi.nlm.nih.gov/17320505). [S2CID](/wiki/S2CID_\(identifier\)) [2722988](https://api.semanticscholar.org/CorpusID:2722988).
  126. **^** Scheen AJ, Junien C (May–June 2012). "[Epigenetics, interface between environment and genes: role in complex diseases]". _Revue Médicale de Liège_. **67** (5–6): 250–7. [PMID](/wiki/PMID_\(identifier\)) [22891475](//pubmed.ncbi.nlm.nih.gov/22891475).

## External
links[[edit](/w/index.php?title=Human_genome&action=edit&section=28)]

![](//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg
/34px-Wikiquote-logo.svg.png)

Wikiquote has quotations related to: _**[Human
genome](https://en.wikiquote.org/wiki/Special:Search/Human_genome)**_

![](//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-
Commons-logo.svg.png)

Wikimedia Commons has media related to [Human
chromosomes](https://commons.wikimedia.org/wiki/Category:Human_chromosomes).

  * [Ensembl](http://www.ensembl.org/) The [Ensembl](/wiki/Ensembl) Genome Browser Project
  * [National Library of Medicine human genome viewer](https://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9606)
  * [UCSC Genome Browser](http://genome.ucsc.edu/).
  * [Human Genome Project](https://web.archive.org/web/20130102065343/http://www.ornl.gov/sci/techresources/Human_Genome/project/info.shtml).
  * [The National Human Genome Research Institute](http://www.genome.gov/)
  * [The National Office of Public Health Genomics](https://www.cdc.gov/genomics/default.htm)
  * [Simple Human Genome viewer](https://grrreggg.github.io/gene/)

  * [v](/wiki/Template:Chromosomes)
  * [t](/wiki/Template_talk:Chromosomes)
  * [e](https://en.wikipedia.org/w/index.php?title=Template:Chromosomes&action=edit)

Human genome

[Nuclear genome](/wiki/Nuclear_DNA)

[Autosome](/wiki/Autosome)

  * [1](/wiki/Chromosome_1)
  * [2](/wiki/Chromosome_2)
  * [3](/wiki/Chromosome_3)
  * [4](/wiki/Chromosome_4)
  * [5](/wiki/Chromosome_5)
  * [6](/wiki/Chromosome_6)
  * [7](/wiki/Chromosome_7)
  * [8](/wiki/Chromosome_8)
  * [9](/wiki/Chromosome_9)
  * [10](/wiki/Chromosome_10)
  * [11](/wiki/Chromosome_11)
  * [12](/wiki/Chromosome_12)
  * [13](/wiki/Chromosome_13)
  * [14](/wiki/Chromosome_14)
  * [15](/wiki/Chromosome_15)
  * [16](/wiki/Chromosome_16)
  * [17](/wiki/Chromosome_17)
  * [18](/wiki/Chromosome_18)
  * [19](/wiki/Chromosome_19)
  * [20](/wiki/Chromosome_20)
  * [21](/wiki/Chromosome_21)
  * [22](/wiki/Chromosome_22)

[Sex chromosome](/wiki/Allosome)

  * [X](/wiki/X_chromosome)
  * [Y](/wiki/Y_chromosome)

[Mitochondrial genome](/wiki/Mitochondrial_DNA)

[Human mitochondrial DNA](/wiki/Human_mitochondrial_genetics)

Related topics

  * Human genome
    * [Human Genome Project](/wiki/Human_Genome_Project)
  * [List of human genes](/wiki/List_of_human_genes)

  * [v](/wiki/Template:Human_genetics)
  * [t](/wiki/Template_talk:Human_genetics)
  * [e](https://en.wikipedia.org/w/index.php?title=Template:Human_genetics&action=edit)

[Human genetics](/wiki/Human_genetics)

Sub-topics

  * Human genome
    * [Human Genome Project](/wiki/Human_Genome_Project)
  * [Evolutionary genetics](/wiki/Human_evolutionary_genetics)
    * [Human-chimp MRCA](/wiki/Chimpanzee%E2%80%93human_last_common_ancestor)
    * [Neanderthal genetics](/wiki/Neanderthal_genetics)
      * [Neanderthal genome project](/wiki/Neanderthal_genome_project)
    * [Timeline](/wiki/Timeline_of_human_evolution)
  * [Genetic variation](/wiki/Human_genetic_variation)
    * [Blood type distribution by country](/wiki/Blood_type_distribution_by_country)
    * [Genealogical DNA test](/wiki/Genealogical_DNA_test)
    * [Genetic genealogy](/wiki/Genetic_genealogy)
    * [Race and genetics](/wiki/Race_and_genetics)
    * [Recent evolution](/wiki/Recent_human_evolution)
    * [Surname DNA project](/wiki/Surname_DNA_project)
  * [Genetic enhancement](/wiki/Human_genetic_enhancement)

[Genetic history](/wiki/Archaeogenetics)  
by region

  * [Sub-Saharan African](/wiki/Genetic_history_of_Sub-Saharan_Africa)
  * [South Asian](/wiki/Genetics_and_archaeogenetics_of_South_Asia)
  * [North African](/wiki/Genetic_history_of_North_Africa)
  * [Middle Eastern](/wiki/Genetic_history_of_the_Middle_East)
    * [Early Anatolian Farmers](/wiki/Early_Anatolian_Farmers)
  * [Caucasus](/wiki/Genetic_history_of_the_Caucasus)
    * [Caucasus hunter-gatherer](/wiki/Caucasus_hunter-gatherer)
  * [Europe](/wiki/Genetic_history_of_Europe)
    * [Western Hunter-Gatherer](/wiki/Western_Hunter-Gatherer)
    * [British Isles](/wiki/Genetic_history_of_the_British_Isles)
    * [Iberia](/wiki/Genetic_history_of_the_Iberian_Peninsula)
    * [Italy](/wiki/Genetic_history_of_Italy)
    * [Eastern Hunter-Gatherer](/wiki/Eastern_Hunter-Gatherer)
  * [Central Asian](/wiki/Genetic_history_of_Central_Asia)
    * [Ancient North Eurasian](/wiki/Ancient_North_Eurasian)
  * [East Asian](/wiki/Genetic_history_of_East_Asians)
  * [Southeast Asian](/wiki/Peopling_of_Southeast_Asia)
  * [American](/wiki/Genetic_history_of_indigenous_peoples_of_the_Americas)
    * [Ancient Beringian](/wiki/Ancient_Beringian)

[Population genetics](/wiki/Population_genetics)  
by group

  * Europe 
    * [Albanians](/wiki/Origin_of_the_Albanians#Genetic_studies)
    * [Basques](/wiki/Origin_of_the_Basques)
    * [Bosniaks](/wiki/Genetic_studies_on_Bosniaks)
    * [Bulgarians](/wiki/Genetic_studies_on_Bulgarians)
    * [Croats](/wiki/Genetic_studies_on_Croats)
    * [Romanians](/wiki/Genetic_studies_on_Romanians)
    * [Russians](/wiki/Genetic_studies_on_Russians)
    * [Sami](/wiki/Genetic_studies_on_Sami)
    * [Serbs](/wiki/Genetic_studies_on_Serbs)
  * [Azerbaijanis](/wiki/Origin_of_the_Azerbaijanis)
  * [Jews](/wiki/Genetic_studies_on_Jews)
  * [Turks](/wiki/Genetic_studies_on_Turkish_people)
  * MENA 
    * [Arabs](/wiki/Genetic_studies_on_Arabs)
    * [Egyptians](/wiki/DNA_history_of_Egypt)
    * [Moroccans](/wiki/Genetic_studies_on_Moroccans)
  * South Asia 
    * [Gujaratis](/wiki/Genetic_studies_on_Gujarati_people)
    * [Sinhalese](/wiki/Genetic_studies_on_Sinhalese)
    * [Tamils (Sri Lankan)](/wiki/Genetic_studies_on_Sri_Lankan_Tamils)
  * East Asia 
    * [Han Chinese](/wiki/Genetic_studies_on_Han_Chinese)
    * [Japanese](/wiki/Genetic_and_anthropometric_studies_on_Japanese_people)
  * Sub-Saharan Africa 
    * [Hutu/Tutsi](/wiki/Genetic_studies_on_Hutu_and_Tutsi)
    * [Khoisan](/wiki/Khoisan#Genetics)
    * [Pygmies](/wiki/African_Pygmies#Genetics)

  * ![Category](//upload.wikimedia.org/wikipedia/en/thumb/9/96/Symbol_category_class.svg/16px-Symbol_category_class.svg.png)**[Category](/wiki/Category:Human_genetics)**

[Authority control](/wiki/Help:Authority_control) ![Edit this at
Wikidata](//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-
ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)

National libraries

  * [Japan](https://id.ndl.go.jp/auth/ndlna/01009113)

Other

  * [Microsoft Academic](https://academic.microsoft.com/v2/detail/197077220)
    * [2](https://academic.microsoft.com/v2/detail/2909424303)

![](//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1)

Retrieved from "[https://en.wikipedia.org/w/index.php?title=Human_genome&oldid
=1042301099](https://en.wikipedia.org/w/index.php?title=Human_genome&oldid=104
2301099)"

[Categories](/wiki/Help:Category):

  * [Genetic mapping](/wiki/Category:Genetic_mapping)
  * [Genomics](/wiki/Category:Genomics)
  * [Human genetics](/wiki/Category:Human_genetics)
  * [Human evolution](/wiki/Category:Human_evolution)
  * [Chromosomes (human)](/wiki/Category:Chromosomes_\(human\))

Hidden categories:

  * [All articles with dead external links](/wiki/Category:All_articles_with_dead_external_links)
  * [Articles with dead external links from January 2020](/wiki/Category:Articles_with_dead_external_links_from_January_2020)
  * [Articles with permanently dead external links](/wiki/Category:Articles_with_permanently_dead_external_links)
  * [Articles with short description](/wiki/Category:Articles_with_short_description)
  * [Short description is different from Wikidata](/wiki/Category:Short_description_is_different_from_Wikidata)
  * [All articles with unsourced statements](/wiki/Category:All_articles_with_unsourced_statements)
  * [Articles with unsourced statements from January 2020](/wiki/Category:Articles_with_unsourced_statements_from_January_2020)
  * [Commons category link from Wikidata](/wiki/Category:Commons_category_link_from_Wikidata)
  * [Use dmy dates from August 2019](/wiki/Category:Use_dmy_dates_from_August_2019)
  * [Articles with NDL identifiers](/wiki/Category:Articles_with_NDL_identifiers)
  * [Articles with MA identifiers](/wiki/Category:Articles_with_MA_identifiers)
  * [Articles with multiple identifiers](/wiki/Category:Articles_with_multiple_identifiers)

## Navigation menu

### Personal tools

  * Not logged in
  * [Talk](/wiki/Special:MyTalk)
  * [Contributions](/wiki/Special:MyContributions)
  * [Create account](/w/index.php?title=Special:CreateAccount&returnto=Human+genome)
  * [Log in](/w/index.php?title=Special:UserLogin&returnto=Human+genome)

### Namespaces

  * [Article](/wiki/Human_genome)
  * [Talk](/wiki/Talk:Human_genome)

### Variants

### Views

  * [Read](/wiki/Human_genome)
  * [Edit](/w/index.php?title=Human_genome&action=edit)
  * [View history](/w/index.php?title=Human_genome&action=history)

### More

###  Search

### Navigation

  * [Main page](/wiki/Main_Page)
  * [Contents](/wiki/Wikipedia:Contents)
  * [Current events](/wiki/Portal:Current_events)
  * [Random article](/wiki/Special:Random)
  * [About Wikipedia](/wiki/Wikipedia:About)
  * [Contact us](//en.wikipedia.org/wiki/Wikipedia:Contact_us)
  * [Donate](https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en)

### Contribute

  * [Help](/wiki/Help:Contents)
  * [Learn to edit](/wiki/Help:Introduction)
  * [Community portal](/wiki/Wikipedia:Community_portal)
  * [Recent changes](/wiki/Special:RecentChanges)
  * [Upload file](/wiki/Wikipedia:File_Upload_Wizard)

### Tools

  * [What links here](/wiki/Special:WhatLinksHere/Human_genome)
  * [Related changes](/wiki/Special:RecentChangesLinked/Human_genome)
  * [Upload file](/wiki/Wikipedia:File_Upload_Wizard)
  * [Special pages](/wiki/Special:SpecialPages)
  * [Permanent link](/w/index.php?title=Human_genome&oldid=1042301099)
  * [Page information](/w/index.php?title=Human_genome&action=info)
  * [Cite this page](/w/index.php?title=Special:CiteThisPage&page=Human_genome&id=1042301099&wpFormIdentifier=titleform)
  * [Wikidata item](https://www.wikidata.org/wiki/Special:EntityPage/Q720988)

### Print/export

  * [Download as PDF](/w/index.php?title=Special:DownloadAsPdf&page=Human_genome&action=show-download-screen)
  * [Printable version](/w/index.php?title=Human_genome&printable=yes)

### In other projects

  * [Wikimedia Commons](https://commons.wikimedia.org/wiki/Category:Human_genome)
  * [Wikiquote](https://en.wikiquote.org/wiki/Human_genome)

### Languages

  * [العربية](https://ar.wikipedia.org/wiki/%D8%AC%D9%8A%D9%86%D9%88%D9%85_%D8%A8%D8%B4%D8%B1%D9%8A)
  * [Asturianu](https://ast.wikipedia.org/wiki/Xenoma_humanu)
  * [বাংলা](https://bn.wikipedia.org/wiki/%E0%A6%AE%E0%A6%A8%E0%A7%81%E0%A6%B7%E0%A7%8D%E0%A6%AF_%E0%A6%9C%E0%A6%BF%E0%A6%A8%E0%A6%B8%E0%A6%AE%E0%A6%B7%E0%A7%8D%E0%A6%9F%E0%A6%BF)
  * [Български](https://bg.wikipedia.org/wiki/%D0%A7%D0%BE%D0%B2%D0%B5%D1%88%D0%BA%D0%B8_%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC)
  * [Bosanski](https://bs.wikipedia.org/wiki/Ljudski_genom)
  * [Català](https://ca.wikipedia.org/wiki/Genoma_hum%C3%A0)
  * [Чӑвашла](https://cv.wikipedia.org/wiki/%C3%87%D1%8B%D0%BD_%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC%C4%95)
  * [Čeština](https://cs.wikipedia.org/wiki/Lidsk%C3%BD_genom)
  * [Cymraeg](https://cy.wikipedia.org/wiki/Y_Genom_Dynol)
  * [Eesti](https://et.wikipedia.org/wiki/Inimese_genoom)
  * [Ελληνικά](https://el.wikipedia.org/wiki/%CE%91%CE%BD%CE%B8%CF%81%CF%8E%CF%80%CE%B9%CE%BD%CE%BF_%CE%B3%CE%BF%CE%BD%CE%B9%CE%B4%CE%AF%CF%89%CE%BC%CE%B1)
  * [Español](https://es.wikipedia.org/wiki/Genoma_humano)
  * [Euskara](https://eu.wikipedia.org/wiki/Giza_genoma)
  * [فارسی](https://fa.wikipedia.org/wiki/%DA%98%D9%86%D9%88%D9%85_%D8%A7%D9%86%D8%B3%D8%A7%D9%86)
  * [Gaeilge](https://ga.wikipedia.org/wiki/G%C3%A9an%C3%B3m_daonna)
  * [Galego](https://gl.wikipedia.org/wiki/Xenoma_humano)
  * [한국어](https://ko.wikipedia.org/wiki/%EC%9D%B8%EA%B0%84_%EC%9C%A0%EC%A0%84%EC%B2%B4)
  * [Hrvatski](https://hr.wikipedia.org/wiki/Ljudski_genom)
  * [Bahasa Indonesia](https://id.wikipedia.org/wiki/Genom_manusia)
  * [Italiano](https://it.wikipedia.org/wiki/Genoma_umano)
  * [עברית](https://he.wikipedia.org/wiki/%D7%92%D7%A0%D7%95%D7%9D_%D7%94%D7%90%D7%93%D7%9D)
  * [Kreyòl ayisyen](https://ht.wikipedia.org/wiki/Jen%C3%B2m_imen)
  * [Magyar](https://hu.wikipedia.org/wiki/Hum%C3%A1n_genom)
  * [日本語](https://ja.wikipedia.org/wiki/%E3%83%92%E3%83%88%E3%82%B2%E3%83%8E%E3%83%A0)
  * [Polski](https://pl.wikipedia.org/wiki/Genom_cz%C5%82owieka)
  * [Português](https://pt.wikipedia.org/wiki/Genoma_humano)
  * [Română](https://ro.wikipedia.org/wiki/Genomul_uman)
  * [Русский](https://ru.wikipedia.org/wiki/%D0%93%D0%B5%D0%BD%D0%BE%D0%BC_%D1%87%D0%B5%D0%BB%D0%BE%D0%B2%D0%B5%D0%BA%D0%B0)
  * [Simple English](https://simple.wikipedia.org/wiki/Human_genome)
  * [Српски / srpski](https://sr.wikipedia.org/wiki/%D0%A5%D1%83%D0%BC%D0%B0%D0%BD%D0%B8_%D0%B3%D0%B5%D0%BD%D0%BE%D0%BC)
  * [Srpskohrvatski / српскохрватски](https://sh.wikipedia.org/wiki/Ljudski_genom)
  * [Suomi](https://fi.wikipedia.org/wiki/Ihmisen_perim%C3%A4)
  * [Tagalog](https://tl.wikipedia.org/wiki/Genome_ng_tao)
  * [தமிழ்](https://ta.wikipedia.org/wiki/%E0%AE%AE%E0%AE%A9%E0%AE%BF%E0%AE%A4_%E0%AE%AE%E0%AE%B0%E0%AE%AA%E0%AE%A3%E0%AF%81%E0%AE%A4%E0%AF%8D%E0%AE%A4%E0%AF%8A%E0%AE%95%E0%AF%88)
  * [ไทย](https://th.wikipedia.org/wiki/%E0%B8%88%E0%B8%B5%E0%B9%82%E0%B8%99%E0%B8%A1%E0%B8%A1%E0%B8%99%E0%B8%B8%E0%B8%A9%E0%B8%A2%E0%B9%8C)
  * [Türkçe](https://tr.wikipedia.org/wiki/%C4%B0nsan_genomu)
  * [Українська](https://uk.wikipedia.org/wiki/%D0%93%D0%B5%D0%BD%D0%BE%D0%BC_%D0%BB%D1%8E%D0%B4%D0%B8%D0%BD%D0%B8)
  * [Tiếng Việt](https://vi.wikipedia.org/wiki/B%E1%BB%99_gen_ng%C6%B0%E1%BB%9Di)
  * [Zazaki](https://diq.wikipedia.org/wiki/C%C3%AAnom%C3%AA_merdumi)
  * [中文](https://zh.wikipedia.org/wiki/%E4%BA%BA%E9%A1%9E%E5%9F%BA%E5%9B%A0%E7%B5%84)

[Edit links](https://www.wikidata.org/wiki/Special:EntityPage/Q720988
#sitelinks-wikipedia)

  * This page was last edited on 4 September 2021, at 07:40 (UTC).
  * Text is available under the [Creative Commons Attribution-ShareAlike License](//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License); additional terms may apply. By using this site, you agree to the [Terms of Use](//foundation.wikimedia.org/wiki/Terms_of_Use) and [Privacy Policy](//foundation.wikimedia.org/wiki/Privacy_policy). Wikipedia® is a registered trademark of the [Wikimedia Foundation, Inc.](//www.wikimediafoundation.org/), a non-profit organization.
  * [Privacy policy](https://foundation.wikimedia.org/wiki/Privacy_policy)
  * [About Wikipedia](/wiki/Wikipedia:About)
  * [Disclaimers](/wiki/Wikipedia:General_disclaimer)
  * [Contact Wikipedia](//en.wikipedia.org/wiki/Wikipedia:Contact_us)
  * [Mobile view](//en.m.wikipedia.org/w/index.php?title=Human_genome&mobileaction=toggle_view_mobile)
  * [Developers](https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute)
  * [Statistics](https://stats.wikimedia.org/#/en.wikipedia.org)
  * [Cookie statement](https://foundation.wikimedia.org/wiki/Cookie_statement)
  * ![Wikimedia Foundation](/static/images/footer/wikimedia-button.png)
  * ![Powered by MediaWiki](/static/images/footer/poweredby_mediawiki_88x31.png)
  *[[v]: View this template
  *[[e]: Edit this template
  *[[t]: Discuss this template

